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Abstract 
 
Fumonisins are carcinogenic mycotoxins which occur world-wide in maize and 
maize-based products intended for human consumption. Consumption of fumonisin-
contaminated maize as a staple diet has been associated with oesophageal and liver 
cancer incidence as well as neural tube defects. This study has confirmed the State 
of Santa Catarina, Brazil as another region where the consumption of maize 
contaminated with fumonisins and high oesophageal cancer incidence co-occur. 
Since fumonisins exert their main biochemical effect by disruption of the sphingolipid 
biosynthetic pathway and are implicated in cancer, the role of fumonisin B1 (FB1) in 
FB1–induced rat hepatocyte nodules was investigated. The current study showed 
that FB1 exposure activated sphingosine accumulation in the nodules which could 
induce the bio-active sphingosine 1-phosphate to provide a selective growth stimulus 
on subsequent FB1 exposure. Since the FB1-induced hepatocyte nodules were not 
resistant to the disruption of sphingolipid biosynthesis, it was not the mechanism 
whereby the altered hepatocytes escaped the mitoinhibition of FB1 and selectively 
proliferated into hepatocyte nodules. A study in maize subsistence farming 
communities investigated the sphingosine and sphinganine levels in blood and urine 
of participants. Fumonisin exposure was assessed in these communities based on 
fumonisin levels in maize that was concurrently collected from the areas where the 
participants resided. Subsequently fumonisin exposure was assessed in individuals 
based on the fumonisin levels in maize collected from each household and by 
acquiring weighed food records for each member of the household. It was confirmed 
in both these studies that communities are chronically exposed to fumonisin levels 
well above the provisional maximum tolerable daily intake determined by the Joint 
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FAO/WHO Expert Committee on Food Additives. Since the sphinganine and 
sphingosine levels in blood and urine of the participants exposed to various levels of 
fumonisin were not significantly different, the sphingoid bases and their ratios could 
not be established as a biomarker of fumonisin exposure. Therefore, an alternative 
biomarker of exposure was investigated during studies into a practical cost effective 
method to reduce fumonisin. The customary maize food preparation practices were 
assessed in a maize subsistence farming community and subsequently optimised to 
reduce the fumonisin levels in the maize under laboratory-controlled conditions. 
Implementation of this optimised and culturally acceptable intervention method of 
sorting and washing maize in a rural community reduced fumonisin contamination in 
home-grown maize by 84%. The intervention study attained a 62% reduction in 
fumonisin exposure based on fumonisin levels in maize-based food and 
consumption as assessed by 24-h dietary recall questionnaires. The alternative 
biomarker of fumonisin exposure, urinary FB1, was investigated during the 
intervention study. The FB1 urinary biomarker measured fumonisin intake at the 
individual level and confirmed the reduction achieved as assessed by food analysis 
and food intake data. The biomarker was thus well correlated with fumonisin 
exposure and confirmed the efficacy of the simple and culturally acceptable 
intervention method. Utilisation of the urinary FB1 biomarker and the customised 
hand-sorting and washing of maize to reduce fumonisin exposures has the potential 
to improve food safety and health in subsistence maize farming communities. 
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Opsomming 
 
Fumonisien is kankerverwekkende mikotoksiene wat wêreldwyd voorkom op mielies 
en mielie-verwante produkte bestem vir menslike verbruik. Daar is ‘n verband tussen 
die voorkoms van slukderm en lewer kanker, sowel as neuraalbuisdefekte, in 
gemeenskappe waar fumonisien-gekontamineerde mielies die stapel voedsel is. Die 
Brasiliaanse Staat, Santa Catarina is uitgewys as nog 'n area waar hoë voorkoms 
van slukdermkanker en hoë fumonisin vlakke in mielies gesamentlik voorkom. 
Aangesien fumonisien verbind word met van kanker en die hoof biochemiese effek 
die ontwrigting van die sfingolipiedbiosintese weg is, is die rol van fumonisien B1 
(FB1) in FB1-geinduseerde rot hepatosietnodules ondersoek. Die studie het getoon 
dat FB1 blootstelling aktiveer sfingosien ophoping in die hepatosietnodules wat 
moontlik die bio-aktiewe sfingosien 1-fosfaat aktiveer om op daaropvolgende FB1 
blootstellings geselekteerde groei stimulasie te ondergaan. Die FB1-geïnduseerde 
hepatosietnodules was nie bestand teen die inhibisie van die sfingolipied biosintese 
nie en dus nie die meganisme waardeur die veranderde hepatosiete mito- inhibisie 
van FB1 vryspring, en selektief ontwikkel in hepatosietnodules nie. ‘n Studie in 
bestaansboerdery gemeenskappe het die sfingosien en sfinganien vlakke in bloed 
en uriene vergelyk met individuele fumonisien blootstelling. Laasgenoemde is 
gebaseer op fumonisien vlakke in gekolleekterde mielies vanuit die deelnemers se 
huise en aannames vanuit die literatuur. Die opvolg studie in die areas het 
individuele fumonisien blootstelling bepaal gebaseer op fumonisien vlakke in die 
mielies van elke huishouding en die inname van mielies deur die voedsel van elke 
individu te weeg. Albei hierdie studies het bevestig dat die gemeenskappe 
blootgestel is aan kroniese fumonisien vlakke wat die maksimum toelaatbare 
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daaglikse inname wat deur die gesamentlike FAO/WHO deskundige komitee op 
voedsel toevoegsels vasgestel is, oorskei. Aangesien die sfingosien en sfinganien 
vlakke nie beduidend verskil in bloed of uriene van mense wat aan verskillende 
fumonisien-kontaminasie vlakke blootgestel is nie, kan die lipiedbasisse en hul 
verhouding nie as ‘n biologiese merker vir fumonisien blootstelling bevestig word nie. 
Dus is ‘n alternatiewe biologiese merker vir fumonisien blootstelling ondersoek 
gedurende ‘n studie oor praktiese bekostigbare maniere om fumonisin blootstelling 
te verlaag. Die tradisionele voedsel voorbereidingspraktyke in ‘n bestaansboerdery 
gemeenskap is bestudeer en onder laboratorium-gekontroleerde toestande 
aangepas om fumonisien vlakke in die mielies optimaal te verlaag. Die kultureel 
aanvaarbare intervensie metode, sortering en was van die mielies, is in ‘n 
bestaansboerdery gemeenskap toegepas waar ‘n 84% verlaging in fumonisien 
vlakke van die mielies verkry is. Die intervensie metode het ‘n 62% verlaging in 
fumonisien blootstelling te weeggebring deur fumonisien vlakke in die mielie-
gebasserde disse te meet en inname daarvan deur die deelnemers met 24-h 
diëetkundige vraelyste vas t e stel. Gedurende die intervensie studie is urienêre FB1, 
die alternatiwe biologiese merker van fumonisien blootstelling, ondersoek. 
Individuele fumonisien blootstelling data, bepaal met die urienêre FB1 biomerker, het 
goed ooreengestem met die voedsel analise en voedsel inname data en het dus die 
doeltreffendheid van die praktiese kultuur aanvaarbare intervensie metode bevestig. 
Benutting van die FB1 urienêre biologies merker en die optimale sortering en was 
van die mielies om die fumonisien blootstelling te verlaag het die potensiaal om 
voedselveiligheid en gesondheid in hierdie bestaansboerdery gemeenskappe 
aansienlik te verbeter. 
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Introduction 
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Objectives of study 
 The investigation of fumonisin levels in maize from rural communities with a 
high prevalence of oesophageal cancer.  
 The mechanism of fumonisin inhibition of the sphingoid bases in rat liver 
nodules. 
 The effect of fumonisin on sphingoid bases in blood and urine of communities, 
as well as individuals in communities, consuming subsistence grown maize.  
 The evaluation of an optimized culturally acceptable method to reduce 
fumonisin contamination in subsistence grown maize by means of an 
intervention study in a rural community. 
 Validation of a urinary biomarker for FB1 exposure. 
 
Fumonisins, carcinogenic mycotoxins, produced predominantly by Fusarium 
verticillioides, occur widely around the world on maize (Zea mays) (Marasas 2001). 
The major naturally occurring fumonisin analogues in maize and maize-based 
products intended for human consumption are fumonisin B1 (FB1), B2 (FB2) and B3 
(FB3) (Shephard et al., 1996). The contamination of maize with fumonisins is of 
concern as these mycotoxins cause various animal diseases and occur in maize and 
maize-based products intended for human consumption (Shephard et al., 1996). In 
addition, high levels of fumonisins have been found in naturally contaminated maize 
from areas where high incidences of oesophageal cancer occur, e.g., Centane 
District, Transkei region of South Africa; Cixian County, Hebei Province, China; and 
Mazandaran Province, Iran (Chu and Li 1994; Rheeder et al, 1992; Shephard et al., 
2000; 2002). Based on current data, the International Agency for Research on 
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Cancer has classified FB1 to be possibly carcinogenic to humans (group 2B 
carcinogen) (IARC, 2002).  
 
The situation in southern Brazil is similar to other regions in the world where high 
oesophageal cancer incidence and high maize consumption co-occur. Brazil is the 
third largest producer of maize in the world, of which the southern region is the 
highest producer and consumer of maize-based products. A considerable portion of 
this maize crop is produced by small farmers and nearly 25% of the harvest is 
consumed on these farms. Santa Catarina, Paraná and Rio Grande do Sul States, 
southern Brazil, have the highest incidences of oesophageal cancer in the country. 
As fumonisin data in the State of Santa Catarina have not been previously reported, 
fumonisin levels and Fusarium verticillioides contamination of maize collected from 
different regions in this state were investigated in this study.  
 
Fumonisins exert their main biochemical effect by inhibiting ceramide synthase, a 
key enzyme in the de novo sphingolipid biosynthetic pathway, preventing the 
conversion of sphinganine to dihydroceramide and the reacylation of sphingosine to 
ceramide (Riley et al., 1994; Wang et al., 1991). The disruption of the sphingolipid 
biosynthetic pathway elevates the levels of the sphingoid bases and their 1-
phosphates and decreases ceramide and more complex sphingolipids, such as 
sphingomyelin and gangliosides, and their intermediates (Riley et al., 2001; Merrill et 
al., 2001). Sphingolipids are predominantly found in cellular membranes and are 
critical for the maintenance of the membrane structure, while complex sphingolipids 
function as precursors for second messengers and are important in sustaining 
cellular growth and differentiation (Merrill et al., 2001).  
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FB1 inhibits cell proliferation in various cell culture systems as well as in rat liver and 
kidney (Gelderblom et al., 1996; Riley et al., 2001; Yoo et al., 1992). FB1-induced 
disruption of sphingolipid biosynthesis can either induce or prevent apoptosis, 
depending on the cell type and the relative amounts of the bio-active sphingolipid 
molecules generated (Desai et al., 2002; Tolleson et al., 1996). In rat liver a 
carcinogen dose above the initiation threshold induces the appearance of altered 
hepatocytes which are resistant to the inhibition of proliferation (Solt et al., 1980). 
These resistant hepatocytes escaped the mitoinhibitory effects of FB1 on normal 
hepatocyte growth and selectively proliferate into hepatocyte nodules (Gelderblom et 
al., 1995; 2001). The exact mechanism involved in the selection of initiated cells by 
FB1 is unknown.  
 
An investigation to determine whether hepatocyte nodules are resistant to the 
inhibitory effect of FB1 on ceramide synthase was conducted in rats. A further aim 
was to determine if the resistant hepatocyte nodules would proliferate to a greater 
extent than normal hepatocytes, which could selectively stimulate their outgrowth. 
Male Fischer 344 rats were subjected to cancer initiation (FB1 containing diet or 
diethylnitrosamine by intraperitoneal injection) and promotion (2-acetylaminofluorene 
with partial hepatectomy) treatments followed by a secondary FB1 dietary regimen. 
Sphinganine and sphingosine levels were determined in control, surrounding and 
nodular liver tissues of the rats. 
 
The inhibition of ceramide synthase by fumonisin causes sphinganine and 
sphingosine to a lesser extent, to increase (Riley et al., 2001; Merrill et al., 2001). 
The resultant increase in the sphinganine/sphingosine ratio occurs prior to changes 
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in other biochemical markers of cellular injury, and has thus been proposed as a 
biomarker of fumonisin exposure (Riley et al., 1994). Various animal studies have 
successfully investigated the sphinganine/ sphingosine ratio as a biomarker of 
fumonisin exposure in serum, urine, liver, kidney and other tissues (Cai et al. 2007; 
Castegnaro et al., 1996; Riley et al., 1994; Van der Westhuizen et al. 2001; Howard 
et al., 2001; Wang et al., 1992). Sphinganine and sphingosine, as well as their ratio, 
have also been investigated in several human studies in blood and urine, but could 
not be correlated with fumonisin exposure (Castegnaro et al., 1998; Solfrizzo et al. 
2004, Van der Westhuizen et al. 1999; Qiu and Liu 2001). 
 
Since further evidence was required to utilise the sphinganine/sphingosine ratio as a 
biomarker of fumonisin exposure in humans, a cross sectional study was undertaken 
in a high (Centane district) and low (Bizana district) oesophageal cancer prevalence 
area in the former Transkei region of the Eastern Cape Province of South Africa. The 
rural farmers from these areas consume fumonisin-contaminated maize as a staple 
diet. Blood and urine samples were collected from male and female volunteers 
residing in the same areas from which the maize samples were collected. The aim 
was to compare the sphinganine and sphingosine levels, as well as their ratio, in 
plasma and urine of participants between the two areas with the contamination level 
of the maize they consumed collected contemporaneously from these areas. 
 
A further study on the possible applicability of the sphinganine/sphingosine ratio was 
conducted by measuring individual fumonisin exposure. This assessment of the 
sphinganine/sphingosine ratio as biomarker of fumonisin exposure in humans, 
required in addition to the sphinganine and sphingosine levels in blood and/or urine, 
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the fumonisin levels in the maize and porridge consumed as well as the amount 
consumed on an individual basis to be determined. This study was conducted in the 
Centane and Bizana districts of the former Transkei over three consecutive years. 
Blood and urine samples were collected from male and female participants who 
donated their maize and maize-based food prepared on the day of collection. 
Correlation between fumonisin exposure and the sphinganine/ sphingosine ratio 
would confirm the sphinganine/sphingosine ratio as a biomarker of fumonisin 
exposure. 
 
In developed countries maize forms a minor part of the diet, whereas in rural 
communities in South Africa, maize consumption can be as high as 460 g per person 
per day (Marasas, 2001). Furthermore, subsistence farming communities that 
consume maize as a staple diet can be exposed to total fumonisin levels of up to 
13.8 g/kg body weight/day. This is of concern as the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) has determined a group provisional 
maximum tolerable daily intake (PMTDI) for fumonisin B1, B2 and B3, alone or in 
combination, of 2 µg/kg body weight/day (Bolger et al., 2001). Reduction of 
mycotoxin exposure and related adverse health effects in these communities can 
realistically be based on practical low-cost measures only. It needs to be 
investigated whether a measurable reduction of exposure can be achieved on a 
practical level in maize subsistence communities. 
 
The traditional maize food preparations in the communities of the Centane 
magisterial district, South Africa, includes the sorting of maize on the cob (ear) into 
visibly healthy (good) and visibly fungal infected (mouldy) maize. However, the 
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resulting good maize can still contain high levels of fumonisin and consumption of 
this good maize can result in exposures above the PMTDI (Bolger et al., 2001; 
Kimanya et al., 2008; Shephard et al., 2005; Van der Westhuizen et al., 2008). 
Therefore the customary maize food preparation practices were assessed and 
subsequently optimised to reduce the fumonisin levels in the maize under laboratory-
controlled conditions. The ultimate goal was to be able to recommend a means of 
fumonisin reduction, which would be both culturally acceptable and practically 
implementable, in the subsistence farming communities. This simple method of 
sorting maize by removal of the infected/damaged kernels and the subsequent 
washing of the good maize kernels effectively reduced fumonisin contamination of 
home-grown maize. 
 
Although previous studies achieved reduction of fumonisin in maize by different food 
preparation procedures, agricultural practices, sorting, mechanical shelling and 
dehulling, no intervention was implemented (Afolabi et al. 2006; Fandohan et al. 
2005; 2006; Kimanya et al. 2009). This study implemented and evaluated the 
effectiveness of the simple and culturally acceptable intervention method, optimised 
under laboratory-controlled conditions, to reduce fumonisin exposure in a maize 
subsistence community. At the baseline phase of the study, participants consumed 
their customarily prepared porridge twice daily for two consecutive days. They 
donated a portion of their porridge for fumonisin analyses and completed 24-hour 
dietary recall questionnaires on the following day. Home-grown maize samples were 
collected, subsamples were retained for fumonisin analyses, and the remaining 
maize was pooled, thoroughly mixed and divided into batches. During the 
intervention phase of the study, participants were trained to apply hand-sorting to the 
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batches by identifying the infected maize kernels to ensure proper selection for 
removal and to follow the correct washing procedure. Porridge was prepared from 
the sorted and washed maize and consumed by the participants twice daily for two 
consecutive days. The two-step method to reduce fumonisin exposure was 
evaluated by comparing fumonisin levels in maize and porridge at baseline with the 
levels following intervention. 
 
The heterogeneous nature of maize contamination means that neither food analysis 
nor dietary questionnaires alone provide reliable measures of exposure. The simple 
intervention method reduced fumonisin exposure as assessed by food intake and 
fumonisin food analysis in a subsistence maize farming community. This part of the 
study validated the urinary FB1 biomarker and confirmed the reduction in fumonisin 
exposure at an individual level. Morning first void urine samples were collected from 
each participant in the above intervention study on the subsequent days following 
the consumption of the porridge meals. Urinary FB1 levels were determined by a 
newly developed LC-MS method. Fumonisin exposure based on fumonisin levels in 
the porridge and the amount consumed were compared with the urinary FB1 levels at 
baseline and intervention.  
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1. Introduction to fumonisins 
 
Fumonisins are secondary metabolites produced predominantly by Fusarium 
verticillioides (Sacc.) Nirenberg (formerly known as F. moniliforme Sheldon) and F. 
proliferatum (Matsushima) Nirenberg (Marasas, 2001). These mycotoxins occur 
widely around the world in maize (Zea mays L.) and maize-based products intended 
for human consumption (Shephard et al., 1996a). At least 28 fumonisin analogues 
have been described and categorised into A, B, C, and P series (Rheeder et al., 
2002). Fumonisin B1, B2 and B3 (FB1, FB2 and FB3) are the most abundant naturally 
occurring fumonisins (Figure 1) of which FB1 is the most significant analogue usually 
dominating at > 70% of the total fumonisins (FB1 + FB2 + FB3) detected in natural 
maize samples (Shephard et al. 1996, Rheeder et al., 2002). The other fumonisin 
series differ from the FB series in that the FA series are acetylated on the amino 
group at the C-2 position whereas the FB series have a free amine; the FC series 


lack the methyl group at the C-1 position and the FP series have a 3-
hydroxypyridinium functional group at the C-2 position (Bezuidenhout et al., 1988; 
Plattner et al., 1992; Musser et al., 1996). 
 

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Fumonisins are not mutagenic nor genotoxic in primary rat hepatocytes (Norred et 
al., 1992). However FB1 exhibits clastogenesis (Ehrlich et al., 2002; Gelderblom et 
al., 1991; Knasmuller et al., 1997; Mobio et al., 2000) and epigenetic properties in 
cell cultures. Fumonisins cause various distinct syndromes in different animals, such 
as leukoencephalomalacia in horses, pulmonary oedema in pigs and neural tube 
defects in mice (Kellerman et al., 1990; Harrison et al., 1990; Gelineau-van Waes et 
al., 2005). In addition, FB1 is hepatocarcinogenic in male BD IX rats and in B6C3F1 
female mice and nephrocarcinogenic in male Fischer 344 rats (Gelderblom et al., 
2001; Howard et al., 2001).  

 
High levels of fumonisins have been reported in naturally contaminated maize from 
areas where high incidences of oesophageal cancer occur, viz., Centane magisterial 
district, Eastern Cape Province, South Africa; South Carolina, USA; Cixian County of 
Hebei Province and Linxian County of Henan Province, China, Northern Italy ,and 
Mazandaran and Isfahan Provinces, Iran (Chu and Li 1994; Doko and Visconti, 
1994; Shephard et al., 2000; 2002a; Sydenham et al., 1991; Wang et al., 2000; 
Yoshizawa et al., 1994; Zhang et al., 1997). Fumonisins have also been associated 
with primary liver cancer in Haimen, Jiangsu Province, China (Ueno et al., 1997). 
Based on the available data, the International Agency for Research on Cancer has 
classified FB1 to be “possibly carcinogenic to humans” (group 2B carcinogen) (IARC, 
2002). In addition, the consumption of fumonisin contaminated maize has been 
reported as one of the risk factors for human neural tube defects (NTD) (Marasas et 
al., 2004). The co-occurrence of high NTD incidence and consumption of fumonisin 
contaminated maize has also been reported in various areas, i.e. the Eastern Cape 
Province of South Africa; the Northern provinces of China and along the Texas-
Mexico border in Northern America (Marasas et al., 2004; Missmer et al., 2006).  
 
 
2. Oesophageal cancer in the Eastern Cape Province of South Africa 
 
The former Transkei region, Eastern Cape Province, South Africa, is one of the 
areas with the highest incidence rates of oesophageal cancer in the world (Makaula 
et al., 1996; Rose, 1973; Somdyala et al. 2003a; 2003b). Population-based cancer 
registry studies have shown that the mean age-standardized incidence rate (ASIR)  

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Chapter 2 - Figure 2: This map highlights the south eastern (Centane) and north 
eastern (Bizana) magisterial areas of the former Transkei 
region, Eastern Cape Province. 
 
for oesophageal cancer were consistently higher in males than females and in the 
Centane (south eastern) than in the Bizana (north eastern) magisterial district 
(Figure 2). Earlier studies in the region reported 20-fold higher oesophageal cancer 
rates in Centane than in Bizana (Rheeder et al., 1992). Even though more recent 
studies have shown a rising incidence rate in Bizana, Centane has maintained 
consistently higher oesophageal cancer incidence rates (Makaula et al., 1996; 
Somdyala et al., 2003a; 2003b). The ASIRs reported recently for men and women of 
32.7 and 20.1, respectively, in 8 magisterial districts of the former Transkei region for 
the period 1998-2002 (Somdyala et al., 2010) were similar to the ASIR for Bizana for 
the period 1996-2000 (Somdyala et al., 2003b) (Table 1). 

Chapter 2 - Table 1 Oesophageal cancer incidence rates (ASIR) in two 
magisterial districts in the former Transkei region. 
 ASIR* 
 High incidence of OC Low incidence of OC 
 Centane Bizana 
Period Males Females Males Females 
1955–1959a 54.2 30.3 2.6 1.8 
1965–1969b 39.7 16.1 10.5 4.4 
1981–1984b 45.0 23.3 19.5 15.0 
1985–1990b 55.6 22.1 37.0 11.7 
1991–1995c 89.2 32.0 22.8 16.6 
1996–2000d 44.8 32.6 31.0 22.7 
*ASIR = Age standardized incidence rate/100,000/annum 
aData from Rose et al. 1973 
bData from Makaula et al. 1996 
cData from Somdyala et al. 2003a 
dData from Somdyala et al. 2003b 
 
 
Chapter 2 - Table 2 Mean total fumonisin levels in maize intended for human 
consumption from Centane and Bizana.
Centane Bizana 
Season n 
Fumonisins 
(mg/kg) n 
Fumonisins 
(mg/kg) 
1985a 12 2.10 (nd–7.90) 12 0.083 (nd–0.55) 
1989a 6 1.63 (nd–6.70) 8 0.47 (nd–4.28) 
2003b 21 2.18 (nd–8.38) 36 0.36 (nd–6.64) 
     
Values are means (range) or means ± standard deviation 
nd = not detected, < 0.05 mg/kg 
aRheeder et al., 1992 
bRheeder unpublished data 
 
The first study to compare fumonisin levels in home-grown maize in the former 
Transkei region reported 25-fold higher contamination levels in Centane than in 

Bizana (Rheeder et al., 1992) (Table 2). The published studies at that time reported 
mean oesophageal cancer ASIRs of 20- and 4-fold higher for males and females 
combined in Centane than in Bizana (Rose, 1973, Rose and Fellingham, 1981). 
These comparatively high and low oesophageal cancer incidence rates in Centane 
and Bizana, respectively, corresponded with high and low levels of fumonisins in the 
home-grown maize from these areas (Rheeder et al., 1992; Marasas, 2001). 
 
 
3. Fumonisin exposure in subsistence farming communities 
 
The maize cultivated around the world consists of more than 50 different varieties 
resulting in cobs of different sizes, shapes, colours, and consistencies. Maize is 
produced to a larger extent than any other grain utilised as staple cereal around the 
world as it is a high yielding crop, simply processed, easily digested and relatively 
inexpensive. Africa produced only 7% of the worldwide production of maize in 2009 
(FAO, 2010). The worldwide consumption of maize as food in 2009 was only 15% of 
the total production, whereas Africa imported an additional 28% of their total 
production for food consumption from countries outside the African continent (IITA, 
2010).  
 
Assessing fumonisin exposure by dietary analyses requires a known level of 
fumonisin contamination in the maize or the maize-based food and the amount of 
maize or maize-based food consumed daily. The dietary exposure of fumonisin is 
expressed as the probable daily intake (PDI) of fumonisin per kg body weight (bw): 
Fumonisin PDI (µg/kg bw/day) = Fumonisin in maize (µg/kg) x Maize consumed (kg/day) 

body weight (kg) 
 
In developed countries maize forms a minor part of the diet as maize intake is 
estimated at less than 10 g/day in the European Union (EU) and the maize that they 
consume tends to be of a very high quality (Bolger et al., 2001). Therefore, even if 
maize were contaminated at extremely high fumonisin levels of 10 mg/kg, their PDI 
would still be within acceptable limits (Gelderblom et al., 2008) (Table 3). Generally  
 
Chapter 2 - Table 3 The probable daily intake (PDI) of fumonisins (FB) at specific 
maize intake quantities and different FB contamination levels 
compared to the group fumonisin provisional maximum 
tolerable daily intake (PMTDI) of 2 µg/kg body weight/day 
determined by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA). 
 Maize Intake (g/day)†  
FB (mg/kg) 10 250 460  
0.2 0 0.8 1.5 
PD
I
 (µg/kg
 b
w
/d
ay)
 
0.5 0.1 2.1 3.8 
1 0.2 4.2 7.7 
2 0.3 8.3 15.3 
4 0.7 16.7 30.7 
10 1.7 41.7 76.7 
†Adult 60 kg 
bw = body weight 
PDI values in Bold are above the PMTDI 
 
in the lesser developed countries, and more specifically in certain rural areas, maize 
forms a progressively larger part of the diet. In large parts of Africa maize is a dietary 
staple consumed almost to the exclusion of all other food commodities (Gelderblom 
et al., 2008). In some of those rural areas maize is grown and consumed by 
subsistence farmers and the maize might be contaminated with much higher levels 
of fumonisin. In contrast to developed countries, in rural communities in South Africa, 

maize consumption as high as 460 g per person per day has been reported 
(Shephard et al., 2007a). Furthermore, subsistence farming communities that 
consume maize as a staple diet can be exposed to total fumonisin levels of up to 
13.8 g/kg body weight/day (Van der Westhuizen et al., 1999). This is of concern as 
the Joint FAO/WHO Expert Committee on Food Additives (JECFA) has determined a 
group provisional maximum tolerable daily intake (PMTDI) for fumonisin B1, B2 and 
B3, alone or in combination, of 2 µg/kg body weight/day (Bolger et al., 2001). The 
committee based its decision on a no observed adverse effect level (NOAEL) for 
nephrotoxicity studies in rodents of 0.2 mg/kg body weight/day and a safety factor of 
100. Table 3 illustrates the challenge to keep the PDI of subsistence farmers below 
the PMTDI determined by JECFA compared to the EU or from the rural areas of 
South America where consumption is estimated at 10 g and 250 g/person/day, 
respectively (Shephard et al., 2002b). 
 
 
4. Biomarkers of fumonisin exposure 
 
Searching for a biomarker of fumonisin exposure required toxicokinetic (absorption, 
distribution, biotransformation and excretion) data (Shephard et al., 2007b). A 
suitable metabolite was sought, but FB1 did not undergo metabolism when it was 
subjected to subcellular enzyme fractions in a primary rat hepatocyte culture study 
(Cawood et al. 1994). Toxicokinetic investigations have shown that FB1 has a half-
life of less than an hour when administered via different routes such as gastric 
administration, intravenous or intraperitoneally in various animal studies (Shephard 
et al., 1994; 1995; Fodor et al., 2006). Most of the administered FB1 was recovered 

unaltered and therefore no metabolite of FB1 suitable as a biomarker for fumonisin 
exposure was found (Shephard et al., 2007b).  
Hair as an alternative biomarker for determining fumonisin exposure has been 
investigated. FB1 was detected by liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) in hair of rats 4 weeks after administration of a single 
gavage dose of FB1 and in vervet monkeys chronically fed diets contaminated with 
F. verticillioides culture material containing relatively high levels of fumonisin 
(Sewram et al., 2001). Composite human hair samples collected from barber shops 
in the former Transkei region had detectable levels of FB1 and very low levels of FB2 
(Sewram et al., 2003). It would thus be possible to utilise hair as a biomarker of 
fumonisin exposure in humans (Shephard et al., 2007b). 
 
The similarities in the structures of fumonisins and the sphingoid base lipids, 
sphinganine and sphingosine, led to the investigation of the mechanism of fumonisin 
action, which revealed that fumonisins inhibit a key enzyme, ceramide synthase, in 
the de novo sphingolipid biosynthetic pathway (Wang et al., 1991) (Figure 3). This 
inhibition prevents the conversion of sphinganine to dihydroceramide and the 
reacylation of sphingosine to ceramide (Riley et al., 1994; Wang et al., 1991). The 
disruption of the sphingolipid biosynthetic pathway elevates sphingoid bases and 
their 1-phosphate levels and decreases ceramide and more complex sphingolipids, 
such as sphingomyelin and gangliosides, and their intermediates (Riley et al., 2001; 
Merrill et al., 2001). Sphingolipids are predominantly found in cellular membranes 
and are critical for the maintenance of the membrane structure, while complex 
sphingolipids function as precursors for second messengers and are important in 
sustaining cellular growth and differentiation (Merrill et al., 2001). This disruption 
	
leads to an elevation of sphinganine levels in cells, and sometimes, to a lesser 
extent, sphingosine levels, thus resulting in an increase in the sphinganine/ 
sphingosine ratio, as observed in plasma and urine in animal studies (Riley et al., 
1993; Shephard et al., 1996b; Van der Westhuizen et al., 2001; Wang et al., 1992). 
The resultant increase in the sphinganine/sphingosine ratio occurs prior to changes 
in other biochemical markers of cellular injury, and has thus been proposed as a 
biomarker of fumonisin exposure (Riley et al., 1994). 
 

Chapter 2 - Figure 3 The de novo sphingolipid biosynthetic pathway and 
degradation pathway illustrating the disruption by FB1. 

(Published in Riley RT, Voss KA Toxicol. Sci. 2006; 92:335-
345.) 
 
A preliminary study comparing four male oesophageal cancer patients with female 
controls from South Africa did not find any significant difference in their serum 
sphinganine/ sphingosine ratios (Castegnaro et al. 1998). The first investigations on 
the sphinganine/ sphingosine ratios in plasma and urine from rural populations 
consuming subsistence maize as their staple diet in Africa were conducted in the 
Eastern Cape and KwaZulu-Natal Provinces of South Africa, as well as in western 
Kenya (Van der Westhuizen et al. 1999). This study and subsequent studies 
conducted in various human populations exposed to different levels of fumonisin 
have not been able to show that sphinganine or sphingosine levels or the 
sphinganine/sphingosine ratio can be utilised as a biomarker for fumonisin exposure 
(Qiu and Liu, 2001; Solfrizzo et al., 2004; Van der Westhuizen et al., 1999).  
 
Although most of the administered FB1 is excreted almost unchanged in faeces, a 
small percentage is excreted in urine (Shephard et al., 1994; 1995). However, urine 
is a more acceptable medium to investigate compared to faeces. Urinary FB1 has 
been investigated as a biomarker of exposure and levels of 8 ng FB1/mL was 
detected in human urine (Shetty and Bhat et al., 1998). ). A recent study in a 
Mexican population consuming various quantities of maize-based tortillas showed 
positive correlation between urinary FB1 and estimates of fumonisin exposure (Gong 
et al., 2008). Urinary FB1 levels of 19–248 pg /mL was determined by high 
performance liquid chromatography coupled to mass spectrometry (HPLC-MS).  
 

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Shephard et al. (2007b) have reviewed the biomarkers of fumonisin exposure 
extensively and subsequent investigations are discussed in the relevant chapters of 
this thesis. 
5. Reduction of fumonisin contamination in subsistence grown maize 
 
In many Sub-Saharan countries, reliant on subsistence maize as a major dietary 
staple, both maize consumption and maize contamination are high and regulatory 
mechanisms to control fumonisin levels are either lacking or are not enforced 
(Gelderblom et al., 2008). Even where regulations on fumonisins in maize are in 
place, they will have no effect on exposure levels in maize subsistence communities 
consuming large quantities of home-grown maize daily (Gelderblom et al., 2008; 
Marasas et al., 2008; Wild and Gong, 2010). These communities are the most 
vulnerable to the toxic and carcinogenic effects of mycotoxins and therefore 
intervention methods should be simple, cost effective and aligned with the local 
customs (Desjardins et al., 2000).  
 
Although previous studies achieved reduction of fumonisin in maize by different food 
preparation procedures, agricultural practices, sorting, mechanical shelling and 
dehulling, no intervention was implemented (Afolabi et al., 2006; Fandohan et al., 
2005; 2006; Kimanya et al., 2009). An intervention study in Guinean villages resulted 
in a 60% aflatoxin reduction in groundnuts by introducing primary prevention 
strategies at postharvest and by introducing the local farmers to readily available 
materials and local agricultural expertise (Turner et al., 2005). In contrast to aflatoxin, 
where unsuitable storage practices contribute to increased levels, fumonisin 
contamination is mainly produced prior to harvesting (Wild and Gong, 2010). 

Preharvest insect herbivory, in particular that of the maize stalk borer, damages 
maize cobs leading to Fusarium infection and production of fumonisins (Miller et al., 
2001). Bt maize has been genetically modified to contain the cry genes from Bacillus 
thuringiensis, which upon expression produce insecticidal proteins toxic to 
Lepidopteran insects, among others the maize stalk borer (Hammond et al., 2004). 
However, the practice in maize subsistence farming communities is to use the best 
cobs from the harvest for subsequent planting. Therefore genetically modified maize 
biotechnology such as Bt maize to reduce fumonisin-contamination is not a viable 
option in these communities due to financial constraints. 
 
Fumonisin contamination of maize is non-homogenous and can be effectively 
reduced by the removal of visibly infected kernels as demonstrated in a Nigerian 
study (Afolabi et al., 2006; Whitaker et al. 1998). Fandohan et al., (2005) reported 
that the processing procedures for traditionally prepared maize meal dishes from 
Benin reduced fumonisin levels in maize by up to 87% depending on the specific 
food type. As fumonisin levels are higher in the pericarp of the maize kernel, different 
mechanical dehulling methods reduced fumonisin contamination by 57–65% 
(Fandohan et al., 2006; Sydenham et al., 1995). Therefore, sorting, winnowing, 
washing and dehulling of maize kernels were very effective in achieving these 
reductions. However, the actual cooking process did not achieve a reduction 
(Fandohan et al., 2005). This was in contrast to the 23% fumonisin reduction 
obtained by the traditional cooking process of stiff porridge prepared from South 
African commercial maize meal (Shephard et al., 2002b). Reduction in fumonisin 
contamination in subsistence grown maize from Tanzania was also achieved by 

selecting specific maize hybrids, reducing plant stress by suitable fertilisers and 
sorting of maize prior to storage (Kimanya et al., 2009). 
 
 
6. Conclusion 
 
Fumonisins cause various animal diseases and syndromes and are carcinogenic to 
rodents. The aetiology of fumonisins in high oesophageal cancer incidence and 
neural tube defects in humans is still under investigation. However, there is a strong 
association between consumption of fumonisin-contaminated maize and the 
incidence of oesophageal cancer. Various biomarkers for fumonisin exposure have 
been validated in animal studies, of which the sphinganine/sphingosine ratio has 
been investigated the most extensively. In contrast to animal studies where 
controlled high doses of fumonisin were administered, most human populations are 
exposed to varying levels of contamination which might be too low to detect 
significant differences in the sphingoid bases. Various methods of reducing 
fumonisins post-harvest in subsistence grown maize have been investigated, but no 
culturally specific intervention had been conducted in these communities.  
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Abstract 
 
In Brazil, the southern region has the highest incidence of oesophageal cancer and 
also the highest production and consumption of maize (Zea mays) products. Maize 
samples intended for human consumption from the western, northern and southern 
regions of Santa Catarina State, southern Brazil, had mean total fumonisin B (B1, B2 
and B3) levels of 3.2, 3.4 and 1.7 mg/kg, respectively. Fusarium verticillioides, the 
predominant fungus in the maize samples, had a mean incidence (% kernels 
infected) of 14%, 11% and 18% for the three regions, respectively. Additional maize 
samples intended for animal feed from the southern region had a mean total 
fumonisin level of 1.5 mg/kg and a mean F. verticillioides incidence of 10%. The 
fumonisin levels in maize from the State of Santa Catarina, Brazil, were similar to the 
high levels determined in other high oesophageal cancer incidence regions of the 
world.  
 
 
Introduction 
 
Fumonisins, produced predominantly by Fusarium verticillioides (Sacc.) Nirenberg 
(formerly known as F. moniliforme Sheldon) and F. proliferatum (Matsushima) 
Nirenberg, occur widely around the world on maize (Zea mays) (Shephard et al., 
1996). The major naturally occurring fumonisin analogues in maize are fumonisin B1 
(FB1), B2 (FB2) and B3 (FB3), see Figure 1.  
 

The contamination of maize with fumonisins is of concern as these mycotoxins 
cause various animal diseases and occur in maize and maize-based products 
intended for human consumption (Shephard et al., 1996). In addition, high levels of 
fumonisins have been found in naturally contaminated maize from areas where high 
incidences of oesophageal cancer occur, e.g., Centane District, Transkei region of 
South Africa; Cixian County, Hebei Province, China; and Mazandaran Province, Iran 
(Chu et al., 1994; Rheeder et al, 1992; Shephard et al., 2000; 2002). Based on 
current data, the International Agency for Research on Cancer has classified FB1 to 
be possibly carcinogenic to humans (class 2B carcinogen) (IARC, 2002). 
 
 
 
Chapter 3 - Figure 1 Chemical structures of fumonisin B1, B2 and B3 (FB1, FB2 
and FB3). 
 
Brazil is the third largest producer of maize in the world, of which the southern region 
is the highest producer and consumer of maize-based products. A considerable 
portion of this maize crop is produced by small farmers and nearly 25% of the 
harvest is consumed on these farms (Orsi et al., 2000). Santa Catarina, Paraná and 

Rio Grande do Sul States, southern Brazil, have the highest incidences of 
oesophageal cancer in the country, with an age-standardized incidence rate (ASIR) 
of 18 per 100,000 (INC, 1989). The situation in southern Brazil is similar to other 
rural areas, where high oesophageal cancer incidence and high maize consumption 
co-occur (Chu et al., 1994; Rheeder et al, 1992; Shephard et al., 2000). In a survey 
conducted in Florianópolis in Santa Catarina, Brazil, oesophageal cancer patients 
accounted for 134 of 2495 total cancer cases registered, mostly originating from the 
southern and western regions of Santa Catarina. These regions are also the main 
maize producing areas of Santa Catarina and these populations consume maize-
based products as their staple diet (Scaff et al., 1999). The first report on the natural 
occurrence of fumonisins in maize in Brazil was from feed samples associated with 
outbreaks of confirmed and suspected mycotoxicoses in various animal species 
collected from farms in the State of Paraná. These samples were contaminated with 
mean levels of 8.9 mg/kg FB1 and 2.8 mg/kg FB2 (Sydenham et al., 1992). The first 
report on the occurrence of fumonisins in Brazilian maize-based food products, 
acquired from markets in Campinas, São Paulo, showed 35 of 72 products to be 
contaminated with FB1, with a mean level of 0.4 mg/kg. However, an additional 9 
maize meal samples, also acquired from these markets, were all contaminated and 
showed a much higher mean FB1 level of 2.3 mg/kg (Machinski et al., 2000). The 
highest natural fumonisin contamination in maize in Brazil was from freshly 
harvested samples from the State of São Paulo that had mean levels of 16.4 mg/kg 
FB1 and 10.7 mg/kg FB2 (Orsi et al., 2000). In a further study, maize samples from 
various cultivars grown in São Paulo State showed mean levels of 5.6 mg/kg FB1 
and 1.9 mg/kg FB2 (Camargos et al., 2000) Maize samples collected at wholesale 
markets during the same season in Central, South and Southeast Brazil, had a mean 
	
FB1 level of 2.2 mg/kg (Vargas et al., 2001). F. verticillioides was the predominant 
Fusarium species detected in Brazilian maize in the southeastern State of São Paulo 
and the southern State of Paraná (Orsi et al., 2000; Sydenham et al., 1992; Almeida 
et al., 2000; Pozzi et al., 1995; Ono et al., 2002). 
 
The current study was undertaken in the western, northern and southern regions of 
the State of Santa Catarina, Brazil. Maize samples were collected from these regions 
during the year 2000 and analyzed for FB1, FB2 and FB3 levels and fungal incidence. 
In Brazil the southern region has the highest incidence of oesophageal cancer, and 
this is the first report of high fumonisin levels in maize from Santa Catarina State, 
southern Brazil. 
 

Materials and methods 
 
Maize samples 
Maize samples from the 1999-2000 harvest season were collected during the year 
2000 from rural areas of the State of Santa Catarina, Brazil. These samples had 
been mechanically harvested and shelled, where after the grain was stored in silos. 
Maize intended for human consumption was collected from mountainous areas in the 
western (39 samples) and northern (17 samples) regions and from the prairies in the 
southern region (20 samples), as well as maize intended for animal feed in the 
southern region (14 samples). The maize samples were sent to the PROMEC Unit, 
South Africa for fumonisin and mycological analyses. 
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Analytical methods 
 
Fumonisin analyses 
The standards were purified according to the method of Cawood et al. (1991). FB1, 
FB2 and FB3 levels were determined according to the method of Shephard et al. 
(2001). Each sample was ground in a laboratory mill to a fine meal and extracted 
with methanol:water (3:1) by homogenization. An aliquot was applied to a strong 
anion exchange solid phase extraction cartridge (Varian, Harbor City, CA) and the 
fumonisins were eluted with 1% acetic acid in methanol. The purified extracts were 
evaporated to dryness, redissolved in methanol and derivatised with o-
phthaldialdehyde. The derivatised extracts were analyzed by reversed-phase high-
performance liquid chromatography (HPLC) using an Ultracarb 5 ODS column 
(Phenomenex, Torrance, CA) and fluorescence detection.  
 
Mycological analyses 
Samples were mycologically analyzed for fungal incidence (% kernels infected) using 
the method of Nelson et al. (1983). Briefly, sub samples of kernels (80–100 g) were 
surface sterilized for 1 min in 3.5% commercial sodium hypochlorite solution and 
rinsed twice in sterile water. One hundred kernels (5 kernels/ 90 mm petri-dish) were 
then transferred to malt extract agar (1.5%) containing novobiocin (150 mg/L) and 
the agar plates were incubated at 25 "C in the dark for 5 to 7 days. All the isolated 
fungi were recorded and their frequencies determined using a stereo-microscope. 
Fusarium species were identified according to Nelson et al. (1983) and other fungi 
were identified on the basis of their cultural and morphological characteristics, i.e., 
Aspergillus and Diplodia species. 


 
Statistical analysis 
The results were statistically analyzed with the Systat 10 software package (SPSS 
Inc., Chicago, IL) and the correlation of the total fumonisin levels with the F. 
verticillioides incidence with the STATA statistical software package (STATA Corp., 
College Station, TX). 
 
Results 
 
The mean fumonisin (FB1, FB2 and FB3) levels determined in the maize samples of 
the different regions are shown in Table 1. FB1, FB2 and FB3 were present in all the 
maize samples, except for 2 samples in which FB3 was not detected. The mean level 
of the total fumonisins in the maize from all three regions in Santa Catarina 
combined was 2.89 mg/kg (n = 90, range 0.02–18.74 mg/kg), indicating the 
occurrence of some very high levels (individual results are not shown). In this study 
31 of 90 maize samples had FB1 levels higher than 2 mg/kg and 5 of 90 samples 
higher than 4 mg/kg, whereas 46 of 90 maize samples had total fumonisin levels 
higher than 2 mg/kg and 15 of 90 samples higher than 4 mg/kg. In the western, 
northern and southern regions 24 of 39, 14 of 17 and 8 of 34 samples, respectively, 
had total fumonisin levels higher than 2 mg/kg. The 14 maize samples intended as 
animal feed, collected from the southern region, had a mean total fumonisin level of 
1.53 mg/kg, whilst the 76 maize samples, intended for human consumption, had a 
mean total fumonisin level of 2.87 mg/kg (Table 1). There were no statistical 
differences (p > 0.05) in the fumonisin levels between the different regions and the 

maize samples intended for human and animal consumption, due in part to large 
individual variation in the samples as indicated by the standard deviations (Table 1). 
 
Chapter 3.1 - Table 1 Fumonisin levels (mg/kg) in maize samples from the State of 
Santa Catarina, southern Brazil. 
     Total Fumonisins 
Region n FB1 FB2 FB3 Mean Range 
West 39 2.06±2.04 0.79±0.80 0.36±0.33 3.21±3.09 0.02–18.74 
North 17 2.24±1.01 0.91±0.63 0.30±0.17 3.42±1.75 1.01–7.73 
South (HCa) 20 1.28±2.14 0.35±0.69 0.10±0.17 1.73±2.99 0.14–13.07 
Combined (HC) 76 1.89±1.90 0.70±0.76 0.28±0.28 2.87±2.87 0.02–18.74 
South (AFb) 14 1.05±0.85 0.37±0.50 0.11±0.11 1.53±1.36 0.15–4.79 
Values are means ± standard deviation 
aHC - Intended for human consumption 
bAF - Intended for animal feed 
Differences between the means in maize intended for human consumption from all 
three regions are not statistically significant (p > 0.05) 
Differences between the means in animal feed and the maize intended for human 
consumption from all three regions are not statistically significant (p > 0.05) 
 
Whereas the fumonisin contamination of the maize samples was 100%, Fusarium 
species were isolated from 93% of the samples. Even though F. verticillioides was 
the predominant fungus isolated from all three regions (Table 2), the incidence did 
not correlate with the fumonisin levels in the maize samples (r = -0.14, p > 0.05). 
There were no statistical differences (p > 0.05) in the mean incidence of F. 
verticillioides in the maize intended for human consumption between the western 
(14%, range 0–62%), northern (11%, 0–66%) and southern regions (18%, 1–42%), 
respectively. There was no statistical difference (p > 0.05) in the mean incidence of 
F. verticillioides between the maize intended for human consumption (14%, range 0–
66%) and the maize intended as animal feed (10%, range 0–36%). There was also 

 
Chapter 3.1 - Table 2 Incidence of fungi in maize samples intended for human 
consumption (HC) and animal feed (AF) from the State of 
Santa Catarina, southern Brazil. 
 Incidence of fungi (% kernels infected 
Region n 
Fusarium 
verticillioides 
Other 
Fusarium 
Speciesa 
Aspergillus 
flavus 
Other 
Speciesb 
Total 
fungi 
West 38c 13.5±15.6 1.55±2.85 3.37±4.91 33.2±18.5 51.6±27.2 
North 17 11.4±18.7 0.88±2.47 10.2±21.9 20.5±15.1 43.0±34.26 
South (HCd) 20 17.6±12.5 1.25±2.59 4.05±7.74 36.1±13.7 59.0±23.9 
Combined (HC) 75 14.1±15.6 1.32±2.68 5.11±11.8 31.1±17.4 51.6±28.3 
South (AFe) 14 10.4±12.0 1.71±2.64 8.64±8.34 37.3±13.2 58.1±27.3 
Values are means ± standard deviation.  
Differences between the means in different regions are not statistically significant (p 
> 0.05). 
aOther Fusarium species includes F. subglutinans and F. graminearum 
bOther species includes Diplodia maydis and D. macrospora 
cSample received as ground meal. Mycological analysis was performed by dilution 
plating. F. verticillioides 0.9 x 106 colony forming units (cfu)/g, other Fusarium 
species 1.0 x 106 cfu/g, other species 1.0 x 106 cfu/g and total fungi 1.4 x 106 cfu/g. 
dHC - Intended for human consumption.  
eAF - Intended for animal feed 
 
no statistical difference (p > 0.05) in the other mycological data obtained from the 
three regions. F. subglutinans was isolated in 16 of 38, 2 of 17 and 11 of 34 samples 
in the western, northern and southern regions, respectively, with a mean incidence 
(% kernels infected) of 0.9% (range, 0–12%) for the combined regions. F. 
graminearum was present in only 9 of 90 samples and other Fusarium species were 
present in 6 of 90 samples. A. flavus were isolated from 26 of 38, 12 of 17 and 23 of 
34 samples in the western, northern and southern regions, respectively, with a mean 
incidence of 5.7% (range, 0–90%) for the combined regions. Diplodia (= 

Stenocarpella) maydis and D. macrospora were recorded in small numbers of 
samples (10 of 90 and 12 of 90, respectively) with a range of 0–2% kernels infected. 
 
 
Discussion 
 
High oesophageal cancer incidence areas in South Africa, China and Iran have been 
associated with populations consuming high levels of maize heavily contaminated 
with fumonisin (Chu et al., 1994, Gao et al., 1997; Rheeder et al, 1992; Shephard et 
al., 2000; 2002). In Brazil, the southern region has the highest incidence of 
oesophageal cancer (INC, 1989). High production and consumption of maize and 
maize-based products occur in southern Brazil (Orsi et al., 2000, Scaff et al., 1999). 
Previous studies that investigated the levels of fumonisin in Brazilian maize were 
confined almost exclusively to Paraná, southern Brazil and São Paulo, south-eastern 
Brazil (Orsi et al., 2000; Sydenham et al., 1992; Camargos et al., 2000; Machinski et 
al., 2000; Ono et al., 1999; 2001; 2002; Hirooka et al., 1996). This study is the first to 
report fumonisin levels in maize in Santa Catarina State, southern Brazil. 
 
The mean FB1 level in maize samples from Santa Catarina intended for human 
consumption was 1.89 mg/kg, which is similar to FB1 levels in other high esophageal 
cancer incidence regions, e.g., 1.84 mg/kg in Centane, South Africa in 1989, 2.27 
mg/kg in Mazandaran, Iran in 1998 and 2.73 mg/kg in Linxian County, China in 1994 
(Chu et al., 1994; Rheeder et al, 1992; Gao et al., 1997). Similar mean FB1 levels 
have been reported in other southern Brazilian States. During the 1997/1998 season 
maize from central, southern and south-eastern Brazil had a mean FB1 level of 2.2 
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mg/kg in 214 samples and in the 1995/1996 season from central-western Paraná a 
mean level of 2.4 mg/kg in 86 samples (Vargas et al., 2001, Ono et al., 1999). The 
first investigation on fumonisin contamination in maize-based food products 
conducted in São Paulo revealed a mean FB1 level of 0.4 mg/kg, whereas maize 
meal samples collected from the same markets had a mean FB1 level of 2.3 mg/kg 
(Machinski et al., 2000). 
 
The mean total fumonisin level in maize intended for human consumption was 2.87 
mg/kg, almost double the 1.53 mg/kg level in the maize intended as animal feed. 
However, the difference was not statistically significant, due in part to individual 
variation in the samples as indicated by the standard deviation. Based on this mean 
total fumonisin contamination of 2.87 mg/kg and the assumption that a 70 kg person 
from the rural area in Brazil consumes 11 to 39 g of dry maize per day (Machinski et 
al., 2000), the probable daily intake (PDI) of fumonisins by this population was up to 
1.6 g/kg body weight/day. This is double the tolerable daily intake (TDI) of 0.8 g/kg 
body weight/day, which was based on a NOEL (no observed effect level) of 25 mg 
FB1 /kg diet in rats and a safety factor of 1000 for carcinogenicity (Gelderblom et al., 
1996). However, the Joint FAO/WHO Expert Committee (JECFA) on Food Additives 
recommended a provisional maximum tolerable daily intake (PMTDI) for total 
fumonisins of 2 g/kg body weight/day based on a NOEL of 0.2 mg/kg weight/day 
and a safety factor of 100 (Bolger et al., 2001). Considering this recommendation the 
exposure of the rural population of Santa Catarina would be below the level 
proposed by JECFA. 
 

Similar to previous Brazilian investigations on the mycoflora of maize, F. 
verticillioides was the predominant fungus isolated in this study (Orsi et al., 2000, 
Sydenham et al., 1992; Almeida et al., 2000; Pozzi et al., 1995; Ono et al., 2002). 
However, the incidence of F. verticillioides was not significantly correlated with the 
fumonisin levels in the maize as reported in other South African maize studies 
(Rheeder et al., 1992; 1995). In contrast to these studies, a correlation was observed 
in investigations on maize conducted in Argentina, South Africa and the United 
States of America (Sydenham et al., 1991; 1993). The presence or absence of 
significant positive correlations might be attributed to various factors that influence 
the production of fumonisins by F. verticillioides, e.g., the maize hybrid, the abiotic 
stress on the host plant and symptomless systemic infection (Rheeder et al., 1992; 
Orsi et al., 2000; Bacon et al., 2001). Even though F. subglutinans was isolated in 29 
of 89 samples, the mean incidence was only 0.9% and that for F. graminearum only 
0.2%, and neither of these two Fusarium species produce fumonisins (Rheeder et 
al., 2002). Therefore, compared to F. verticillioides the incidence of the other 
Fusarium species in this study was insignificant. The second most abundant genus 
of fungi isolated from the maize was Aspergillus (5.7%). Co-contamination with 
aflatoxin and fumonisin has previously been reported in Brazilian maize from central, 
southern and south-eastern Brazil, specifically in the states of Paraná and São Paulo 
(Vargas et al., 2001; Almeida et al., 2000; Ono et al., 2002). Further investigation is 
required into the seasonal variation of the chemical and mycological data in the 
maize of Santa Catarina, Brazil, as differences may be expected due to changing 
environmental conditions such as annual rainfall, temperature and insect infestation. 
Additional epidemiological data on ASIR of oesophageal cancer in Santa Catarina 
are also urgently required. The high level of fumonisin contamination in maize 

intended for human consumption in yet another region where the incidence of 
oesophageal cancer is high, is a further indicator for an association between the 
consumption of maize contaminated with fumonisins and oesophageal cancer. 
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Abstract 
 
In order to investigate the role of sphingolipid disruption in the cancer promoting 
potential of fumonisin B1 (FB1) in the development of hepatocyte nodules, male 
Fischer 344 rats were subjected to cancer initiation (FB1 containing diet or 
diethylnitrosamine [DEN] by intraperitoneal injection) and promotion (2-
acetylaminofluorene with partial hepatectomy [2-AAF/PH]) treatments followed by a 
secondary FB1 dietary regimen. Sphinganine and sphingosine levels were measured 
by high performance liquid chromatography in control, surrounding and nodular liver 
tissues of the rats. The disruption of sphingolipid biosynthesis by the secondary FB1 
treatment in the control rats was significantly (p<0.05) enhanced by the 2-AAF/PH 
cancer promotion treatment. The nodular and surrounding sphinganine levels 
returned to baseline following FB1 initiation and 2-AAF/PH promotion. When 
comparing the groups subjected to the secondary FB1 treatment, the initiation 
effected by FB1 was less (p<0.01) sensitive to the accumulation of sphinganine in the 
nodular and surrounding tissues than DEN initiation and the 2-AAF/PH control 
treatment. In contrast, the sphingosine level of FB1 initiation was marginally 
increased in the nodules compared to the surrounding liver after 2-AAF/PH 
promotion and significantly (p<0.05) higher with the secondary FB1 treatment. 
Although, the FB1 -induced hepatocyte nodules were not resistant to the disruption of 
sphingolipid biosynthesis, the nodular sphingosine levels were increased and might 
provide a selective growth stimulus possibly induced by bio-active sphingoid 
intermediates such as sphingosine 1-phosphate. 

Introduction 
 
Fumonisin B1 (FB1) is the major mycotoxin predominantly produced by Fusarium 
verticillioides occurring ubiquitously on corn (Shephard et al., 1996). Ingestion of 
fumonisin-contaminated feed results in various animal diseases (Shephard, 2001). 
High incidences of human esophageal cancer (Rheeder et al., 1992; Chu and Li, 
1994; Yoshizawa et al., 1994) and liver cancer (Ueno et al., 1997) have been 
associated with the consumption of fumonisin-contaminated corn. Fumonisins are 
not mutagenic (Gelderblom et al., 1991; Knasmuller et al., 1997) nor genotoxic in 
primary rat hepatocytes (Norred et al., 1992), however FB1 exhibits clastogenesis 
(Ehrlich et al., 2002) and epigenetic properties (Mobio et al., 2000) in cell cultures. 
FB1 is hepatocarcinogenic in male BD IX rats (Gelderblom et al., 1991; 2001) and in 
B6C3F1 female mice and nephrocarcinogenic in male Fischer 344 rats (Howard et 
al., 2001). 
 
FB1 inhibits ceramide synthase, a key enzyme in de novo sphingolipid biosynthesis, 
preventing the conversion of sphinganine to dihydroceramide and the reacylation of 
sphingosine to ceramide (Riley et al., 1994; Wang et al., 1991). The disruption of the 
sphingolipid biosynthetic pathway elevate sphingoid bases and their 1-phosphate 
levels and decrease ceramide and more complex sphingolipids, such as 
sphingomyelin and gangliosides, and their intermediates (Riley et al., 2001; Merrill et 
al., 2001). However, an increase in the sphingoid bases can only occur once the 
capacity of sphingosine kinase to metabolize these bases to their 1-phosphates has 
been exceeded (Riley et al., 2001). Sphingolipids are predominantly found in cellular 
membranes and are critical for the maintenance of the membrane structure, while 

complex sphingolipids function as precursors for second messengers and are 
important in sustaining cellular growth and differentiation (Merrill et al., 2001). FB1 
inhibits cell proliferation in various cell culture systems as well as in rat liver and 
kidney (Gelderblom et al., 1996; Riley et al., 2001; Yoo et al., 1992). FB1 -induced 
disruption of sphingolipid biosynthesis can either induce or prevent apoptosis, 
depending on the cell type and the relative amounts of the bio-active sphingolipid 
molecules generated (Desai et al., 2002; Tolleson et al., 1996). The impairment of 
apoptotic pathways during liver cancer promotion results in an imbalance between 
cell death and proliferation and thus the outgrowth of hepatocyte nodules in the 
presence of a promoter (Schulte-Hermann et al., 1993). In this regard cells with 
decreased ceramide and increased sphingosine 1-phosphate levels might be 
selected to survive and proliferate, provided that increased sphingoid bases are not 
growth inhibitory in these cells (Riley et al., 2001). Hence, the disruption of 
sphingolipid biosynthesis has been implicated in the carcinogenic activity of FB1 
(Riley et al., 2001; Voss et al., 2002).  
 
Cancer initiation by chemicals in rat liver is generally characterized by the 
appearance of phenotypically altered resistant hepatocytes (Solt et al., 1980). These 
resistant hepatocytes escape the mitoinhibitory effects of FB1 on normal hepatocyte 
growth and selectively proliferate into hepatocyte nodules (Gelderblom et al., 1995; 
2001). The exact mechanism involved in the selection of initiated cells by FB1 is 
unknown. The purpose of this study was to determine whether hepatocyte nodules 
are resistant to the inhibitory effect of FB1 on ceramide synthase, resulting in a 
growth differential which could selectively stimulate their outgrowth. 
 

Materials and methods 
 
Chemicals 
FB1 was purified as described previously by Cawood et al. (1991). 
Diethylnitrosamine (DEN), 2-acetylaminofluorene (2-AAF), sphinganine and 
sphingosine were obtained from Sigma Chemical Company (St. Louis, MO, USA). 
C20-sphinganine was a generous gift from Prof. A. H. Merrill Jr. All other chemicals 
and solvents were analytical grade from Merck (Darmstadt, Germany). 
 
Animals 
Male Fischer (F344) rats were bred and maintained on the AIN76 diet (AIN, 1977) at 
the Primate Unit of the MRC Diabetes Research Group in a controlled environment 
of 23-25°C and 12 h light/dark cycles. During the experimental period the rats were 
caged individually with normal access to feed and water. The experimental protocol 
was approved by the Ethics Committee for Research on Animals of the Medical 
Research Council, Tygerberg, South Africa. 
 
Experimental procedures 
Experimental male Fischer 344 rat (150-200 g) groups were subjected to various 
cancer initiation and promotion regimens, whereas control rat groups were subjected 
only to the promotion regimens (Table 1). Initiation treatment consisted of either a 3-
week FB1 dietary treatment (500 mg/kg feed) or a single intraperitoneal (i.p.) 
injection of diethylnitrosamine (DEN, 200 mg/kg body weight). Promotion treatment 
followed two weeks after the initiation treatment and consisted of 2-acetylamino-
fluorene (2-AAF, 20 mg /kg body 
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Chapter 4.1 - Table 1 Treatment protocol of the control and experimental rat groups for studying whether hepatocyte nodules are 
resistant to the inhibitory effect of FB1 on ceramide synthase. 

Group number and  
Treatment code 
Initiationa 
21 days 
Recovery 
14 days 
Promotionb 
4 days 
Recovery 
14 days 
Secondary treatment 
4 days 
Control groups      
1 Control Control diet Control diet - Control diet Control diet 
2 Control/FB1 Control diet Control diet - Control diet 250 mg FB1/kg diet 
3 2-AAF/PH Control diet Control diet 2-AAF/PH Control diet Control diet 
4 2-AAF/PH/FB1 Control diet Control diet 2-AAF/PH Control diet 250 mg FB1/kg diet 
Experimental groups      
5 FB1/2-AAF/PH 500 mg FB1/kg diet Control diet 2-AAF/PH Control diet Control diet 
6 FB1/2-AAF/PH/FB1 500 mg FB1/kg diet Control diet 2-AAF/PH Control diet 250 mg FB1/kg diet 
7 DEN/2-AAF/PH DEN/Control diet Control diet 2-AAF/PH Control diet Control diet 
8 DEN/2-AAF/PH/FB1 DEN/Control diet Control diet 2-AAF/PH Control diet 250 mg FB1/kg diet 
 
aInitiation treatment consisted of either a 3-week FB1 (500 mg/kg) dietary treatment (groups 5 and 6) or a single i.p. injection (200 
mg/kg) of diethylnitrosamine (DEN, groups 7 and 8).  
bPromotion treatment consisted of 2-acetylaminofluorene (2-AAF, 20 mg/kg) gavage doses on three consecutive days followed by 
partial hepatectomy (PH). 
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weight) gavage doses on three consecutive days followed by partial hepatectomy 
(PH) (Semple-Roberts et al., 1987). The rats were anaesthetized with 2-3% 
fluothane (95% O2) and received 5% glucose supplementation in their drinking water 
for 12 hours post-operative. After initiation and promotion all the rats received control 
diets for a two-week recovery period. Subsequently, 50% of all the groups were 
subjected to a secondary two-week FB1 dietary treatment (250 mg/kg feed). At the 
end of the experimental period all the rats were sacrificed (sagatal anaesthesia) and 
the macroscopically distinguishable encapsulated hyperplastic nodules were 
separated by scooping the nodules from the surrounding liver tissue. The nodular, 
surrounding and control liver tissues were collected, frozen on dry ice and stored at -
80°C. 
 
Sphingolipid analyses 
Homogenized liver extracts were prepared from all the liver tissues in phosphate 
buffer (Van der Westhuizen et al., 2001a) and the levels of the sphingolipid bases, 
sphinganine and sphingosine, quantified by reversed-phase HPLC as fluorescent 
derivatives (Van der Westhuizen et al., 2001b). Protein content of the liver extracts 
was determined by a modified Lowry method (Markwell et al., 1978). 
 
Statistical analysis 
The data were tested for normality, using the Kolmogorov-Smirnov test, as well as 
for equality of variances. T-tests were used to test for group differences (2 groups), 
using the Pooled Method when variances were equal, and the Satterthwaite Method 
when variances were unequal. 
 

Results 
 
Control treatments 
The liver sphinganine (p<0.001) and sphingosine (p<0.05) levels, as well as the 
sphinganine/ sphingosine ratio (p<0.01), were significantly increased in rats 
subjected to the secondary FB1 treatment compared to the baseline levels of the 
untreated control rats (Table 2). Although both the sphinganine and sphingosine 
levels were significantly (p<0.05) increased in the liver of the rats subjected to the 2-
AAF/PH promotion regimen, the sphinganine/ sphingosine ratio was similar to the 
baseline ratio. The sphingosine level in the 2-AAF/PH treated rats was similar to the 
rats subjected to the secondary FB1 treatment. The secondary FB1 treatment 
significantly enhanced the accumulation of sphinganine (p<0.05) and the 
sphinganine/sphingosine ratio (p<0.01) induced by the 2-AAF/PH promoting 
regimen. 
 
Initiation protocols using FB1 and DEN regimens 
 
(i) Feeding the control diet during the secondary treatment period 
Hepatocyte nodules were observed in the livers of all the rats, which were subjected 
to either FB1 or DEN initiation treatment prior to the 2-AAF/PH promotion regimen as 
reported previously (Gelderblom et al., 1992; 1996). Histological features of the 
nodules have been described previously (Gelderblom et al., 2002). The nodules 
were scattered randomly throughout the liver and sharply demarcated from the 
surrounding liver and showed increased mitotic figures, mixed eosinophilic and clear 
cell changes. Oval cells were observed forming a rim around the nodules (Figure 1).


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Chapter 4.1 - Table 2 Sphinganine (Sa) and sphingosine (So) levels in rat liver of the different control and experimental groups in 
control, surrounding and nodular tissuesa 
Group number  Sphinganine Sphingosine Sa/So 
Treatment regimen (n) (pmol/mg protein) (pmol/mg protein) Ratio 
Control     
1 Control 4 1.13 ± 0.15 (1.03–1.35) a 14.7 ± 4.32 (9.57–19.2) a 0.08 ± 0.02 (0.06–0.11) a 
2 Control/ FB1 4 16.2 ± 2.04 (14.4–18.6) B 27.2 ± 6.75 (17.2–31.6) b 0.63 ± 0.17 (0.46–0.86) B 
3 2-AAF/PH 4 1.91 ± 0.46 (1.29–2.39) b 28.3 ± 7.34 (17.9–34.1) b 0.07 ± 0.03 (0.05–0.11) a 
4 2-AAF/PH/ FB1 6 46.3 ± 25.7 (20.3–90.0) B 36.8 ± 20.3 (11.8–59.0) b 1.38 ± 0.39 (0.78–1.79) B 
Surrounding     
5 FB1/2-AAF/PH 4 1.22 ± 0.30 (1.01–1.65) a 20.5 ± 6.32 (11.7–26.6) a 0.06 ± 0.02 (0.04–0.09) a 
6 FB1/2-AAF/PH/ FB1 4 13.0 ± 3.13 (9.00–16.1) B 32.7 ± 4.49 (28.8–38.9) B 0.39 ± 0.06 (0.31–0.45) B 
7 DEN/2-AAF/PH 6 1.11 ± 0.64 (0.59–2.11) a 17.0 ± 10.4 (5.80–32.7) a 0.08 ± 0.03 (0.04–0.12) a 
8 DEN/2-AAF/PH/ FB1 4 28.6 ± 7.44 (19.4–36.6) B 48.4 ± 17.4 (25.2–67.2) b 0.62 ± 0.12 (0.50–0.77) B 
Nodules     
5 FB1/2-AAF/PH 4 2.59 ± 1.33 (1.29–3.98) a 36.8 ± 13.9 (25.7–55.3) b 0.06 ± 0.03 (0.03–0.09) a 
6 FB1/2-AAF/PH/ FB1 4 15.4 ± 6.58 (9.55–24.4) b 47.2 ± 10.8 (33.3–57.0) B 0.32 ± 0.10 (0.22–0.45) b 
7 DEN/2-AAF/PH 5 1.15 ± 0.34 (0.60–1.51) a 21.8 ± 10.4 (9.82–34.6) a 0.06 ± 0.02 (0.04–0.07) a 
8 DEN/2-AAF/PH/ FB1 6 27.6 ± 8.09 (16.8–38.5) B 50.4 ± 10.5 (38.1–65.3) B 0.55 ± 0.12 (0.37–0.68) B 
 
aValues represent means  standard deviation with the range in brackets.  
 Values in a column followed by the same letter are not significantly different from the control, if the letter differs then p<0.05, if the 
cases differ then p<0.01. 
The DEN cancer initiation regimen followed by the 2-AAF/PH promotion did not 
significantly affect either the sphinganine or sphingosine levels in both the nodular 
and surrounding tissues compared to the baseline levels. The FB1 cancer initiation 
regimen did also not significantly affect the sphingoid bases in either the nodular or 
surrounding tissues as all the levels returned to baseline levels, except for the 
nodular sphingosine level which was significantly (p<0.05) increased above the 
baseline level.  
 

Chapter 4 - Figure 1: Hepatocyte nodules in a rat from experimental group 6. Note 
the hepatocyte nodules (1) and proliferating oval cells in the 
surrounding tissue (2) (H&E×100). 
 
(ii) Feeding the FB1-containing diet during the secondary treatment period 
The FB1 cancer initiation treatment significantly increased the sphinganine levels to a 
similar extent in the surrounding (p<0.01) and nodular (p<0.05) tissues when 
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compared to the rats that received a control diet during the secondary treatment 
period. The sphinganine levels in the nodular and surrounding tissues were similar to 
the control rats treated with the secondary FB1, but were significantly (p<0.05) lower 
than the control rats subjected to the combined 2-AAF/PH promotion and secondary 
FB1 regimens. The nodular sphingosine level was significantly (p<0.05) higher 
compared to the surrounding tissue, but was similar to the control rats subjected to 
the combined 2-AAF/PH promotion and secondary FB1 regimens. The 
sphinganine/sphingosine ratios in both the surrounding (p<0.001) and nodular 
(p<0.05) tissues were significantly increased above the baseline ratio, but were 
significantly lower (p<0.05) than the ratios observed in both the control and 2-
AAF/PH groups subjected to the secondary FB1 treatment. When DEN was used as 
cancer initiator the sphinganine and sphingosine levels were similarly increased in 
both the surrounding and nodular tissues compared to the rats fed a control diet 
during the secondary treatment period. The sphinganine levels in the surrounding 
(p<0.01) and nodular (p<0.05) tissues were significantly higher than when FB1 was 
used as a cancer initiator. Both the surrounding and nodular sphinganine levels were 
significantly increased (p<0.01) over the baseline level and markedly (not 
significantly) lower than the 2-AAF/PH treated rats subjected to the secondary FB1 
treatment. A similar effect was noticed for the sphingosine level, except that the 
sphingosine levels were markedly higher in comparison to the 2-AAF/PH rats, 
subjected to the secondary treatment. The sphinganine/sphingosine ratio was similar 
in the nodular and surrounding tissues and in the control rats subjected to the 
secondary FB1 treatment, but was significantly (p<0.01) lower than the 2-AAF/PH 
subjected to the secondary FB1 treatment. 
 

Discussion 
 
In normal regenerating liver disruption of sphingolipid biosynthesis induced by FB1 
enhanced the accumulation of sphinganine (Li et al., 2000). In the present study the 
2-AAF/PH promotion regimen significantly sensitized the liver to the accumulation of 
sphinganine by the two-week secondary FB1 treatment. Additionally, the significant 
increase in sphingosine, four weeks post 2-AAF/PH treatment, could have enhanced 
the sphingosine 1-phosphate levels and led to stimulation of cell proliferation and 
suppression of apoptosis (Desai et al., 2002). As in previous studies, hepatocyte 
nodules developed in the livers of all the rats subjected to the cancer initiation (FB1 
or DEN) treatment followed by the 2-AAF/PH promotion regimen (Gelderblom et al., 
1992; 1996). In the absence of the secondary FB1 treatment, the sphinganine levels 
returned to baseline in both the nodules and surrounding tissue six weeks after 
cessation of FB1 initiation treatment followed by the 2-AAF/PH promoting regimen. 
This reversibility of ceramide synthase inhibition was also apparent upon removal of 
FB1-contaminated diet in animal studies or when FB1 is removed from the media in 
primary as well as transformed cell culture systems (Enongene et al., 2002; 
Gelderblom et al., 1995; Wang et al., 1999; Yoo et al., 1992). In the presence of the 
secondary FB1 treatment, the sphinganine level was enhanced to a similar extent in 
nodular and surrounding liver, comparable with the control rats treated with the 
secondary FB1. However, in the absence of the secondary FB1 treatment, the 
nodular sphingosine in the FB1 initiated rats did not return to baseline level, but 
remained increased similar to the control group subjected to both the 2-AAF/PH and 
the secondary FB1 regimens. The increased nodular sphingosine might be attributed 
to an increase in cell proliferation induced by the 2-AAF/PH promotion regimen. In 

the presence of the secondary FB1 treatment, the sphingosine level was selectively 
further increased above the surrounding tissue, especially in the FB1-induced 
initiated cell population. It would appear that nodules induced by FB1 are sensitized 
to accumulate sphingosine, which could selectively support cell proliferation of 
initiated cells through the production of sphingosine 1-phosphate. 
 
When utilising DEN as the cancer initiator model, in the absence of the secondary 
FB1 treatment, sphingolipid biosynthesis was not disrupted in the nodular or 
surrounding tissue. However, DEN initiation, followed by the secondary FB1 
treatment, disrupted sphingolipid biosynthesis significantly in the nodules and 
surrounding liver tissue. Both the nodular and surrounding sphingosine were 
significantly increased to a similar level as in the FB1 -induced nodules subjected to 
the secondary FB1 treatment. It would appear that DEN sensitized nodules and 
surrounding liver treated with the secondary FB1 regimen, accumulated sphinganine 
to a higher extend than FB1 -initiated liver. However, the sphinganine level was still 
lower than in the control rats subjected to the combined 2-AAF/PH promotion and 
secondary FB1 regimen. The increased sensitivity in DEN rats towards the disruption 
of sphingolipid metabolism by FB1, implies that FB1 pre-treatment rendered the liver 
more resistant to the accumulation of sphinganine, but not sphingosine, which 
tended to selectively accumulate in the FB1-induced hepatocyte nodules. This 
resulted in a significantly lower sphinganine/sphingosine ratio in the FB1-induced 
nodules compared to the DEN-induced nodules. 
 
The present study confirmed that normal proliferating hepatocytes are more sensitive 
to the disruption of sphingolipid biosynthesis by FB1 than quiescent hepatocytes. The 

inhibitory effect of FB1 on ceramide synthase was reversible in hepatocyte nodules, 
although an apparent delayed effect on the reversal of sphingosine was observed. 
The FB1-induced hepatocyte nodules were not resistant to the disruption of 
sphingolipid biosynthesis, implying that it might not be a major growth stimulus in 
their outgrowth. However, the delayed recovery effect of the sphingosine levels in 
the FB1-induced nodules compared to the surrounding tissue, and the sensitization 
of sphingosine accumulation in the nodules upon subsequent FB1 exposure, could 
provide a selective growth stimulus resulting in their selective outgrowth. 
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Abstract 
 
High oesophageal cancer incidence rates have been associated with the 
consumption of fumonisin contaminated maize in the former Transkei region, 
Eastern Cape Province, South Africa. In this cross sectional study plasma and urine 
of male and female participants from Centane magisterial area (highest incidence 
area) in 1997 and Bizana (lower incidence area) in 2000, were analysed for the 
sphingoid bases, sphinganine and sphingosine. Good home-grown and visibly 
mouldy maize samples were analysed for fumonisin B1, B2 and B3. Both the mean 
plasma female (p=0.01) and male (p>0.05) sphinganine, as well as the sphingosine 
levels, were higher in Centane than in Bizana resulting in higher mean sphinganine/ 
sphingosine ratios. The mean male and female urinary sphingosine levels were 
significantly higher (p<0.0001) in Centane than in Bizana; whereas the mean female 
ratios were significantly lower (p<0.05) in Centane than in Bizana. The mean urinary 
sphingosine levels in the male participants were significantly lower than the female 
participants within both the magisterial areas. Based on the mean total fumonisin 
levels in good home-grown maize collected from Centane in 1997, 2000 and Bizana 
in 2000, the estimated fumonisin exposure was 4.4, 6.7 and 5.8 µg/kg body 
weight/day, respectively, exceeding the maximum tolerable daily intake for total 
fumonisins determined by JECFA by two to three-fold. 
 
 
Introduction 
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Fumonisins are mycotoxins produced predominantly by Fusarium verticillioides 
(Sacc.) Nirenberg (formerly known as F. moniliforme Sheldon) and F. proliferatum 
(Matsushima) Nirenberg (Marasas, 2001) and the major naturally occurring 
analogues are fumonisin B1 (FB1), B2 (FB2) and B3 (FB3) (Shephard et al., 1996a). 
Fumonisins cause distinct syndromes in different animals such as 
leukoencephalomalacia in horses, pulmonary oedema in pigs and neural tube 
defects in mice (Kellerman et al., 1990; Harrison et al., 1990; Sadler et al., 2002). 
Fumonisins are not mutagenic (Gelderblom et al., 1991; Knasmüller et al., 1997) nor 
genotoxic in primary rat hepatocytes (Norred et al., 1992), however FB1 exhibits 
clastogenesis (Ehrlich et al., 2002), epigenetic properties (Mobio et al., 2000) and 
other DNA related damage in cell cultures (De Lorenzi et al., 2005, Galvano et al., 
2002). FB1 is hepatocarcinogenic in male BD IX rats (Gelderblom et al., 2001) and 
B6C3F1 female mice and nephrocarcinogenic in male Fischer 344 rats (Howard et 
al., 2001). As fumonisins occur widely around the world in maize and maize-based 
products intended for human consumption there are health implications (Shephard et 
al., 1996a; Thiel et al., 1992). The Centane magisterial area, former Transkei region 
of the Eastern Cape Province, South Africa, is one of the areas with the highest 
incidence of oesophageal cancer in the world, whereas the Bizana magisterial area 
has comparatively low oesophageal cancer incidence rates (Makaula et al., 1996; 
Somdyala et al., 2003). These comparatively high and low oesophageal cancer 
incidence rates in Centane and Bizana, respectively, corresponded with high and low 
levels of fumonisins in the home-grown maize from these areas (Rheeder et al., 
1992; Shephard et al., 2007). High levels of fumonisins have also been found in 
naturally contaminated maize from other areas where high incidences of 
oesophageal cancer occur, viz., Charleston, SC, USA; Cixian County, Hebei 
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Province, China; Northern Italy and Santa Catarina, Southern Brazil (Chu and Li, 
1994; Doko and Visconti, 1994; Sun et al., 2007; Sydenham et al., 1991; Van der 
Westhuizen et al., 2003). 
 
Ueno et al. (1997) hypothesized that in high risk areas for primary liver cancer 
consumption of maize with high levels of fumonisin and trichothecenes promote 
hepatocarcinogenesis initiated by aflatoxin B or hepatitis B virus. Marasas et al. 
(2004) proposed that fumonisins are potential risk factors for birth defects arising 
from neural crest cells because of their interference with folate utilization. A recent 
study along the Texas-Mexican border confirmed that fumonisin exposure increased 
the risk for neural tube defects (Missmer et al., 2006). In an evaluation the 
International Agency for Research on Cancer (IARC) declared fumonisin B1 to be a 
group 2B carcinogen (IARC, 2002). A risk assessment by the Joint FAO/WHO 
Expert Committee on Food Additives determined a group provisional maximum 
tolerable daily intake for total fumonisin of 2 µg/kg body weight/day (Bolger et al. 
2001). 
 
Due to similarities in the structures of fumonisins and the sphingoid base lipids, 
sphinganine and sphingosine, investigation into the mechanism of action has 
revealed that fumonisins inhibit a key enzyme, ceramide synthase, in the de novo 
sphingolipid biosynthetic pathway (Wang et al., 1991). This inhibition disrupts 
sphingoid metabolism resulting in elevated sphingoid bases and their 1-phosphate 
levels and decreased ceramide and more complex sphingolipids and their 
intermediates (Riley et al., 2001; Merrill et al., 2001). This disruption leads to an 
elevation of sphinganine levels in cells, and sometimes, to a lesser extent, 
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sphingosine levels, thus resulting in an increase in the sphinganine/sphingosine 
ratio, as observed in plasma and urine in animal studies (Riley et al., 1994; 
Shephard et al., 1996b; Van der Westhuizen et al., 2001; Wang et al., 1992). As the 
increase in the sphinganine/ sphingosine ratio due to fumonisin exposure was 
observed before other biochemical markers of cellular injury, the 
sphinganine/sphingosine ratio was proposed as a biomarker for fumonisin exposure 
(Riley et al., 1993).  
 
The first studies in Africa on sphinganine/sphingosine ratios in plasma and urine 
from rural populations consuming home-grown maize as their staple diet were 
conducted in two coastal provinces of South Africa and in western Kenya (Van der 
Westhuizen et al., 1999). The sphinganine/sphingosine ratio seemed not sensitive 
enough to act as a biomarker in humans even at the highest estimated fumonisin 
exposure levels of 47 µg/kg body weight/day assuming a 70 kg adult consumes 
460 g maize/day (Van der Westhuizen et al., 1999; Shephard et al., 2002). A 
preliminary study comparing four male oesophageal cancer patients with female 
controls did not find any significant difference in their serum sphinganine/sphingosine 
ratios (Castegnaro et al., 1998). No significant association was found between 
sphingoid base levels and their ratio and the level of risk for oesophageal squamous 
cell carcinoma in a study conducted in a high oesophageal cancer incidence region 
(Linxian) in China (Abnet et al., 2001a). An exposure study conducted in Henan 
Province in China reported significantly higher urinary sphinganine/sphingosine 
ratios in males only when the mean dietary consumption levels exceeded 110 µg 
FB1/kg body weight/day (Qiu and Liu, 2001). A comparative study conducted in 
Argentina, Brazil and Italy showed that human urinary sphinganine/sphingosine 
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ratios were significantly higher in populations consuming fumonisin contaminated 
maize compared to populations consuming hardly any maize (Solfrizzo et al., 2004). 
In a Croatian study on human serum and urinary sphingoid base levels from the 
Balkan endemic nephropathy area with presumed exposure to maize contaminated 
with fumonisins, it was concluded that impairment in the metabolism of sphingolipids 
might be considered as an early indicator of disease (Ribar et al., 2001). 
 
Further studies are necessary to provide convincing evidence for using the 
sphinganine/ sphingosine ratio as a biomarker of human fumonisin exposure. The 
aim of this study was to compare the sphinganine and sphingosine levels as well as 
the sphinganine/sphingosine ratio in participants consuming subsistence grown 
fumonisin contaminated maize from a high (Centane) and low (Bizana) oesophageal 
cancer incidence area in the former Transkei region of the Eastern Cape Province of 
South Africa. Therefore, sphingosine and sphinganine levels and the 
sphinganine/sphingosine ratios were assessed in plasma and urine of male and 
female participants, while fumonisin levels were determined in maize samples 
collected contemporaneously from these regions. 
 
 
Materials and methods 
 
Chemicals 
Sphinganine and sphingosine were obtained from Sigma Chemical Company (St. 
Louis, MO, USA). C20-sphinganine was a generous gift from Prof. A. H. Merrill Jr., 
(School of Biology, Parker H. Petit Institute for Bioengineering and Bioscience, 
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Georgia Institute of Technology, Atlanta, USA). All other chemicals and solvents 
were analytical grade from Merck (Darmstadt, Germany). 
 
Sampling areas 
Following ethical approval from the Medical Research Council and informed consent, 
154 blood and 150 urine samples were collected from male and female participants 
during July 1997 from the Centane magisterial area, former Transkei region, Eastern 
Cape Province, South Africa. Home-grown maize was sampled from households in 
the same areas where these participants resided by random collection of visibly 
healthy maize (good maize) from 40 households. In addition, samples of visibly 
mouldy home-grown maize were hand selected from 31 of these households. In a 
similar manner 150 blood and 148 urine samples were collected from participants in 
the Bizana magisterial area of the former Transkei region during August 2000. As for 
the previous collection, 41 good and 30 mouldy home-grown maize samples were 
collected in Bizana and for comparison 41 good and 20 mouldy maize samples in 
Centane during July 2000. 
 
Analytical methods 
 
(i) Determination of sphinganine and sphingosine levels in plasma and urine 
Sphinganine and sphingosine levels in plasma and urine were determined according 
to the method of Shephard and Van der Westhuizen (1998) with minor modifications. 
The concentrations were assessed by high-performance liquid chromatography with 
C20-sphinganine as an internal standard. The derivatised extracts were separated 
on a reversed-phase Synergi 4µ Max-RP (75 x 4.6 mm I.D.) column (Phenomenex, 
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Torrance, CA, USA) and the isocratic mobile phase methanol/0.005 M potassium 
phosphate buffer (pH 3.35) (90:10) was pumped at a flow rate of 1 ml/min. 
 
(ii) Determination of fumonisins in maize 
Fumonisin levels in maize were determined according to the method of Shephard 
(2001). The derivatised extracts were separated on a reversed-phase Ultracarb 5 
ODS (20) (150 x 4.6 mm I.D.) column (Phenomenex, Torrance, CA, USA) and the 
isocratic mobile phase of methanol/0.1 M sodium dihydrophosphate (pH 3.35) 
(77:23) was pumped at a flow rate of 1 ml/min. 
 
(iii) Chromatography 
The chromatographic system consisted of a Rheodyne 7725i injector (Cotati, CA, 
USA) with 200 µL loop, Waters Model 510 solvent delivery system (Milford, MA, 
USA), Borwin Chromatography Integration Software (Varian JBMS Developpements, 
Le Fontanil, France) and Waters Fluorescence 474 detector (excitation–335 nm and 
emission–440 nm). 
 
Statistical analysis 
The plasma and urine data were analysed within a multivariate General Linear Model 
(GLM), whereas the fumonisin data were compared using univariate GLM. The data 
were tested for normality and equality of variances, with natural log transformation of 
all variables, except that of the sphinganine/sphingosine ratio variable. Hochberg's 
GT2 method was used to analyse multiple comparisons, due to unequal cell sizes. 
The SPSS version 13 software package (SPSS Inc., Chicago, IL, USA) was used for 
statistical analysis. 

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Results 
 
The means and standard deviation of the sphinganine and sphingosine levels and 
the sphinganine/sphingosine ratios of the male and female participants of the two 
magisterial areas in plasma are shown in Table 1 and in urine in Table 2. Both the 
mean female (p=0.01) and male (p>0.05) plasma sphinganine levels were higher in 
Centane than in Bizana. The statistical insignificance of the difference in the male 
participants might be due to the large variation observed both in Centane (2.4–174 
nM) and in Bizana (1.6–41 nM). Although the mean male and female sphingosine 
levels were higher in Centane than Bizana, this difference (p>0.05). was not 
significant. Significantly higher mean plasma sphinganine/sphingosine ratios in male 
as well as in female participants were detected in Centane compared to Bizana. 
 
Chapter 5.1 - Table 1 Plasma (Sa) and sphingosine (So) levels and the Sa/So 
ratios from two magisterial areas in the former Transkei 
region of the Eastern Cape Province, South Africa* 
Region Gender n 
Sphinganine 
(nM) 
Sphingosine 
(nM) 
Sa/So 
Ratio 
Centane 1997 Male 53 21.5±32.4aA†‡ 80.1±93.1aA 0.34±0.24aA 
 Female 99 16.5±19.4aA 72.2±78.6aA 0.30±0.27aA 
 Combined 152 18.2±24.8A 75.0±83.7A 0.32±0.26A 
Bizana 2000 Male 30 11.1±18.9aA 54.9±26.9aA 0.20±0.11aB 
 Female 120 9.92±10.8aB 55.6±36.9aA 0.17±0.16aB 
 Combined 150 10.16±10.5B 55.5±35.0A 0.18±0.15B 
*Mean values ± standard deviations 
†Lower case letters within columns: Means are significantly (p<0.05) different when 
followed by different letters for intra-magisterial area comparisons between males 
and females. 
‡Upper case letters within columns: Means are significantly (p<0.05) different when 
followed by different letters for inter-magisterial area comparisons of males, females 
and combined groups. 
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However, within the magisterial areas the plasma sphingoid base parameters 
between male and female participants were very similar. As the female participants 
were about twice the number of male participants in Centane and four-fold the 
number of male participants in Bizana the combined male and female mean plasma 
sphinganine level was significantly higher in Centane than in Bizana. The mean 
combined plasma sphinganine/sphingosine ratio was also significantly higher in 
Centane than in Bizana. 
 
Chapter 5.1 - Table 2 Urinary sphinganine (Sa) and sphingosine (So) levels and 
the Sa/So ratios from two magisterial areas in the former 
Transkei region of the Eastern Cape Province, South Africa* 
Region Gender n 
Sphinganine 
(nM) 
Sphingosine 
(nM) 
Sa/So 
Ratio 
Centane 1997 Male 54 2.87±4.90aA†‡ 14.2±22.3aA 0.31±0.34aA 
 Female 93 5.61±7.79bA 26.4±32.6bA 0.27±0.20aA 
 Combined 147 4.60±6.98A 21.9±29.8A 0.28±0.26A 
Bizana 2000 Male 31 1.11±0.44aA 4.14±1.77aB 0.29±0.09aA 
 Female 117 5.62±6.58bA 17.6±21.8bB 0.36±0.10aB 
 Combined 148 4.68±6.13A 14.8±20.1B 0.34±0.10B 
*Mean values ± standard deviations 
†Lower case letters within columns: Means are significantly (p<0.05) different when 
followed by different letters for intra-magisterial area comparisons between males 
and females. 
‡Upper case letters within columns: Means are significantly (p<0.05) different when 
followed by different letters for inter-magisterial area comparisons of males, females 
and combined groups. 
 
A different result profile was observed in the urinary sphingoid base parameters 
compared to the plasma result profile (Tables 1 and 2). The mean male urinary 
sphinganine level was higher in Centane than in Bizana, but due to the large 
variation in Centane the difference was not significant. The female sphinganine 
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levels were almost identical in the two areas. Mean male as well as female urinary 
sphingosine levels and therefore the combined levels were significantly higher 
(p<0.0001) in Centane than in Bizana. This resulted in the mean male urinary 
sphinganine/sphingosine ratios being similar in Centane and Bizana; whereas the 
mean female ratios were significantly lower (p<0.05) in Centane than in Bizana.  
 
Chapter 5.1 - Table 3 Fumonisin levels (mg/kg) in maize collected from two 
magisterial areas in the former Transkei region of the 
Eastern Cape Province, South Africa* 
Region/  
Maize n 
FB1 
(mg/kg) 
FB2 
(mg/kg) 
FB3 
(mg/kg) 
Total‡ 
Fumonisins 
(mg/kg) 
Range of 
Fumonisins 
Centane 1997       
Good 40 0.40±0.82 0.14±0.40 0.04±0.09 0.58±1.30 nd†-7.19 
Mouldy 31 2.82±4.28 1.66±2.51 0.37±0.52 4.85±7.26 0.03-37.8 
Centane 2000       
Good 41 0.55±1.06 0.28±0.70 0.054±0.12 0.88±1.78 nd-7.96 
Mouldy 20 8.06±9.09 3.91±4.44 0.93±1.17 12.9±14.6 0.32-51.8 
Bizana 2000       
Good 41 0.63±1.09 0.24±0.51 0.055±0.12 0.92±1.70 nd-6.41 
Mouldy 30 5.75±7.41 2.88±3.75 0.74±1.04 9.37±12.1 0.39-53.0 
*Mean values ± standard deviations are not significantly different for inter- or intra-
magisterial area comparisons of good and mouldy maize. 
‡Total fumonisins represents the mean of all samples, with not detected taken as 
zero. 
†nd = not detected (< 0.005 mg/kg) 
 
Due to the higher number of female than male participants, the combined mean 
urinary sphinganine/sphingosine ratios were also significantly lower (p<0.05) in 
Centane than in Bizana. Furthermore, the mean urinary sphingosine levels in the 
male participants were significantly lower than the female participants within both the 
magisterial areas. 
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The percentage of good home-grown maize samples positive for fumonisins in both 
magisterial areas were very similar (38/40 and 37/41 in Centane in 1997 and 2000, 
respectively, and 40/41 in Bizana in 2000). The mean total fumonisin (FB1 + FB2 + 
FB3) levels in the good maize collected from households in 1997 from Centane was 
lower than the mean fumonisin levels in the maize collected in 2000 from both the 
Bizana and Centane areas, whereas the mean total fumonisin levels in the mouldy 
maize in Centane in 2000 was more than two-fold higher than in 1997 (Table 3). 
However, no statistically significant differences were observed between the mean 
fumonisin levels in good home-grown maize or in mouldy home-grown maize 
between any of these collections. 
 
 
Discussion 
 
In this cross sectional study we observed that the plasma sphinganine and 
sphingosine levels of both the male and female participants were higher in the high 
oesophageal cancer incidence area of Centane than in the low incidence area of 
Bizana. However, these increased mean sphinganine levels were significantly higher 
only in the female participants, which were about twice the number of male 
participants in Centane and four-fold the number of male participants in Bizana. The 
relative number of male and female participants in this study, and other similar 
studies (Shephard et al., 2007; Van der Westhuizen et al., 1999), reflect the socio-
economic situation in these regions where males are generally absent as migrant 
workers. Nevertheless, the plasma sphinganine/ sphingosine ratios in both the males 
and females, as well as the combined ratios, were significantly higher in Centane 
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than in Bizana. Previous studies conducted in these areas have shown that the 
home-grown maize consumed as the staple cereal in Centane was contaminated 
with higher levels of fumonisins than the maize consumed in Bizana (Marasas, 2001; 
Rheeder et al., 1992; Shephard et al., 2007). 
 
Although the male urinary sphingosine and sphinganine levels were higher in 
Centane compared to Bizana, the difference in sphinganine, due to a large variation, 
was not significant. If the unanticipated higher mean female sphinganine/sphingosine 
ratio in Bizana were as a result of an increased mean sphinganine level in Bizana, it 
would have conformed to the expectation that the sphinganine/sphingosine ratios 
would be higher in an area where higher levels of fumonisin contaminated maize are 
consumed by the participants (Qui and Li, 2001; Riley et al., 1993; Solfrizzo et al., 
2004). However, the higher female ratio was due to a significantly lower sphingosine 
level in Bizana compared to Centane, similarly to the mean male urinary 
sphingosine. Thus the plasma and urinary sphingosine levels in both males and 
females were higher in Centane than in Bizana.  Serum sphingosine levels were 
correlated with age, tocopherols, carotenoids, selenium, retinol and cholesterol 
serum levels in a cross-sectional study conducted in a high oesophageal cancer risk 
area in Henan Province, China, whereas no associations were observed between 
serum sphinganine levels and demographic characteristics, diet and physiologic 
parameters (Abnet et al., 2001b). In this study, as observed in previous studies, the 
male participants had significantly lower urinary sphingosine levels than the female 
levels in both Centane and Bizana (Castegnaro et al., 1996; 1998; Van der 
Westhuizen et al., 1999). 
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The mean total fumonisin (FB1 + FB2 + FB3) level in good home-grown maize 
collected from Centane in 1997 and 2000 was 580 and 880 µg/kg, respectively, 
whereas Bizana in 2000 had a mean total fumonisin level of 920 µg/kg. Previous 
studies conducted in Centane reported mean total fumonisin levels of 2110, 1975 
and 1955 µg/kg and 85, 565 and 930 µg/kg in Bizana (Marasas, 2001; Rheeder et 
al., 1992; Rheeder et al. unpublished data). The mean total fumonisin levels for 
Centane in 1997 compared well with previously reported levels, whereas the level for 
Bizana in 2000 was higher than previously reported. Based on the mean total 
fumonisin level in good home-grown maize collected from Centane in 1997, 2000 
and Bizana in 2000 and the assumption that a 60 kg person consumes 456 and 379 
g of dry maize per day in Centane and Bizana, respectively (Shephard et al., 2007), 
the estimated probable daily intake (PDI) of fumonisins in these areas was 4.4, 6.7 
and 5.8 µg/kg body weight/day, respectively. The PDI for fumonisin in Centane in 
1997 was marginally lower than that in Bizana. Therefore, the significantly higher 
combined mean male and female plasma sphinganine level of 18 nM, resulting in a 
mean combined plasma sphinganine/ sphingosine ratio of 0.32, in Centane than the 
sphinganine level of 10 nM, resulting in a 0.18 ratio, in Bizana, could not be ascribed 
to a higher fumonisin exposure level. However, the trend of higher PDI in Centane 
than in Bizana was again observed in 2000. In an extreme situation of low socio-
economical status mouldy maize might be consumed, and then based on the above 
assumptions for this study, fumonisin exposure could result in estimated PDI of 36.9, 
98.0 and 59.2 g/kg body weight/day, respectively. A recent study conducted in 
these areas observed mean PDI of 2.2 – 17.4 and 0.84 – 8.0 µg/kg body weight/day 
in Centane and Bizana, respectively (Shephard et al., 2007). The mean estimated 
fumonisin exposure levels amongst consumers of beer in these areas could be 6.5 
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µg/kg body weight/day (Shephard et al., 2005). Consumption of beer brewed from 
mouldy home-grown maize will increase the PDI of fumonisins significantly. These 
studies show that in Centane and Bizana most of the fumonisin exposure levels were 
above the provisional maximum tolerable daily intake set by the Joint FAO/WHO 
Expert Committee on Food Additives of 2 µg total fumonisin/kg body weight/day 
(Bolger et al., 2001). 
 
The combined urinary sphinganine/sphingosine ratios in Centane ranged from 0.02 
to 1.70 compared to 0.12 to 0.65 in Bizana. These urinary sphinganine/sphingosine 
ratio ranges were higher than previously reported in China where the urinary ratio 
ranged from 0.028 to 0.25 prior to fumonisin exposure and following exposure of 0.4 
to 740 g FB1/kg body weight/day, the urinary ratio ranged from 0.037 to 0.32, with a 
single exception which had a value of 0.87 (Qiu and Liu 2001). Given the very high 
levels of fumonisin exposure, these results would suggest that urinary 
sphinganine/sphingosine ratios would not be a viable and sensitive biomarker 
(Shephard et al., 2007). Participants from a study conducted in southern Brazil and 
northern Argentina exposed to mean fumonisin intakes of 0.57 and 0.55 g FB1/kg 
body weight/day, respectively, had mean urinary ratios of 1.57 and 0.69, 
respectively. In comparison, non-maize consuming participants from this study in 
southern Italy and central Argentina had a mean urinary ratio of 0.36, which was not 
significantly different from the ratio in participants from northern Argentina (Solfrizzo 
et al., 2004). It was thus concluded that the high sphinganine/sphingosine ratios 
observed in southern Brazil were not the result of fumonisin exposure, but of other 
unknown confounding factors. 
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Fumonisin exposure not only disrupts the base sphingolipids, but also results in 
decreased levels of the more complex sphingolipids causing a cascade of cellular 
effects, e.g. disruption of cellular membranes and effecting the homeostasis of 
cellular growth and differentiation (Riley et al., 2001; Merrill et al., 2001). However, 
the sampling from the two magisterial areas was from two different years and the 
fumonisin levels in maize fluctuate annually, thus complicating the investigation into 
the long term effect of fumonisin exposure and the consequence on the sphingoid 
bases and their role as a biomarker in humans. Therefore future studies should be 
aimed at a comparison of sphingolipid biomarkers and fumonisin exposure on an 
individual basis over an extended period. 
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Abstract 
 
Low and high oesophageal cancer incidence areas of the former Transkei region of 
South Africa have been associated with corresponding low and high levels of 
fumonisin contaminated home-grown maize. This is the first study in South Africa 
assessing fumonisin B (FB) mycotoxin exposure by quantifying individual maize 
consumption with weighed food records and FB levels from maize in each 
participant’s household and concurrently evaluating sphinganine sphingosine and 
sphinganine/sphingosine ratios in plasma and urine of these participants as possible 
biomarkers of FB exposure. The high consumption of maize in Bizana (n = 36) and 
Centane (n = 30) of 0.41 ± 0.21 and 0.39 ± 0.19 kg/day, respectively, confirms the 
reliance on maize as the dietary staple. Mean total FB (FB1+FB2+ FB3) levels in 
home-grown maize were 0.495 ± 0.880 and 0.665 ± 0.660 mg/kg in Bizana and 
Centane, respectively. Mean fumonisin exposure based on individual consumption 
was 3.9 ± 7.3 and 4.1 ± 7.6 µg/kg body weight/day, respectively, for Bizana and 
Centane. The mean combined sphinganine/sphingosine ratios in Bizana and 
Centane were similar and ranged from 0.10-0.55 in plasma (n = 41) and urine (n = 
62). There was no association between sphingoid base levels and/or 
sphinganine/sphingosine ratios in the plasma and urine and individual fumonisin 
exposure, negating the sphingoid bases as potential biomarkers of fumonisin 
exposure in humans. 
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Introduction 
 
Fumonisins, mycotoxins mainly produced by Fusarium verticillioides and F. 
proliferatum, occur world-wide in maize and maize-based products intended for 
human consumption (Marasas, 2001; Shephard et al., 1996a). Fumonisin B1, B2 and 
B3 (FB1, FB2 and FB3) are the major naturally occurring fumonisin analogues in 
maize. Oesophageal and liver cancer as well as neural tube defects in humans have 
been linked to fumonisins (Marasas et al., 2004; Rheeder et al., 1992; Sun et al., 
2007). The former Transkei region, Eastern Cape, South Africa, has one of the 
highest oesophageal cancer incidence rates in the world (Makaula et al., 1996). 
Early studies in the region reported a 20-fold lower oesophageal cancer incidence 
rate in the Bizana than in the Centane magisterial district. Even though more recent 
studies have shown a rising incidence rate in Bizana, Centane has maintained 
consistently higher oesophageal cancer incidence rates (Makaula et al., 1996; 
Somdyala et al., 2003a,b).  
 
Previous studies have shown that fumonisin levels in home-grown maize were up to 
25-fold lower in Bizana than in Centane (Rheeder et al., 1992), whereas a more 
recent study has shown similar high fumonisin levels in both areas (Van der 
Westhuizen et al., 2008). High levels of fumonisins have also been reported in 
naturally contaminated maize from other areas where high incidences of 
oesophageal cancer occur, viz., Charleston, SC, USA; Cixian County, Fusui County, 
Guangxi Autonomous Region and Huaian County, Jiangsu Province, China; 
Northern Italy and Santa Catarina, Southern Brazil (Doko and Visconti, 1994; Sun et 
al., 2007; Sydenham et al., 1991; Van der Westhuizen et al., 2003). The International 
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Agency for Research on Cancer (IARC) declared FB1 as a group 2B carcinogen 
(possibly carcinogenic in humans) (IARC, 2002). The 56th meeting of the Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) determined a group 
provisional maximum tolerable daily intake (PMTDI) for FB1, FB2 and FB3, alone or in 
combination, of 2 µg/kg body weight/day (Bolger et al., 2001).  
 
Fumonisins inhibit the key enzyme, ceramide synthase, in the de novo sphingolipid 
pathway leading to a disruption in levels of the sphingoid bases in mammalian cells. 
The ratios of the sphingoid bases, sphinganine and sphingosine, in plasma and urine 
of various animal species have been reported as possible biomarkers of PDI (Riley 
et al., 1994; Shephard et al., 1996b; Van der Westhuizen et al., 2001; Wang et al., 
1992). However, subsequent studies conducted in various human populations 
exposed to different levels of fumonisin have not been able to show that sphinganine 
or sphingosine levels or the sphinganine/sphingosine ratio can be utilised as a 
biomarker for fumonisin exposure (Qiu and Liu, 2001; Solfrizzo et al., 2004; Silva et 
al., 2009; Van der Westhuizen et al, 1999, 2008). Previous studies comparing the 
Bizana and Centane populations as a whole failed to find an association between 
calculated fumonisin exposure (based on mean fumonisin levels of maize collected 
in the respective areas and an estimated mean maize consumption) and the mean 
plasma or urinary sphinganine/sphingosine ratios (Van der Westhuizen et al., 1999, 
2008). 
 
The aim of this study was to assess the potential of plasma and urinary sphinganine 
and sphingosine levels and/or sphinganine/sphingosine ratios as biomarkers of 
fumonisin exposure at an individual level within the Bizana and Centane populations. 
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Fumonisin exposure was determined individually from maize consumption and 
fumonisin levels in maize from the participants’ household. 
 
 
Materials and Methods 
 
Chemicals 
Fumonisin (FB1, FB2 and FB3) standards were isolated (>95% purity) at the 
PROMEC Unit according to the method of Cawood et al. (1991). Sphinganine and 
sphingosine were obtained from Sigma Chemical Company (St. Louis, MO, USA) 
and C20-sphinganine standard (D-erythro-C20-dihydro-sphingosine) from Matreya 
Inc. (Pleasant Gap, PA, USA). All other chemicals and solvents were analytical 
grade from Merck (Darmstadt, Germany). 
 
Study population and sampling 
The study was approved by the Ethics Committee of the Medical Research Council 
and informed consent was obtained from each participant. Participants were drawn 
over the study period (2001–2003) from selected households in north-western 
Bizana (n = 24) and south-eastern Centane (n = 24) magisterial districts, former 
Transkei Region, Eastern Cape Province, South Africa. The total number of 
participants during the study period were 8 male and 28 female participants from 
Bizana of whom blood (n = 21, 2001–2002) and spot urine (n = 36, 2001–2003) 
samples were collected randomly during the day and 11 male and 20 female 
participants from Centane of whom blood (n = 20) and urine (n = 26) samples were 
collected similarly. The maize sampled from the participants' households during the 
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study period was healthy home-grown maize used to prepare maize-based meals at 
the time of collection. Where home-grown maize was not available, commercial 
maize (meal or samp, dehulled dried maize kernels that have been stamped broken 
into large pieces) were collected from the households. In household with both home-
grown and commercial maize both kinds were collected (see Table 3).  
 
Analytical methods 
 
(i) Determination of fumonisins in maize 
Fumonisin levels in maize were determined according to the method of Shephard 
(2001). Briefly, maize was ground in a laboratory mill to a fine meal and extracted 
with 100 mL methanol/water by homogenization. A 10 mL aliquot was applied to a 
strong anion exchange solid phase extraction cartridge and the fumonisins were 
eluted with acetic acid in methanol. The purified extract was evaporated to dryness 
with nitrogen gas at 60 °C and the dried residue was stored at 4 °C awaiting 
chromatographic analysis. The redissolved (200 µL methanol) extracts were 
derivatised and separated (20 µL injection) on a reversed-phase Luna 4µ C18 (2) 
(150 x 4.6 mm I.D.) column (Phenomenex, Torrance, CA, USA) and the isocratic 
mobile phase of methanol/0.1 M sodium dihydrogenphosphate (pH 3.35) (77:23) was 
pumped at a flow rate of 1 ml/min. The chromatographic system consisted of a 
Rheodyne 7725i injector (Cotati, CA, USA), Waters Model 510 solvent delivery 
system (Milford, MA, USA), Borwin Chromatography Integration Software (Varian 
JBMS Developpements, Le Fontanil, France) and Waters Fluorescence 474 detector 
(excitation – 335 nm and emission – 440 nm). 
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(ii) Determination of sphinganine and sphingosine levels in plasma and urine 
Sphingoid bases were determined according to the method of Castegnaro et al. 
(1998) with minor adjustments. Briefly, sphinganine and So were extracted from 
plasma and urine samples by shaking with ethyl acetate. The organic layer was 
separated by centrifugation (500 g, 10 min, 4 °C) and evaporated to dryness with 
nitrogen gas below 40 °C. The dried residue was redissolved in a potassium 
hydroxide/chloroform solution and hydrolysed at 37 °C for 90 min. After incubation 
the hydrolysed residue was washed with alkaline water and centrifuged (500 g, 10 
min, 4 °C). The chloroform layer was evaporated to dryness with nitrogen gas at 40 
°C and stored at 4 °C awaiting chromatographic analysis. The redissolved (275 µL 
methanol) extracts were derivatised with o-phthaldialdehyde and separated (50–75 
µL injection) on the same HPLC system used for the fumonisin analyses with a 
reversed-phase Synergi 4 µ Max-RP (75 x 4.6 mm I.D.) column (Phenomenex, 
Torrance, CA, USA) and an isocratic mobile phase of methanol/5 mM potassium 
phosphate buffer (pH 3.35) (90:10) pumped at a flow rate of 1 mL/min. Quantification 
was performed with C20– sphinganine as an internal standard. 
 
Fumonisin exposure 
Individual fumonisin exposure for each participant was calculated as µg/kg body 
weight/day based on the total fumonisin (TFB = FB1 + FB2 + FB3) level in healthy 
home-grown and/or commercial maize collected from each participant’s household. 
At the time of collection most of the participants were consuming food prepared from 
home-grown maize as opposed to commercial maize. Maize consumption was 
assessed by acquiring weighed food records for each member of the household with 
respect to maize dishes (Shephard et al., 2007). 
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Statistical analysis 
The data were analysed within a one-way Analysis of Variance (ANOVA) model. The 
data was tested for normality and equality of variances, with natural log 
transformation of all variables. The Stata/IC version 10.1 software package 
(StataCorp, Texas, USA) was used for statistical analysis. 
 
 
Results 
 
Study population, maize intake and fumonisin exposure 
The participants were predominantly female, particularly from Bizana, primarily due 
to migrant labour and therefore participating males tended to be older. The combined 
mean age of the Bizana participants was 49 ± 17 years compared to the 48 ± 18 
years of Centane (Table 1). 
 
Chapter 5.2 - Table 1 The combined (2001–2003) age and weight (mean ± 
standard deviation) in male and female participants from the 
two magisterial districts in the former Transkei. 
Region Gender n 
Age 
(years) 
Weight 
(kg) 
Bizana     
 Male 8 61 ± 14 63 ± 10 
 Female 28 46 ± 17 75 ± 23 
 Combined 36 49 ± 17 72 ± 21 
Centane     
 Male 11 48 ± 19 66 ± 14 
 Female 20 48 ± 18 69 ± 10 
 Combined 31 48 ± 18 68 ± 12 
Means are not significantly different. 
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In Bizana the combined mean body weights was 72 ± 21 kg, whereas in Centane it 
was 68 ± 12 kg. The mean maize intakes for males (0.36 ± 0.22) and females (0.43 
± 0.21 kg/day) in Bizana were similar to that obtained in Centane which were 0.44 ± 
0.19 and 0.37 ± 0.19 kg/day, respectively, for males and females (Table 2).  
 
Chapter 5.2 - Table 2 The combined (2001–2003) maize intake and probable daily 
intake (PDI) (mean ± standard deviation) in male and female 
participants from the two magisterial districts in the former 
Transkei 
Region Gender n 
Maize 
intake 
(kg/day) n 
PDI1 
(µg/kg 
bw/day) 
PDI1 
Range 
(µg/kg 
bw/day) 
Participants 
exceeding 
PMTDI2 
(n) 
Bizana        
 Male 8 0.36±0.22 7 4.8±7.5 0.49–21 2 
 Female 28 0.43±0.21 23 3.6±7.4 > 0.01–29 6 
 Combined3 36 0.41±0.21 30 3.9±7.3 > 0.01–29 8 
Centane        
 Male 10 0.44±0.19 10 1.9±2.0 0.04–5.5 4 
 Female 20 0.37±0.19 20 5.2±9.1 0.21–35 8 
 Combined 30 0.39±0.19 30 4.1±7.6 0.04–35 12 
1PDI based on mean total fumonisin levels, maize intake and individual body weight 
(bw) (µg/kg body weight/day) 
2Provisional maximum tolerable daily intake (PMTDI) = 2 µg fumonisin/kg bw/day 
(JECFA) 
3Combined = Combining the results obtained for the male and female participants 
 Means are not significantly (p > 0.05) different within nor between magisterial 
districts 
 
The maize samples collected in the two magisterial districts over the three harvesting 
seasons (2001–2003) had a wide range of fumonisin levels, due to seasonal 
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variation, resulting in large standard deviations (Table 3). The mean TFB level of the 
home-grown maize in the 2003 season compared with the 2001 and 2002 seasons 
were significant lower (p < 0.05) in Bizana and although the 2002 and 2003 seasons 
also had lower levels than 2001 in Centane, these differences were not significantly 
(p > 0.05) different. In 2003 the mean TFB of the home-grown maize was marginally 
(p = 0.57) higher in Centane than in Bizana. There was no significant difference (p =  
 
Chapter 5.2 - Table 3  The total fumonisin levels (mean ± standard deviation) in 
home-grown (separately) and commercial (combined) maize 
from the two magisterial districts in the former Transkei. 
Region 
Maize 
Season 
n 
Total fumonisin1 
(mg/kg) 
Range 
(mg/kg) 
Bizana Home-grown    
 2001 7 1.020±1.465a2 0.015–3.975 
 2002 9 0.485±0.525a 0.045–1.430 
 2003 9 0.090±0.160A3b nd4–0.500 
 Total 25 0.495±0.880 nd–3.975 
Centane Home-grown    
 2001 3 1.140±0.705a 0.720–1.955 
 2002 9 0.540±0.675a 0.040–1.980 
 2003 3 0.565±0.560aB 0.195–1.205 
 Total 15 0.665±0.660 0.040–1.980 
Bizana Commercial    
 2001-2003 9 0.530±0.520 0.130–1.580 
Centane Commercial    
 2001-2003 11 0.235±0.305 0.005–0.900 
Combined Commercial 20 0.370±0.430 0.005–1.580 
1Mean total fumonisin (FB1 + FB2 + FB3)  
2Lower case letters: Means in a column are significantly (p < 0.05) different when 
followed by different letters for seasonal comparison in Centane 
3Upper case letters: Means in a column are marginally (p = 0.57) different when 
followed by different letters for seasonal comparison between areas. 
4nd = not detected (< 0.005 mg/kg) 
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0.062) in the mean (2001–2003) TFB levels of the home-grown maize between 
Bizana and Centane. The mean TFB in commercial maize (2001–2003) from Bizana 
compared to Centane were also not significantly different (p > 0.05). Although there 
were also no significant difference between the mean TFB (2001–2003) of the home-
grown maize and the commercial maize within the areas, the TFB in Bizana 
commercial maize (n = 9) was higher (p > 0.05) than in home-grown maize (n = 25), 
whereas in Centane the TFB in commercial maize (n = 11) was lower (p > 0.05) than 
in home-grown maize (n = 15). The most abundant fumonisin analogue, FB1, 
contributed 76% of the TFB contamination with 58/60 maize samples positive for 
fumonisin (results not shown). The mean probable daily intake (PDI) of fumonisin by 
the combined participants in Bizana and Centane were also similar at 3.9 ± 7.3 and 
4.1 ± 7.6 µg/kg body weight (bw)/day, respectively, with a range of < 0.1–35 µg/kg 
bw/day for the entire study period (Table 2). 
 
Sphingoid base levels and ratios in plasma and urine 
There were no significant differences in gender or season (data not shown) in the 
plasma sphingoid bases, sphinganine and sphingosine, or in the sphinganine/ 
sphingosine ratio within or between areas (Table 4). The sphinganine levels for all 
participants ranged from 1.9 to 10 and 1.1–21 nM in Bizana and Centane, 
respectively, compared to the sphingosine ranging from 8.3 to 40 and 4.8 to 52 nM, 
respectively, (ranges not shown in Table 4). The sphinganine/sphingosine ratios 
were similar within and between the magisterial districts ranging from 0.10 to 0.51 
standard deviations. When comparing the plasma to urinary sphingoid bases the 
levels were also similar, except for the ten- and fivefold lower sphinganine and 
sphingosine level, respectively, in the Centane males. 
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Chapter 5.2 - Table 4 The combined plasma (2001-2002) and urinary (2001-2003) 
sphinganine and sphingosine levels and the 
sphinganine/sphingosine (Sa/So) ratios (mean ± standard 
deviation) in male and female participants from the two 
magisterial districts in the former Transkei. 
Plasma/ 
Urine 
Region/ 
Gender n 
Sphinganine 
(nM) 
Sphingosine 
(nM) 
So/Sa 
Ratio 
Plasma Bizana     
 Male 7 4.4±1.4 19±10 0.26±0.10 
 Female 14 6.3±2.8 22±10 0.30±0.08 
 Combined1 21 5.6±2.5 21±10 0.29±0.09 
Plasma Centane     
 Male 8 7.2±6.4 23±16 0.29±0.10 
 Female 12 6.9±6.5 21±12 0.27±0.12 
 Combined 20 7.0±6.3 22±14 0.28±0.11 
Urine Bizana     
 Male 8 3.4±7.0 21±46 0.17±0.09 
 Female 28 8.1±16 34±68 0.22±0.08 
 Combined 36 7.1±14 31±63 0.21±0.08 
Urine Centane     
 Male 8 0.72±0.55a2 4.1±1.9a 0.17±0.10 
 Female 18 4.6±5.1b 20±22b 0.21±0.13 
 Combined 26 3.4±4.6 15±20 0.20±0.12 
1Combined = Combining the results obtained for the male and female participants 
2Means in a column are significantly (p < 0.05) different when followed by different 
letters 
 
A different urinary sphingoid base profile to that in plasma was observed when 
comparing male and female levels. Although the sphinganine and sphingosine levels 
were lower in males than females in Bizana (p > 0.05) and Centane (p < 0.05); the 
sphinganine/sphingosine ratios were similar between the areas. The higher urinary 
sphinganine and sphingosine levels in both males and females in Bizana compared 
to Centane were not significant, due to the large standard deviations. When 

	
comparing the plasma to urinary sphingoid bases the levels were also similar, except 
for the ten- and fivefold lower Sa and So level, respectively, in the Centane males. 
 
Chapter 5.2 - Table 5 Comparison of the respective plasma and urinary 
sphinganine/ sphingosine (Sa/So) ratios (mean ± standard 
deviation) for probable daily intakes (PDI) above and below 
the provisional maximum tolerable daily intake (PMTDI). 
Region n 
PDI1 
(µg/kg bw/day) n 
Plasma ratio 
(Sa/So) n 
Urine ratio 
(Sa/So) 
PDI below PMTDI2 
Bizana 22 0.71±0.61 14 0.30±0.08 22 0.20±0.09 
Centane 18 0.83±0.68 9 0.26±0.10 13 0.21±0.14 
Combined3 40 0.77±0.64 23 0.28±0.09 35 0.20±0.11 
PDI above PMTDI 
Bizana 8 12.6±10.1 7 0.26±0.09 8 0.21±0.09 
Centane 12 9.1±10.3 11 0.30±0.12 12 0.19±0.12 
Combined 20 10.5±10.1 18 0.29±0.11 20 0.20±0.11 
1Probable daily intake (PDI) based on mean total fumonisin levels, maize intake and 
individual body weight (bw) (µg/kg bw/day) 
2Provisional maximum tolerable daily intake (PMTDI) = 2 µg fumonisin/kg bw/day 
(JECFA) 
3Combined = Combining the results obtained for Bizana and Centane magisterial 
districts 
Means are not significantly (p > 0.05) different within nor between magisterial 
districts 
 
The participants were divided into groups with PDIs below and above the PMTDI 
determined by JECFA (Table 5). There was no difference between the mean plasma 
and urinary sphinganine/sphingosine ratios for PDIs above or below the PMTDI. 
Individual fumonisin exposures compared to the individual sphinganine/sphingosine 
ratios for all the participants from the Bizana and Centane magisterial districts in 
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plasma (2001–2002, r = 0.1098, p > 0.05,) and urine (2001–2003, r = 0.0638, p > 
0.05) failed to show a relationship (p > 0.05) (Figure 1). 
 

Chpater 5.2- Figure 1 Individual fumonisin exposures compared to the individual 
sphinganine/ sphingosine ratios for all the participants from 
the Bizana and Centane magisterial districts in plasma (r = 
0.1098, p > 0.05) and urine (r = 0.0638, p > 0.05). 
 
 
Discussion 
 
This is the first study in Southern Africa assessing individual fumonisin exposure to 
evaluate sphinganine, sphingosine and sphinganine/sphingosine ratios in plasma 
and urine of each participant as possible biomarkers of FB exposure in humans. The 
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mean dry maize intake for all participants over the entire study period was 0.41 and 
0.39 kg/day in Bizana and Centane, respectively. This is comparable to a previous 
study using the same food consumption methodology conducted on a larger 
population in these areas which reported mean intake levels of 0.38 and 0.46 kg/day, 
respectively (Shephard et al., 2007). The high consumption emphasizes that maize 
is almost the sole source of food in these rural areas and that the mean fumonisin 
levels in both Bizana and Centane would result in PDIs exceeding the JEFCA 
PMTDI. The standard set by the FDA for the United States is 2 mg TFB/kg maize 
and the European Commission regulation is 1 mg TFB/kg maize intended for direct 
human consumption (European Commission Regulations, 2007; FDA, 2001). Based 
on results obtained from this study in Centane, a 68 kg participant consuming 0.39 
kg maize/day at 1 mg TFB/kg maize (European Commission regulation) would result 
in a PDI of 5.7 µg/kg body weight/day. This participant would have to consume less 
than 0.14 kg maize/day to achieve a PDI below the PMTDI at the regulatory level set 
by the European Commission. Even a participant from Bizana (72 kg) consuming 
commercial maize at the current TFB (0.495 mg/kg) would result in a PDI of 2.8 
µg/kg body weight/day. Furthermore, regulating fumonisin levels in maize at a 
national level will have no effect on fumonisin exposure in rural communities 
consuming large quantities of maize (Gelderblom et al., 2008). Therefore finding 
measures to reduce fumonisin contamination of maize in this region is imperative. 
 
Seasonal variation of the fumonisin levels in the maize from this area is evident from 
the current study which is in agreement with previous studies (Van der Westhuizen 
et al., 2008). Despite the large seasonal variations in fumonisin contamination of the 
home-grown maize within and over the three study seasons, the combined mean 
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fumonisin exposure was similar in Bizana and Centane. Bizana had a higher mean 
TFB level in 2001 than previously reported in this area and Centane had lower levels 
in 2002 and 2003 than ever reported (Rheeder et al., 1992; Marasas, 2001, Van der 
Westhuizen et al., 2008). Maize from Bizana in 2003 had a significantly lower TFB 
level than maize in Centane and was comparable to the lowest level reported for 
Bizana, conforming in 2003 to the previously observed pattern for this region 
(Rheeder et al., 1992). In the current study fumonisin exposure was assessed at 3.9 
µg/kg bw/day in Bizana and 4.3 µg/kg bw/day in Centane. Comparative fumonisin 
exposure levels 3.4 (Bizana) and 8.7 (Centane) µg/kg bw/day, were obtained in an 
earlier study estimating PDI, assuming an adult body weight of 60 kg and a mean 
fumonisin level calculated from all previous studies conducted in these areas 
(Shephard et al., 2007).  
 
The combined PDI in each area was approximately double the JECFA PMTDI; with 
20/59 participants exposed to levels exceeding the PMTDI showing that certain 
individual participants were exposed to extremely high levels of fumonisin. As 
studies in experimental animals showed that fumonisin exposure causes an increase 
in sphingoid base levels in plasma and urine, specifically in sphinganine and thus the 
sphinganine/sphingosine ratio (Enongene et al., 2002; Van der Westhuizen et al., 
2001; Wang et al., 1999), this study investigated the sphingoid levels and ratios as 
potential biomarkers of fumonisin exposure. It was hypothesised that the 
sphinganine levels and the sphinganine/sphingosine ratio in plasma and urine would 
be elevated in participants exposed to higher fumonisin levels. A previous study 
observed that there was no relationship between estimated mean fumonisin 
exposures (based on mean fumonisin levels and mean maize consumption) within 
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communities and the mean plasma and urinary sphingoid bases and sphinganine/ 
sphingosine ratios in males and females (Van der Westhuizen et al., 2008). This 
study measured sphingoid bases and fumonisin exposure on an individual basis 
enabling direct comparison. However, despite a very wide range of fumonisin 
exposure, sphinganine, sphingosine and sphinganine/sphingosine ratios failed to 
show a relationship with FB exposure. In addition, neither plasma nor urinary 
sphingoid base profiles showed any association with the extent of exposure. Even 
comparison of the PDI of the participants exposed above and below the PMTDI did 
not show any difference in plasma or urinary sphingoid base profiles. Therefore, the 
sphingoid bases and ratios could not be associated with the fumonisin exposure in 
this study. This is in agreement with similar studies conducted in Burkino Faso; 
Henan, China and Southern Italy, Southern Brazil and Central Argentina (Nikiéma et 
al., 2008; Qiu and Liu, 2001; Silva et al., 2009; Solfrizzo et al., 2004). 
 
Despite the large intra- and inter seasonal variation in fumonisin contamination of the 
home-grown maize as well as the large variation in individual sphingoid base levels, 
the combined fumonisin exposure levels and sphinganine/sphingosine ratios 
between the areas were similar. In conclusion, neither plasma nor urinary sphingoid 
base levels and sphinganine/sphingosine ratios could be associated with fumonisin 
exposure on an individual basis and therefore negated the sphingoid bases as 
potential biomarkers in humans. Future studies should investigate alternative 
biomarkers and a very recent study in Mexico has indicated that FB1 in urine may be 
more promising to monitor fumonisin exposure in humans (Gong et al., 2008). 
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Abstract 
 
Subsistence farming communities with low socio-economic status reliant on a mono 
cereal maize diet are exposed to fumonisin levels that exceed the provisional 
maximum tolerable daily intake of 2 µg/kg body weight/day recommended by the 
Joint FAO/WHO Expert Committee on Food Additives. In the rural Centane 
magisterial district, Eastern Cape Province, South Africa, it is customary during food 
preparation to sort visibly infected maize kernels from good maize kernels and to 
wash the good kernels prior to cooking. However, this customary practice seems not 
to sufficiently reduce the fumonisin levels. This is the first study to optimise the 
reduction of fumonisin mycotoxins in home-grown maize based on customary 
methods of a rural population under laboratory-controlled conditions. Maize obtained 
from subsistence farmers was analysed for the major naturally occurring fumonisins 
(FB1, FB2 and FB3) by fluorescence HPLC. Large variations were observed in the 
unsorted and the experimental maize batches attributable to the non-homogeneous 
distribution of fumonisin contamination in maize kernels. Optimised hand-sorting of 
maize kernels by removing the visibly infected/damaged kernels (fumonisins, 53.7 ± 
15.0 mg/kg, 2.5% by weight) reduced the mean fumonisins from 2.32 ± 1.16 mg/kg 
to 0.68 ± 0.42 mg/kg. Hand washing of the sorted good maize kernels for a period of 
10 min at 25°C resulted in optimal reduction with no additional improvement for wash 
periods up to 15 h. The laboratory optimised sorting reduced the fumonisins by 71 ± 
18% and an additional 13 ± 12% with the 10 min wash. Based on these results and 
on local practices and practicalities the protocol that would be recommended to 
subsistence farmers consists of the removal of the infected/damaged kernels from 
the maize followed by a 10 min ambient temperature water wash. 
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Introduction 
 
Fumonisins, carcinogenic mycotoxins, occur worldwide in maize and maize-based 
products consumed by humans (Shephard et al., 1996). Fumonisin B1, B2 and B3 
(FB1, FB2 and FB3) are the major naturally occurring fumonisin analogues in maize 
(Shephard et al., 1996). The most abundant of the fumonisin mycotoxins, FB1, was 
evaluated by the International Agency for Research on Cancer as a Group 2B 
carcinogen, i.e. possibly carcinogenic to humans (IARC, 2002). Several studies have 
reported an association between high incidence rates of oesophageal cancer and 
consumption of fumonisin contaminated maize by rural populations, e.g., Eastern 
Cape Province, South Africa; Jiangsu Province, China and Santa Catarina, Brazil 
(Marasas, 2001; Sun et al., 2007; Van der Westhuizen et al., 2003). Fumonisin 
exposure has also been associated with primary liver cancer in Jiangsu Province, 
China (Sun et al., 2007), and has been implicated in the aetiology of neural tube 
defects (Marasas et al., 2004).  
 
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has determined 
a group provisional maximum tolerable daily intake (PMTDI) for fumonisin B1, B2 
and B3, alone or in combination, of 2 µg/kg body weight/day (Bolger et al., 2001). As 
maize is a dietary staple in sub-Saharan Africa, chronic exposure to high levels of 
these potent mycotoxins is a regular occurrence (Shephard et al., 2006). Recent 
studies conducted in populations at high risk for oesophageal cancer from the 
Centane magisterial district of the Eastern Cape Province, South Africa, reported 
mean probable daily intake (PDI) levels of 4.4-8.7 µg/kg body weight/day (Shephard 
et al., 2007; Van der Westhuizen et al., 2008). The high level of fumonisin exposure 
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in these populations, reliant on subsistence maize as a major dietary staple, stresses 
the importance of reducing exposure and thereby lowering the associated risk for 
disease development. This is of particular importance as international regulations on 
fumonisin in maize will have no effect on exposure levels in these rural populations 
consuming large quantities of home-grown maize daily (Gelderblom et al., 2008; 
Marasas et al., 2008; Wild and Gong, 2010). 
 
Reduction of mycotoxin exposure and related health effects in subsistence farming 
communities can realistically only be based on practical low-cost measures. An 
intervention study in Guinean villages resulted in a 60% aflatoxin reduction in 
groundnuts by introducing practical primary prevention measures based on improved 
storage (Turner et al., 2005). In contrast to aflatoxin, where unsuitable storage 
practices contribute to increased levels, fumonisin contamination is mainly produced 
prior to harvesting (Wild and Gong, 2010). Fandohan et al. (2005) reported that the 
processing procedures for traditionally prepared maize meal dishes from Benin 
reduced fumonisin levels in maize by up to 87% depending on the specific food type. 
Sorting, winnowing, washing and dehulling of maize kernels were very effective in 
achieving these reductions, but the actual cooking process did not achieve a 
reduction. In contrast a 23% fumonisin reduction due to the cooking process in 
traditionally prepared stiff porridge prepared from South African commercial maize 
meal was reported (Shephard et al. 2002).  
 
Although the traditional maize food preparations in the communities of the Centane 
magisterial district includes the sorting of maize on the cob (ear) into visibly healthy 
(good) and visibly fungal infected (mouldy) maize this customary practice does not 
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seem to sufficiently reduce the fumonisin levels (Kimanya et al., 2008a; Shephard et 
al., 2005; Van der Westhuizen et al., 2008). The aim of this study was to assess the 
customary maize food preparation practices and subsequently to optimise the 
reduction of fumonisin contamination in home-grown maize by hand-sorting and 
washing of maize kernels under laboratory-controlled conditions. The ultimate goal 
was to be able to recommend a means of fumonisin reduction, which will be both 
culturally acceptable and practically implementable, in the subsistence farming 
communities. 
 
 
Methods and Materials 
 
Chemicals 
Fumonisin (FB1, FB2 and FB3) standards were isolated at the PROMEC Unit 
according to the method of Cawood et al. (1991). All other chemicals and solvents 
were analytical grade from Merck (Darmstadt, Germany). 
 
Focus groups and maize collection 
Focus groups (n = 17), consisting of 6-10 females each that traditionally prepared 
the maize meals were recruited from the Centane magisterial district, Eastern Cape 
Province, South Africa. The interviews were conducted in the local language 
(isiXhosa) by the trained fieldworker with a questionnaire on the customary sorting 
and washing of maize kernels prior to cooking maize-based meals. It is the norm in 
this area to sort the unshelled maize cobs into “fit for human consumption” (good 
maize) and “visibly infected” (mouldy maize) groups. Good home-grown maize, as 
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separated by the participants, was donated for the laboratory study and a 
commensurate amount of rice was provided. The home-grown maize cobs were 
shelled, the kernels pooled and stored at 4°C prior to laboratory experiments. 
 
Mycological analyses 
Home-grown maize was mycologically analyzed for fungal incidence (% kernels 
infected). Briefly, a random kernel subsample (80-100 g) was surface sterilised for 1 
min in 3.5% commercial sodium hypochlorite solution and rinsed twice in sterile 
water. One hundred kernels (5 kernels/ 90 mm petri-dish) were transferred to malt 
extracted agar (1.5%) containing novobiocin (150 mg/L) prior to incubation at 25°C 
for 5 to 7 days. All the isolated fungi were recorded and their frequencies determined 
using a stereo-microscope. Fusarium species were identified according to Leslie and 
Summerell (2006) and other fungi were identified on the basis of their morphology 
and characteristics in culture, i.e., Aspergillus and Stenocarpella species. 
 
Hand sorting of home-grown maize kernels 
Following shelling of the donated good home-grown maize cobs, the kernels 
(approximately 23 kg) were thoroughly and repeatedly mixed, whereafter six maize 
subsamples (500 g) were randomly selected and stored at 4°C prior to fumonisin 
analyses. Four maize kernel batches (3 kg each) were also randomly selected from 
the pooled home-grown maize. The maize kernels from each batch were separately 
hand-sorted on the laboratory bench. Visibly infected/damaged kernels were 
removed by hand from each kernel batch and separately stored at 4°C for duplicate 
fumonisin analyses. The remaining sorted good kernels from each batch were  
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
Chapter 6.1 - Figure 1 Flow diagram of the wash experiments in Table 3. The size 
of the subsamples is indicated in brackets at each fraction. 
(A) Flow diagram of the temperature experiment conducted 
in duplicate on each of two 3 kg batches. (B) Flow diagram 
of the hour experiment (The day experiment was conducted 
similarly). 
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utilised for the washing experiments. Fumonisins (FB1 + FB2 + FB3) were expressed 
as mg/kg maize. 
 
Washing Experiments 
 
Effect of Temperature 
The effect of water temperature on fumonisin reduction was investigated at 25°C and 
40°C. The use of ambient (25°C) water was selected as it precludes the necessity of 
heating water and the higher temperature was selected as it would not be to warm 
for hand washing. Two of the sorted good kernel batches were subdivided into four 
subsamples (~ 750 g each, Figure 1A). Aliquots (100 g kernels) of each of the 
subsamples were stored at 4°C prior to fumonisin analyses. Two subsamples from 
each batch were washed at each selected temperature using water to maize ratios of 
1:1. The washing procedure consisted of a 5 min hand agitation. The washed maize 
kernels were dried on paper towels on the laboratory bench at room temperature 
overnight (> 18 h) and stored at 4°C prior to fumonisin analyses.  
 
Effect of Wash Duration 
The effect of the duration of the water washes on fumonisin reduction was 
investigated at 5, 10, 30 and 60 min. Four randomly selected subsamples (100 g 
kernels) of the third good kernel sample batch were stored at 4°C for fumonisin 
analyses (S1-S4, Figure 1B). The washing experiment was conducted at ambient 
temperature using the remaining good kernels with maize to water ratio of 1:2. The 
washing procedure entailed a 5 min hand agitation, and for the longer time periods a 
1 min agitation, prior to sequential collecting of duplicate subsamples at each time 
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point. The respective maize subsamples were dried as described above. The final 
sorted good kernel batch was used to investigate the effect of longer washing 
periods (15 and 24 h), with duplicate aliquots being withdrawn for fumonisin analyses 
as described above.  
 
Determination of fumonisins in maize 
The maize kernel samples were milled (Falling AB Stockholm, Sweden) prior to 
single fumonisin analyses, except for the infected/damaged kernel samples (n = 4), 
sorted from each batch, which were analysed in duplicate. In brief, according to the 
method of Sydenham et al. (1996), a milled maize sample (20 g) was homogenised 
in methanol-water and subsequent to centrifugation an aliquot of the supernatant 
was cleaned-up using strong anion exchange cartridges (Bond-Elut, Varian, Harbor 
City, CA, USA). The fumonisins were eluted with acetic acid-methanol, dried under 
nitrogen and stored at 4°C prior to analysis.  
 
Chromatography 
The preformed o-phthaldialdehyde derivatives were separated on a reversed-phase 
Luna 4µ C18 (2) (150 x 4.6 mm I.D.) column (Phenomenex, Torrance, CA, USA) and 
the isocratic mobile phase of methanol/0.1 M sodium dihydrogenphosphate (pH 
3.35) (77:23) was pumped at a flow rate of 1 mL/min. The chromatographic system 
consisted of a Rheodyne 7725i injector (Cotati, CA, USA), Waters Model 515 solvent 
delivery system (Milford, MA, USA), Waters Breeze Chromatography Integration 
Software and Waters Fluorescence 474 detector (excitation - 335 nm and emission - 
440 nm).  
 

	
 
Results 
 
Focus groups 
Information was obtained from the focus groups regarding customary maize 
preparation prior to cooking. All the focus groups reported sorting the maize into 
good and mouldy maize cobs directly after the harvest. Mouldy cobs are discarded, 
with the exception of one group reporting the use of mouldy cobs for samp (dehulled 
stamped maize kernels) preparation. The good maize cobs are shelled either after 
sorting or just prior to food preparation. Thirty-five percent of the focus groups 
reported winnowing and removal of plant debris. Visibly mouldy kernels are removed 
by hand and the remaining “good” kernels are washed to dispose of any debris prior 
to cooking. Thirty percent of the focus groups reported a quick ambient water rinse, 
35% wash the kernels for 3-8 min, 10% washed maize for 3-5 h and 25% used warm 
water. Wash water is discarded in the field (70%) or given to farm animals (30%). 
 
Mycological analyses 
 
The mycological results of 100 representative maize kernels are presented in Table 
1. 17% of the maize kernels were infected with F. verticillioides. Other Fusarium 
species identified were F. graminearum (9%) F. subglutinans (5%) F. anthophilum 
(1%). Low levels of Stenocarpella species were observed. In contrast to previous 
studies conducted in other parts of the African continent, where A. flavus and the 
resultant aflatoxins are major contributors to the mycotoxin contamination load of the 
subsistence maize (Bankole et al., 2004; Kimanya et al., 2008b; Fandohan et al., 


2005; Wild and Gong, 2010), no A. flavus was detected in the maize collected for 
this study. Aflatoxin has only rarely been detected in South African commercial or 
subsistence maize (Shephard, 2003). 
 
Chapter 6.1 - Table 1 Mycological assessment of home-grown maize 
Fusarium species Infected kernels (%) 
F. verticillioides 17 
F. graminearum 9 
F. subglutinans 5 
F. anthophilum 1 
Stenocarpella species 
S. maydis 5 
S. macrospora 1 
 
Hand sorting of home-grown maize kernels 
The mean fumonisin level of the unsorted home-grown maize samples (randomly 
selected) was 2.320 ± 1.155 mg/kg and the sorted good maize of all four batches 
was 0.68 ± 0.42 mg/kg (Table 2). The coefficient of variation (CV) of the unsorted (n 
= 6) and sorted good maize (n =16) samples was 50% and 61%, respectively, 
showing the non-homogeneous distribution of fumonisin contamination in maize. The 
ratios of FB1, FB2 and FB3 to (FB1 + FB2 + FB3) were 71 ± 2%, 21 ± 2%, and 7 ± 1%, 
respectively. An overall mean fumonisin reduction of 71 ± 18% was obtained by 
sorting out the visible/damage kernels. The mean weight of the infected/damaged 
kernels was 0.075 kg per 3 kg batch (2.5 ± 0.5%) with a mean fumonisin level of 
53.7 ± 15.0 mg/kg. 
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Chapter 6.1 - Table 2 Fumonisin levels (mean ± standard deviation) in maize 
kernels before and after sorting with the related reduction 
Maize n 
Fumonisins (Range) 
(mg/kg) 
Unsorted Maize 6 2.32 ± 1.16 (0.82–4.08) 
Sorted Good Maize 16 0.68 ± 0.42 (0.16–1.69) 
Infected/damaged kernels 7a 53.7 ± 15.0 (37.5–76.2) 
  Reduction (%) 
Sorting  71 ± 18 (27–93) 
 Means are not significantly different due to large standard deviations attributable to 
the non-homogenous distribution of fumonisin contamination 
aDuplicate samples from four batches, of which one sample were lost 
 
Washing Experiments 
 
Effect of Temperature 
The sorted good kernel batches used for these experiments had a mean fumonisin 
level of 0.57 mg/kg compared to the means obtained for the 25°C and 40°C washes 
of 0.59 and 0.48 mg/kg, respectively (Table 3). The reduction in fumonisin level 
achieved by sorting for this kernel batch was 75 ± 15%. An additional 4 ± 6% 
reduction was obtained by washing the sorted good maize for 5 min at 40°C. No 
apparent reduction was achieved by washing the sorted good maize for 5 min at 
25°C under these experimental conditions. 
 
Effect of Wash Duration 
The mean fumonisin level of the sorted good maize batch used in the hour 
experiment was 0.95 mg/kg (Table 3). Even under these conditions, where the 
sorting reduction was only 59% and with water to maize ratio of 2:1, the 5 min wash 
obtained only an additional 5 ± 8% reduction. Therefore, no significant differences  
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Chapter 6.1 - Table 3 Fumonisin levels (mean ± standard deviation) in sorted good 
kernels (SGK) and percentage reduction (mean ± standard 
deviation) in the different washing experiments 
 
 
 
n 
Fumonisins 
(mg/kg) 
Reductiona 
(%) 
Temperature Experiment    
SGKb (no wash) 8 0.574 ± 0.338  
5 min (25°C) 4 0.585 ± 0.302 0 ± 13 
5 min (40°C) 4 0.476 ± 0.144 4 ± 6 
Hour Experiment    
SGK (no wash) 4 0.950 ± 0.669  
5 min 2 0.844 ± 0.189 5 ± 8 
10 min 2 0.638 ± 0.290 13 ± 12 
30 min 2 0.664 ± 0.775 12 ± 33 
60 min 1c 0.731 9 
Day Experiment    
SGK (no wash) 4 0.623 ± 0.148  
15 h 4 0.372 ± 0.389 11 ± 17 
24 h 4 0.239 ± 0.170 17 ± 7 
Means are not significantly different due to large standard deviations attributable to 
the non-homogenous distribution of fumonisin contamination 
aReduction based on mean unsorted level in homogeneity test 
bSorted good kernels (SGK) 
cLost one subsample 
 
were seen between the two wash ratios as the fumonisin reductions obtained with 
the 5 min washes at 25°C and 40°C (maize to water ratio 1:1) were 0 ± 13 and 4 ± 
6%. An additional 13 ± 12% reduction was obtained after the 10 min wash, while 
longer wash periods, i.e. 30 and 60 min did not further improve the removal of 
fumonisins. The sorted good kernel batch used for the day experiment had a mean 
fumonisin level of 0.62 mg/kg and the reduction achieved by sorting was 73 ± 6.0%. 
The additional 11 ± 17% reduction obtained with the 15 h wash was similar to the 
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results obtained with the 10 min wash, whereas the additional 24 hour wash 
reduction was only slightly higher at 17 ± 7%. 
 
 
Discussion 
 
This is the first study to optimise the reduction of fumonisin mycotoxins in home-
grown maize based on customary methods of a rural population under laboratory-
controlled conditions. Separating visibly infected from good kernels by sorting, 
followed by washing, are customary practices and practically implementable in the 
subsistence farming communities in the Centane magisterial district, South Africa. 
 
Mycotoxin contamination of grains is characterised by the non-homogeneous 
distribution of the toxins among the grain kernels resulting in large inter-kernel 
variation. Even though great care was taken to thoroughly mix the large pool of 
maize kernels in this study, large variations in the fumonisins were observed in the 
unsorted and the treatment maize batches attributable to the non-homogeneous 
distribution of fumonisin contamination in maize kernels (Gilbert, 2002). In a specific 
study on the overall variance associated with determination of fumonisins in shelled 
maize, 61% of the total variance was associated with sampling, and only 22% with 
the actual analytical method (Whitaker et al., 1998). This observation was confirmed 
in the current study where the CV of the unsorted and sorted good maize samples 
randomly selected from a thoroughly mixed pool was 50% and 61%, respectively. 
Similar high CV values of up to 47% have been recorded in previous studies on 
maize batches (Canela et al., 1996). Nevertheless, the lack of homogeneity, which is 
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a major problem in sampling, represents an opportunity for reduction in 
contamination of the batch by the removal of only the most obviously infected or 
damaged kernels. This has also been recognised in industrial processing. A study of 
the cleaning of maize by screens and gravity separator during silo discharge 
indicated that removal of 7% of the maize by weight reduced the shelled maize 
fumonisin level from 7.90 mg/kg to 3.24 mg/kg, a reduction of 59% (Malone et al., 
1998). Such a reduction method was the basis for prioritising visual sorting and the 
discarding of infected kernels as the first stage in achieving a practical and effective 
reduction strategy in subsistence maize. Fumonisins accumulate preferentially in the 
outer layers or pericarp of the maize kernel (Duncan and Howard, 2010). Steeping of 
maize kernels in water for periods between 6 and 48 hours showed that fumonisins 
can be leached from the pericarp layer (Canela et al., 1996). FB1 levels in the steep 
water exceeded the levels in kernels after a period of 12-24 hours. In the industrial 
process of wet milling, 22% of the initial fumonisins were removed in the steep water 
during a laboratory scale wet milling experiment (Bennett and Richard, 1996).  
 
The removal of infected/damaged kernels in the current study was very effective and 
the mean fumonisin reduction by sorting was 71 ± 18%, while only 2.5% by weight of 
the maize was discarded. Hence a small sacrifice in food quantity substantially 
improved the quality of the maize kernels for food preparation. In terms of washing, 
an additional 13 ± 12% was achieved with the 10 min wash and although a 24-hour 
wash resulted in the greatest reduction (17%), the long wash duration would not be 
practical in the rural setting. No significant difference in fumonisin reduction between 
the maize to water ratio of 1:1 and 1:2 was observed. These results indicate that the 
greatest effect can be achieved by optimum sorting, and the additional effect of 
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washing was considerably smaller. This has the advantage in the rural communities 
that whatever maize dish is prepared, sorting will be appropriate. 
 
The possible impact of a combined reduction (71% by sorting and an additional 13% 
by 10 min washing) in fumonisin levels on the estimated PDI values obtained in a 
previous study was re-estimated. The PDI of 8.7 µg/kg body weight/day was based 
on the assumptions that a 60 kg adult consumed 0.456 kg maize-based food (dry 
weight)/day with a mean fumonisin level of 1.14 mg/kg (Shephard et al., 2007). An 
approximately 84% reduction in fumonisin contamination would potentially lower the 
fumonisin level to 0.183 mg/kg and thus reduce the estimated PDI to 1.4 µg/kg body 
weight/day. Therefore the fumonisin reduction achieved in this study could potentially 
result in PDIs below the JEFCA PMTDI. 
 
Based on these results and on local practices and practicalities the protocol that 
would be recommended to subsistence farmers consists of the removal of the 
infected/damaged kernels from the maize followed by a 10 min ambient temperature 
water wash with sufficient water to cover the maize. It remains necessary to 
emphasise that maize wash water needs to be discarded, rather than used for 
further cooking. The use of mouldy maize on occasion is a cause for concern as it 
could dramatically increase the PDI of fumonisin and the associated health risk in the 
subsistence farming community. This practical culturally acceptable method of 
sorting maize by removal of the infected/damaged kernels and the subsequent 
washing of the good maize kernels effectively reduced fumonisin contamination of 
home-grown maize. The recommendations based on these experiments will be 
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tested in an intervention study conducted in the high oesophageal cancer incidence 
area of Centane magisterial district, South Africa. 
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Abstract 
High oesophageal cancer incidence rates have been associated with home-grown 
maize highly contaminated with fumonisins in the Centane magisterial area, South 
Africa. The aim of this study was to implement a simple intervention method to 
reduce fumonisin exposure in a subsistence farming community. The hand-sorting 
and washing procedures based on the traditional maize-based food preparation 
practices were previously customised under laboratory-controlled conditions. Home-
grown maize and maize-based porridge collected at baseline were analysed for 
fumonisin B1, B2 and B3. The geometric mean (95% confidence interval) of the 
fumonisin contamination in the home-grown maize at baseline was 1.67 (1.21–2.32) 
mg/kg and 1.24 (0.75–2.04) mg/kg (dry weight) in the porridge. Fumonisin exposure 
was based on individual stiff porridge consumption and the specific fumonisin levels 
in the porridge (dry weight) consumed. Porridge (dry weight) consumption at 
baseline was 0.34 kg/day and fumonisin exposure was 6.73 (3.90–11.6) µg/kg body 
weight/day. Female participants (n=22) were trained to recognise and remove visibly 
infected/damaged kernels and to wash the remaining maize kernels. The discarded 
kernels represented 3.9% by weight and the fumonisins varied from 17.1–76.9 
mg/kg. The customised hand-sorting and washing procedures reduced fumonisin 
contamination in the maize and porridge by 84% and 65%, respectively. The 
intervention reduced fumonisin exposure by 62% to 2.55 (1.94–3.35) µg/kg body 
weight/day. This simple intervention method has great potential to improve food 
safety and health in subsistence farming communities consuming fumonisin 
contaminated maize as their staple diet. 
Keywords: fumonisin, exposure, home-grown maize, reduction, intervention, 
subsistence farmers, South Africa 
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Introduction 
 
Maize is a dietary staple in large parts of Africa and often consumed almost to the 
exclusion of all other food commodities (Shephard et al. 2008). This total reliance on 
maize leads to chronic exposure to fumonisins and often to other mycotoxins co-
contaminating maize, e.g. aflatoxin (Fandohan et al. 2005). As subsistence 
communities would not benefit from international or national regulations to control 
fumonisin exposure, alternative measures to reduce fumonisin contamination in 
home-grown maize are required (Gelderblom et al. 2008; Shephard et al. 2008; Wild 
and Gong 2010). 
 
Consumption of fumonisin contaminated maize by subsistence farmers in high 
oesophageal cancer incidence areas has been reported in several countries e.g., 
Italy, China, USA and Brazil (Doko and Visconti 1994; Marasas 2001; Sun et al. 
2007; Sydenham et al. 1991; Van der Westhuizen et al. 2003). Primary liver cancers 
in China and increased occurrence of neural tube defects in Mexico have also been 
associated with high fumonisin exposure (Marasas et al. 2004, Sun et al. 2007). As 
fumonisins are ubiquitously present in maize-based food, the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) has determined a group provisional 
maximum tolerable daily intake (PMTDI) for fumonisin B1, B2 and B3, (FB1, FB2 and 
FB3) alone or in combination, of 2 µg/kg body weight (bw)/day (Shephard et al. 1996; 
Bolger et al. 2001). 
 
Fumonisin contamination of maize is non-homogenous and can be effectively 
reduced by the removal of visibly infected kernels (Afolabi et al. 2006; Fandohan et 
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al. 2005; L van der Westhuizen et al. unpublished data). This is of particular 
importance in rural subsistence communities with low socio-economic status reliant 
on a mono cereal diet for most of the year. These communities are the most 
vulnerable to the toxic and carcinogenic effects of mycotoxins and therefore 
intervention methods should be simple, cost effective and aligned with the local 
customs (Desjardins et al. 2000). A Nigerian study on sorting of maize by 
subsistence farmers into visibly poor and good quality samples reported reduction in 
fumonisin exposure provided that poor quality maize is not consumed (Afolabi et al. 
2006). A reduction of up to 87% in fumonisins was reported in naturally 
contaminated maize processed according to various traditional practices, such as 
sorting, winnowing and washing in Benin, West Africa (Fandohan et al. 2005). 
Another study conducted in Benin recommended that subsistence farmers use 
appropriate shelling and dehulling methods to reduce fumonisin in contaminated 
maize (Fandohan et al. 2006). Improper shelling methods, causing kernel damage, 
and storage under humid conditions resulted in increased levels of fumonisin. As 
fumonisin levels are higher in the pericarp of the maize kernel, different mechanical 
dehulling methods reduced fumonisin contamination by 57–65% (Fandohan et al. 
2006; Sydenham et al. 1995). Selecting specific maize hybrids, fertilizing and sorting 
of maize prior to storage were reported to reduce fumonisin contamination of 
subsistence grown maize in Tanzania (Kimanya et al. 2009). 
 
Although these fumonisin studies achieved reduction in maize by different food 
preparation procedures, agricultural practices, sorting, mechanical shelling and 
dehulling, no intervention was implemented (Afolabi et al. 2006; Fandohan et al. 
2005; 2006; Kimanya et al. 2009). An aflatoxin intervention study, conducted in a 
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subsistence farming community, reported that improved sorting, drying and storage 
conditions substantially reduced the levels in groundnuts and exposure in individuals 
assessed with the aflatoxin-albumin biomarker (Turner et al. 2005). Studies 
conducted in the Centane magisterial district of the Eastern Cape Province, South 
Africa, have reported some of the highest rates for oesophageal cancer, associated 
with high levels of fumonisin-contaminated home-grown maize (Marasas 2001; 
Gelderblom et al. 2008). Recently the customary practices of hand-sorting and 
washing kernels, prior to food preparation, optimised under laboratory-controlled 
conditions achieved a 73% reduction of fumonisins in home-grown maize (L van der 
Westhuizen et al. unpublished data).  
 
The aim of this study was to implement and evaluate the effectiveness of this 
customised simple intervention method – hand-sorting and washing of maize kernels 
– to reduce fumonisin exposure in a subsistence-farming community residing in an 
area of South Africa with high oesophageal cancer incidence. 
 
 
Material and Methods 
 
Chemicals 
Fumonisin (FB1, FB2 and FB3) standards were isolated and purified according to the 
method of Cawood et al. (1991). All other chemicals and solvents were analytical 
grade from Merck (Darmstadt, Germany). 
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Participants 
The study was approved by the Ethics Committee of the Medical Research Council 
of South Africa. Following informed consent apparently healthy females (n = 22) who 
prepared maize-based meals from home-grown maize were recruited from the 
Centane magisterial district of the Eastern Cape Province. 
 
Baseline phase of the field study (maize and food collection) 
Participants were requested to prepare maize-based food (stiff porridge) from maize 
following their customary practices and to consume approximately two x 0.5 kg stiff 
porridge portions per day for two consecutive days. Twenty-four-hour dietary recall 
questionnaires, utilising full-scale photographs of small, medium and large stiff 
porridge portions, were completed in the local vernacular (isiXhosa) to establish 
compliance and determine the actual quantity of maize intake. Individual maize 
intakes (dry weight, g/day) were estimated using the local maize porridge recipes 
and by assigning specific weights to the small, medium and large stiff porridge 
portions as reportedly consumed by the participants (Burger et al. 2010). Stiff 
porridge samples (~ 0.5 kg) were collected on the two consecutive days and stored 
at -20°C prior to fumonisin B1, B2 and B3 analyses. Home-grown maize kernel 
samples (n = 22, ~ 5 kg) used for porridge preparation were collected from each 
participant on the first day of their participation. A subsample (~ 0.5 kg) of each 
maize collection was retained for fumonisin analyses. The remaining kernels were 
pooled, thoroughly mixed, divided into four kg batches (n = 22) and set aside for the 
intervention study. An additional subsample (4 kg) was retained for duplicate 
fumonisin analyses. 
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Intervention phase of the field study (maize and food collection) 
The participants were trained by the field workers, by demonstrating the removal of 
infected kernels with the aid of photographs that visually illustrated infected and 
damaged maize kernels. The photographs (A4 size) depicted the infected kernels 
optimally removed by a plant pathologist under laboratory conditions. Although it is 
not possible to visually recognise fumonisin-contaminated kernels from the systemic, 
symptomless mode of association between Fusarium verticillioides and the maize 
plant, higher fumonisin levels usually occur in symptomatic kernels (Munkvold and 
Desjardins 1997; Rheeder et al. 1992). Furthermore, F. subglutinans symptomology 
on maize is similar to F. verticillioides and to some degree also F. proliferatum, but 
produces little or no fumonisin (Reynoso et al. 2004). Following the training session, 
each participant sorted an individual 4 kg maize kernel batch under the supervision 
of the field workers. The sorting should be incorporated into the food preparation and 
need not take longer than 10 minutes. On completion of the sorting by the 
participants, the infected and damaged maize kernels of each batch were weighed 
separately and retained for fumonisin analyses. 
 
After sorting, the fieldworkers demonstrated the 10 minute maize washing procedure 
(sufficient water to cover kernels), consisting of a five minute hand agitation followed 
by a one minute agitation immediately prior to the 10 minute end point. Each 
participant washed their remaining “good” kernels under the supervision of the field 
workers. Subsamples (0.5 kg) of each sorted and washed sample were dried at 
ambient temperature prior to fumonisin analyses. The remaining kernels of each 
sample were pooled, dried at ambient temperature for two days, thoroughly mixed, 
milled and stored. A subsample (5 kg) was retained for duplicate fumonisin analyses. 
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The fieldworkers prepared the traditional stiff porridge from the milled, sorted and 
washed maize on two consecutive days and the participants consumed at a 
communal ‘food party’ a weighed portion (0.5 kg) each. Another 0.5 kg portion was 
supplied to each participant for a subsequent meal at a later stage on the same day. 
Subsamples of the porridge, prepared from the pooled milled samples, were 
collected on the consecutive days and stored at -20°C prior to analyses. A 24-hour 
dietary recall questionnaire was completed on the two consecutive days following the 
food parties to assess the porridge intake (dry weight).  
 
Fumonisin analyses 
The maize kernel [baseline unsorted (n = 22), sorted and washed good (n = 21*) and 
sorted visibly infected/damaged (n = 21) kernels] were ground and analysed for 
fumonisin according to the method of Shephard et al. (2002) with minor 
modifications. [*One of the participants recruited at the baseline phase of the study 
did not participate in the intervention phase of the study]. The pooled and milled 
maize from the sorted and washed good kernels, which had been retained for the 
intervention study, was also analysed. In brief, a 20 g maize subsample was 
extracted with 100 mL methanol:water (3:1) by shaking for 1 hour, centrifuged and 
filtered. The pH was adjusted and an aliquot (10 mL) of each extract was cleaned-up 
on a strong anion exchange (SAX) solid phase extraction cartridge. The fumonisins 
were eluted with acetic acid-methanol, dried under nitrogen and stored at 4°C prior 
to analysis. The results were expressed as mean mg total fumonisins (FB1 + FB2 + 
FB3)/kg maize. 
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Maize-based food (stiff porridge) 
The fumonisin content of the maize porridge was determined according to the 
method of Shephard et al. (2002) with minor modifications. In brief, the moisture 
content of the maize porridge was first measured by drying a sample (30 g) to 
constant weight in an oven at 60°C for 48 hours. The moisture content was obtained 
from a separate subsample for each porridge sample. Prior to fumonisin extraction of 
the maize porridge (40 g), water was added to obtain a final volume of 30 mL in the 
sample and extracted after the addition of 70 mL methanol. Each porridge/water/ 
methanol mixture was blended for 30 seconds in a liquidiser to a homogeneous 
consistency and was then mechanically shaken for one hour. The remainder of the 
extraction and fumonisin analyses were conducted as described above for the maize 
kernels. The results were expressed as mean mg total fumonisins/kg porridge (dry 
weight). 
 
Chromatography 
Sample residues were redissolved in 200 µL methanol and aliquots derivatised with 
o-phthaldialdehyde. The derivatised-fumonisins were separated on a Phenomenex 
(Torrance, CA) Luna 5 µm C18(2) column (75 x 4.6 mm I.D.) using a mobile phase of 
methanol 0.1 M sodium phosphate buffer (78:22, pH 3.35) pumped at a flow rate of 1 
mL/min. Quantification was by peak area comparison with a similarly derivatised 
standard. The chromatographic system consisted of a Rheodyne 7725i injector 
(Cotati, CA, USA), Waters Model 515 solvent delivery system (Milford, MA, USA), 
Waters Breeze Chromatography Integration Software and Waters Fluorescence 474 
detector (excitation - 335 nm and emission - 440 nm).  
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Fumonisin exposure 
Fumonisin exposures were assessed on an individual basis as the total fumonisin 
level in the stiff porridge (dry weight) consumed by each participant during the 
baseline and intervention phases of the study. Porridge (dry weight) consumption 
was assessed by 24-hour dietary recall questionnaires. 
 
Statistical analysis 
The fumonisin data were tested for normality and equality of variances, with natural 
log transformation of all variables. The fumonisin data before and after intervention 
were compared using a t-test. The STATA version 9 software package 
(StataCorp,Texas, USA) was used for statistical analysis. Means were expressed 
geometrically (95% confidence interval). 
 
 
Results 
 
Participants 
The mean age of the participants was 45 years with a range of 18–70 years and their 
mean body weight was 65 kg (57–73 kg) with a range of 47–127 kg (Results not 
shown). The participant compliance was good as 21/22 completed the baseline 
phase and 20/22 completed the intervention phase of the field study. 
 
Fumonisins in maize 
The individual home-grown maize (n = 22) collected at baseline had a mean 
fumonisin level of 1.67 (1.21–2.32) mg/kg with a range of 0.36–4.90 mg/kg and a 
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coefficient of variation (CV) of 65%, whereas the pooled sample of the home-grown 
maize was 1.32 mg/kg (Table 1). The mean fumonisin level of the individual sorted 
and washed maize kernels (n = 21) was 0.27 (0.20–0.36) mg/kg with a range of 
0.09–0.70 mg/kg and a CV of 56% compared, to 0.26 mg/kg in the pooled, sorted 
and washed maize sample. The participants achieved 84% mean reduction by hand-
sorting and washing the maize kernel batches, whereas the individual variation in 
reduction was 13%. The individual batches (n = 21) of the discarded visibly 
infected/damaged kernels had a mean weight of 0.15 (0.13–0.18) kg representing 
3.9 (3.2–4.6) % of the initial 4 kg maize batches. The infected and damaged maize 
kernels removed by each participant had a mean fumonisin level of 34.6 (27.8–41.3) 
mg/kg and ranged from 17.0–76.9 mg/kg with a CV of 42%.  
 
Fumonisins in maize-based food (stiff porridge) 
The moisture content obtained separately for each porridge sample (n = 22) was 
[68.2 (66.7–69.8)%]. Analytical results were expressed as mg total fumonisin/kg 
porridge (dry weight). The fumonisin level in the stiff porridge (n = 22) collected at 
baseline was 1.24 (0.75–2.04) mg/kg with a range of 0.08–6.58 mg/kg and a CV of 
95%. The porridge prepared by fieldworkers for the intervention phase of the study 
had a mean fumonisin level of 0.43 (0.38–0.50) mg/kg and a CV of 32%. The 
intervention procedure reduced the fumonisin level in traditional stiff porridge by 
65%.  
 
Fumonisin exposure 
The mean actual on plate stiff porridge consumption as recorded from the 24-hour 
dietary recall questionnaires at baseline was 1.06 (0.92–1.12) kg/day and following
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Chapter 6.2 - Table 1 Mean porridge (dry weight) consumption, fumonisin levels in maize and food as well as fumonisin exposure 
in the Centane area of the Transkei region in South Africa 
 
Porridge 
Consumption 
kg (dry weight)/day 
Fumonisins 
in Maize 
mg/kg 
Fumonisins 
in Porridge 
mg/kg (dry weight) 
Fumonisin PDI 
µg/kg b.w./day 
PDI 
> PMTDI 
Baseline 0.34a (0.28–0.40) 
1.67a 
(1.21–2.32) 
1.24a 
(0.75–2.04) 
6.73a 
(3.90–11.62) 18/21
  
Intervention 0.38a (0.31–0.47) 
0.27b 
(0.20–0.36) 
0.43b 
(0.38–0.50) 
2.55b 
(1.94–3.35) 13/20 
Reduction  84% 65% 62%  
Notes: Porridge consumption = dry weight based on 24-h dietary recall assessment. 
Fumonisins  = FB1 + FB2 + FB3 
Fumonisins in porridge = fumonisin levels in stiff porridge (dry weight). 
PDI = probable daily intake of fumonisins. 
Fumonisin PDI = based on fumonisin levels in stiff porridge (dry weight) and stiff porridge consumption (dry weight). 
bw = body weight. 
PMTDI = provisional maximum tolerable daily intake of 2 µg fumonisin/kg body weight/day (JECFA). 
Values = geometrical mean (95% confidence interval). 
Means are significantly (p < 0.05) different when followed by different letters within columns. 
*Good compliance, 21/22 recruited participants completed baseline and 20/22 completed intervention phase of the field study. 
intervention 1.09 (0.87–1.12) kg/day. The mean stiff porridge (dry weight 
consumption at baseline was 0.34 (0.28–0.40) kg/day compared to 0.38 (0.31–0.47) 
kg/day following intervention. Mean probable daily intake (PDI) for fumonisins at 
baseline was 6.73 (3.90–11.6) µg/kg body weight/day compared to 2.55 (1.94–3.35) 
µg/kg body weight/day following intervention. The reduction in fumonisin exposure 
achieved by preparing porridge from sorted and washed maize kernels was 62%. At 
baseline 18/21 participants had PDI’s above the PMTDI determined by JECFA (2 
µg/kg body weight/day) compared to 13/20 following intervention.  
 
 
Discussion 
 
This is the first intervention study to reduce fumonisin exposure based on the 
customary maize-based food preparation practices in a subsistence farming 
community. The simple two-step intervention method (sorting and washing) prior to 
the actual cooking of the maize did not prolong the food preparation time unduly and 
would thus be culturally sustainable. During the intervention, fieldworkers trained the 
participants to identify the infected/damaged maize kernels to ensure proper 
selection for removal and to follow the correct washing procedures. When taking into 
consideration the non-homogeneous nature of the fumonisin contamination, the 13% 
variation in the reduction by each participant show the effective implementation of 
the hand-sorting and washing procedure. The simple and culturally acceptable 
intervention method reduced fumonisin contamination by 84%; surpassing the 73% 
reduction achieved under laboratory-controlled conditions (L van der Westhuizen et 
al. unpublished data). 
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The reduction achieved by visual means is comparable with a mean fumonisin 
reduction of 82% obtained by mechanical means with near-infrared spectroscopy 
where the discarded infected/damaged kernels comprised 5% by weight (Pearson et 
al. 2004). Although the process of sorting and washing of maize is part of the 
customary cooking procedure, the 65% reduction of fumonisins in the porridge 
during intervention is indicative of the improvement that can be achieved. Therefore 
it is imperative that the participants understand the importance of the 
infected/damaged kernel removal and the accurate identification in order to achieve 
maximum benefit. For example, in a Tanzanian study the customary sorting of maize 
by removal of infected/damaged maize by subsistence farmers, as opposed to the 
optimized method introduced in the current study in the context of educational 
training, was not effective in minimizing fumonisin exposure (Kimanya et al. 2008). In 
the present study fumonisin levels were lower in the porridge (1.24 mg/kg) than in 
the home-grown maize (1.67 mg/kg) at baseline as it was not prepared from the 
same pool of maize. In addition the fumonisins levels in the home-grown maize 
collected from each household’s supply ranged from 1.21 to 2.32 mg/kg. However, 
following intervention the mean fumonisin level in the porridge (0.43 mg/kg) was 
higher than in the sorted and washed maize (0.27 mg/kg) from which it was 
prepared. This could be ascribed to lower recoveries in maize than in porridge and to 
the non-homogenous nature of fumonisin kernel contamination (Shephard et al. 
2002; Whitaker et al. 1998). 
 
The mean stiff porridge (wet weight) consumption obtained from the 24-hour dietary 
recall questionnaires at baseline was 1.06 (0.92–1.12) kg/day and during 
intervention was 1.09 (0.87–1.12) kg/day. This confirmed that the participants 
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complied with the requested consumption of the two x 0.5 kg stiff porridge during the 
baseline phase and for the second portion of porridge supplied during the 
intervention phase of the study. The stiff porridge (dry weight) consumption at 
baseline (0.34 kg/day) and during intervention (0.38 kg/day) were comparable to 
maize-based food (dry weight) consumption (0.43 kg/day for females in Centane) 
assessed with weighed food records from a previous study (Shephard et al. 2007). In 
the present study the PDI (6.74 µg/kg body weight/day) at baseline was based on 
individual stiff porridge consumption and the specific fumonisin levels in the porridge 
(dry weight) consumed. PDIs estimated from various assumptions in previous 
investigations in Centane were 8.15 µg/kg body weight/day for females (Shephard et 
al. 2007) and 4.41 and 6.69 µg/kg body weight/day for all participants during the 
1997 and 2000 harvest seasons, respectively (Van der Westhuizen et al. 2008). 
These studies highlighted that the mean exposure to fumonisin in this region 
exceeded the JEFCA PMTDI (Bolger et al. 2001). In the current study 18/21 
participants at baseline were exposed to fumonisin levels above the PMTDI (2 µg/kg 
body weight/day) set by JECFA. The 62% reduction in fumonisin exposure (PDI) 
achieved with the hand-sorting and washing procedure resulted in a slightly 
decreased number of participants exposed to levels above the PMTDI despite the 
fact that the daily exposure was radically reduced. This was due to the high 
consumption of a single food commodity and additional measures to further reduce 
fumonisin exposure should be considered. Preliminary investigation into weaning 
food during the current study showed that it would also have reduced fumonisin 
levels as the only difference is that larger amounts of water are utilized during the 
weaning food preparation.  
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The customised hand-sorting and washing of fumonisin contaminated-maize by the 
subsistence farmers to reduce fumonisin exposure was implemented effectively. The 
possible impact of the intervention on human health is difficult to assess without 
epidemiological studies utilising a reliable biomarker of exposure. However, this 
simple and culturally acceptable method has the potential to improve food safety and 
health in these subsistence farming communities, exposed to unsafe levels of 
fumonisin. 
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Fumonisin B1 as a urinary biomarker of 
exposure in a maize intervention study among 
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Abstract 
Background: The consumption of maize highly contaminated with carcinogenic 
fumonisins has been linked to high oesophageal cancer rates. The aim of this study 
was to validate a urinary fumonisin B1 (UFB1) biomarker as a measure of fumonisin 
exposure and to investigate the reduction in exposure following a simple and 
culturally acceptable intervention. 
Methods: At baseline home-grown maize, maize-based porridge and first void urine 
samples were collected from female participants (n=22), following their traditional 
food practices in Centane, South Africa. During intervention the participants were 
trained to recognise and remove visibly infected kernels, and to wash the remaining 
kernels. Participants consumed the porridge prepared from the sorted and washed 
maize on each day of the two-day intervention. Porridge, maize and urine samples 
were collected for FB1 analyses. 
Results: The geometric mean (95% confidence interval) for FB1 exposure based on 
porridge (dry weight) consumption at baseline and following intervention was 4.84 
(2.87–8.14) and 1.87 (1.40–2.51) µg FB1/kg body weight/day, respectively, (62% 
reduction, p<0.05). UFB1C, UFB1 normalized for creatinine, was reduced from 470 
(295–750) at baseline to 279 (202–386) pg/mg creatinine following intervention (41% 
reduction, p=0.06). The UFB1C biomarker was positively correlated with FB1 intake 
at the individual level (r=0.4972, p<0.01).Urinary excretion of FB1 was estimated to 
be 0.075% (0.054%–0.104%) of the FB1 intake. 
Conclusion: UFB1 reflects individual FB1 exposure and thus represents a valuable 
biomarker for future fumonisin risk assessment.  
Impact: The simple intervention method, hand sorting and washing, could positively 
impact on food safety and health in communities exposed to fumonisins. 


Introduction 
 
Fumonisins are a group of mycotoxins; mainly produced by Fusarium spp. as 
secondary metabolites, of which fumonisin B1, B2 and B3 (FB1, FB2 and FB3) are the 
most prevalent (1). Fumonisins are carcinogenic to rodents, have been associated 
with oesophageal and liver cancer in subsistence maize farming communities around 
the world, as well as occurrence of neural tube defects (2, 3, 4, 5). There are 
numerous fumonisin analogues of which FB1 is the most abundant naturally 
occurring fumonisin on maize and maize-based food world-wide and was classified 
as “possibly carcinogenic to humans” by the International Agency for Research on 
Cancer (6). The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has 
determined a group provisional maximum tolerable daily intake (PMTDI) for FB1, FB2 
and FB3, alone or in combination, of 2 µg/kg body weight/day (7). 
 
In many Sub-Saharan countries, where both maize contamination and maize 
consumption are high, regulatory mechanisms to control mycotoxin levels, including 
fumonisin, are either lacking or are not enforced (8). Therefore reducing exposure 
levels by intervention, specifically those based on simple low-cost measures 
acceptable to these communities, becomes critical to protect the population at 
greatest risk (9). Such an approach gave promising results with respect to aflatoxins 
in groundnuts (10). 
 
Conventional assessment of mycotoxin exposure, probable daily intake (PDI), is 
based on the amount of food consumed and the contamination level of the food (11). 
Accuracy of the PDI can be improved by determining food consumption and the level 
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of the mycotoxin in the food on an individual basis (12). The quality of food 
consumption information in the subsistence community setting depends on the 
validity of the assessment methods and measuring of food on the plate prior to and 
after food consumption, a labour-intensive activity (11). Utilization of validated 
biomarkers of exposure, taking advantage of measuring individual internal dose, 
would not require measurement of consumption or contamination level of the food 
and thus promises to be more accurate than estimations by other assessment 
methods (13). Aflatoxin, deoxynivalenol and ochratoxin A urinary biomarkers, as well 
as the aflatoxin-albumin adduct in blood, have been implemented in human studies 
(14–16). The aflatoxin biomarker applications in human health and intervention 
studies have demonstrated the value of mycotoxin-related biomarkers (13).  
 
Various animal studies have successfully investigated the sphinganine/ sphingosine 
ratio as a biomarker of fumonisin exposure (11, 17). The sphingolipid bases, 
sphinganine and sphingosine, as well as their ratio, have also been investigated in 
several human studies in blood and urine, but could not be correlated with fumonisin 
exposure (11, 12, 18). A recent study has reported a HPLC-MS method for urinary 
FB1 (UFB1) which was sufficiently sensitive to be positively correlated with fumonisin 
exposure in a Mexican population consuming different amounts of maize-based 
tortillas (19). 
 
In a previous study, customary sorting and washing of maize kernels as food 
preparation procedures were optimized under laboratory-controlled conditions to 
achieve optimal fumonisin reduction in contaminated home-grown maize (20). These 
simple and culturally acceptable food preparation practices reduced fumonisin 
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exposure as assessed by food intake profiles and fumonisin food analysis in a 
subsistence farming community residing in a high oesophageal cancer incidence 
area (21). The aim of this study was to validate the UFB1 biomarker and confirm the 
reduction in fumonisin exposure at an individual level. 
 
 
Material and methods 
 
Participants 
The study was approved by the Ethics Committee of the Medical Research Council 
of South Africa. Following informed consent, apparently healthy females (n=22) aged 
between 20 and 70 who prepared maize-based meals from home-grown maize, 
were recruited from the Centane magisterial district, Eastern Cape Province, South 
Africa. 
 
Baseline phase of the field study 
At baseline, participants consumed their customarily prepared maize-based food 
(~0.5 kg porridge) twice daily for two consecutive days (Table 1). Porridge samples 
(~0.5 kg) were collected on both days for FB1 analyses. Morning first void urine 
samples were collected from each participant on the subsequent days for FB1 
biomarker analysis. The first-void urine collections were done approximately 12 
hours after the participants consumed the last porridge meal. Dietary recall 
questionnaires were recorded to determine maize intake (dry weight) in the 24 h 
prior to urine collection (21). Home-grown maize samples (~5 kg) were collected 
from each participant of which subsamples (~0.5 kg) were retained for FB1 analyses. 

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The remaining kernels were pooled, thoroughly mixed, divided into 4 kg batches 
(n=22) and set aside for the intervention study. 
 
Chapter 6.3 - Table 1 Both the baseline and intervention phases of the study 
were conducted over 3 consecutive days for each participant. Morning first void urine 
samples were collected from the participant individually on each day following the 
twice daily consumption of the porridge. The training was conducted following the 
completion of the baseline phase preceding the intervention phase of the study. 
 
 
Intervention phase of the field study 
Participants were trained to recognise infected kernels (most likely to be 
contaminated) and on the washing procedure (10 min) for the remaining maize 
kernels. Following training each participant first removed visibly infected kernels and 
subjected the remaining maize kernels to a washing step. Subsamples of the sorted 
and washed maize of each participant were collected for FB1 analysis and the 
remainder of the maize kernels pooled for porridge preparation. On the first day of 
the intervention phase porridge was prepared and weighed as 0.5 kg portions which 
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were consumed as two separate meals (midday and evening) by the participants. 
First void urine was collected on the following morning and 24-h dietary recall 
questionnaires completed as described above. The procedure was repeated on the 
second day of the intervention. All the maize and porridge samples were stored at 
4°C and -20°C, respectively prior to FB1 analysis at the PROMEC Unit. Urine 
samples were stored at -20°C and sent on dry ice for FB1 analysis at the University 
of Leeds.  
 
Analyses 
The maize and porridge samples were analysed for FB1 following solid phase 
extraction clean-up, derivatization with o-phthaldialdehyde and detected by 
fluorescence HPLC (21, 22). The urine samples were cleaned-up by solid phase 
extraction and analysed for FB1 by HPLC-MS with a limit of detection (LOD) of 
20 pg/mL (19). Urinary creatinine was determined according to the alkaline-picrate 
method (23) with minor modifications to adapt to a 96-well plate format. Inter-
individual variation in urine concentration was normalized by utilisation of urinary 
creatinine. The biomarker data are presented as both pg FB1/mL urine (UFB1) and 
pg FB1/mg creatinine (UFB1C). 
 
Probable daily intake (PDI) assessment 
Porridge (dry weight) consumption was assessed by 24-h dietary recall 
questionnaires utilising full-scale photographs of small, medium and large porridge 
portions. Individual maize intakes (dry weight, g/day) were estimated using the local 
maize porridge recipes and by assigning specific weights to the portions sizes (21). 
Individual fumonisin PDI was assessed as FB1 level in the porridge (dry weight) 

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consumed by each participant during the baseline and intervention phases of the 
study. 
 
FB1 excretion in urine 
The 24-h urine output was estimated by assuming that the first void urine volume 
represented an 8-h collection. The urinary FB1 excretion was calculated as follows: 
 
Excretion (%) = UFB1 (pg/mL) x 8-h urine output (mL/day) x 3 x 100 
PDI (µg/kg body weight/day) x body weight (kg) x 106 
 
 
Statistical analysis 
Individual FB1 PDI and UFB1 were assessed as the mean of two days. UFB1C data 
was not normally distributed and was natural log transformed to facilitate data 
analysis. Mean FB1 levels in urine and maize were expressed geometrically (95% 
confidence interval) unless otherwise stated. Student’s t test was used to compare 
the FB1 exposure at baseline and following intervention. Correlation and regression 
analyses were performed to examine the association between the PDI and UFB1 or 
UFB1C level. Urine samples below the LOD were assigned a value of half the LOD. 
Multiple linear regression modelling was used to investigate the independent 
contribution of FB1 PDI and age to the biomarker levels. STATA9.0 (STATA corp, 
Texas, USA) and Number Cruncher Statistical Systems (NCSS) 2004 Dawson 
Edition (NCSS, Kaysville, Utah) were used for the analysis. 
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Results 
 
Participants 
The mean age of the participants was 42 (range 20–70) years, their mean body 
weight was 65 (47–127) kg and their mean maize consumption (dry weight) at 
baseline was 0.34 (0.28–0.40) kg/day and following intervention it was 0.38 (0.31-
0.47) kg/day as reported in the previous study (20). The mean FB1 level in home-
grown maize at baseline [1.16 (0.84–1.56) mg/kg] was significantly reduced (84%, 
p<0.05) following the sorting and washing of the kernels during intervention [0.19 
(0.14–0.25) mg/kg]. The FB1 represented 72% of the total fumonisins (FB1 + FB2 + 
FB3) in the maize (FB2 and FB3 levels were reported in a previous study) (20). The 
porridge at baseline had a mean FB1 of 0.89 (0.55–1.44) mg/kg compared to 0.32 
(0.27–0.37) mg/kg following intervention (64% reduction, p<0.05) (Table 2). 
 
PDI assessment 
The mean PDI of FB1 at baseline was 4.84 (2.87–8.14) µg/kg body weight/day and 
following intervention the PDI was significantly reduced (62%, p<0.05) to 1.87 (1.40–
2.51) µg/kg body weight/day (Table 2). The mean FB1 exposure at baseline 
exceeded the JECFA recommended PMTDI (2 µg/kg body weight/day), and was 
below this PMTDI following intervention. Before intervention 15/21 (71%) participants 
had PDIs exceeding the recommended PMTDI, while this frequency was reduced to 
10/19 (53%) following intervention (chi square=1.5038, p=0.22). However, FB1 
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Chapter 6.3 - Table 2 The geometric means (95% confidence limits) of FB1 levels 
in porridge and urine, as well as PDI in Centane, a rural area 
from the Eastern Cape Province of South Africa. 
 
FB1 Porridge 
(mg/kg) 
FB1 PDI# 
(µg/kg b.w./day) 
UFB1 
(pg/mL) 
UFB1C† 
(pg/mg 
creatinine) 
Baseline 0.89a (0.55–1.44) 
4.84a 
(2.87–8.14) 
225a 
(144–350) 
470a 
(295–750) 
Intervention 0.32b (0.27–0.37) 
1.87b 
(1.40–2.51) 
109b 
(85–138) 
279a 
(202–386) 
Reduction 64% 62% 52% 41% 
#PDI based on FB1 levels in porridge (dry weight) consumed as assessed with 24-h 
dietary recall questionnaires 
†UFB1 was normalized with urinary creatinine 
 Means are significantly (p < 0.05) different within columns when followed by different 
letters 

Urine 
At baseline 43/44 (98%) and following intervention 40/42 (96%) of the urine samples 
had FB1 above the LOD. Following intervention the mean UFB1 was reduced from 
225 (144–350) pg/mL to 109 (85–138) pg/mL, a 52% reduction (p=0.02) (Table 2). 
Following normalization with urinary creatinine, UFB1C at baseline and following 
intervention was 470 (295–750) pg/mg and 279 (202–386) pg/mg creatinine, 
respectively, (41% reduction, p=0.06). Individual FB1 intake to UFB1C at baseline 
and intervention combined is significantly correlated (r=0.4972, p<0.01). In addition 
the linear regression relationship between FB1 intake and UFB1C, at baseline only 
and at baseline and intervention combined, is shown in Figure 1. There is a 
significant positive correlation between FB1 intake and UFB1C level (regression 

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coefficient 0.4154, p<0.01). However, the multiple regression model is better fitted 
when age, a positive contributor (regression coefficient 0.0227, p<0.01), is 
introduced as the older women were apparently exposed to higher FB1 levels. 

 
 
Chapter 6.3 - Figure 1 The relationship between UFB1C and FB1 intake (natural log 
transformed data) at baseline (left) and at baseline and 
intervention combined (right) is shown. The lines show the 
predicted linear regression for UFB1C and the grey curves 
indicate the 95% confidence limits. 
 
FB1 excretion in urine 
The urine output as well as the urinary excretion was similar at baseline and 
following intervention. The estimated mean 24-h urine output at baseline and during 
intervention combined was 933 (793–1,099) mL/day. The mean percentage FB1 
excreted in urine based on FB1 intake and the estimated mean daily urine output 
was 0.075%/day (0.054%/day to 0.104%/day). 
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Discussion 
 
This is the first published study describing a quantitative correlation between a 
fumonisin biomarker and intake of this mycotoxin measured at the individual level. 
The investigation provides further validation following a previous report showing a 
positive correlation between the FB1 urinary biomarker and different levels of maize-
based tortilla consumption in a Mexican population (19). In addition, the current 
investigation applied an optimized sorting and washing method to maize which 
reduced fumonisin exposure in a subsistence farming community as previously 
assessed by food analysis and food intake data (21). The biomarker was well 
correlated with FB1 exposure at the individual level and confirmed the efficacy of this 
simple and culturally acceptable intervention method. 
 
Surveys previously conducted in subsistence farming communities in Africa have 
shown that mycotoxin contamination, such as fumonisin and aflatoxin, can be 
reduced by hand-sorting and/or washing of maize kernels (24, 25). Featured in this 
paper and our previous publication (21) the first intervention study to reduce 
fumonisin exposure by implementing these practices has been conducted recently in 
a rural subsistence-farming community in South Africa. The customary sorting and 
washing of maize kernels as food preparation procedures were optimized under 
laboratory-controlled conditions. The participants were trained to apply the simple 
two-step method by identifying the infected maize kernels to ensure proper selection 
for removal and to follow the correct washing procedures. The intervention method is 
practical and culturally acceptable as it represents the optimisation of existing local 
practices. The FB1 level in the maize-based porridge, prepared from the maize 
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sorted and washed by the participants following training, was significantly (p<0.05) 
reduced by 64% compared to the porridge prepared by the participants prior to 
training. The intervention study method effectively reduced the PDIs of FB1 by 62% 
(21).  
 
The tortillas the participants consumed in the Mexican study were prepared from 
maize kernels which were boiled in alkaline water followed by prolonged steeping in 
fresh water (19, 26). Subsequently, the cooked kernels were washed and ground to 
yield masa from which the tortillas were prepared. The cooking of kernels in alkaline 
water partially converts the fumonisins to their hydrolysed analogues and therefore 
the tortillas contain both fumonisins and hydrolysed fumonisins. The geometric mean 
UFB1C (134 pg/mg creatinine) in the high tortilla consumption group in the Mexican 
study (19) was more than three-fold lower than at baseline in Centane (470 pg/mg 
creatinine). Based on the UFB1 level in the high tortilla consumption group, FB1 
exposure was estimated to be 0.37 µg/kg body weight/day assuming a 1,500 mL/day 
urine output, a 60 kg body weight and an assumption of a 1% excretion of ingested 
FB1 in urine based on data in swine and non-human primates (27, 28). It is notable 
that in the current study the measured urinary excretion of FB1 was significantly 
lower than 1% (see below) and hence the intakes in Mexico may have been 
underestimated if urinary FB1 excretion in the two populations is similar. Re-
estimating the PDI in the Mexican study based on the estimated mean 24-h urine 
output and the urine excretion rate estimated for this study, the FB1 PDI in Mexico 
(3.04 µg/kg body weight/day) was slightly lower than observed in Centane (4.83 
µg/kg body weight/day). A recent study conducted in China with male and female 
participants reported median UFB1C levels of 390 and 3,910 pg/mg creatinine, 
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respectively, in a high risk hepatocellular carcinoma area (Fusui) and in a high risk 
oesophageal cancer area (Huaian) (18). The median level reported for Fusui was 
similar to Centane (451 pg/mg creatinine), whereas the median level in Huaian was 
more than eight-fold higher. 
 
The mean UFB1 excretion in the Centane population based on individual body 
weight, an estimated urine output, the actual FB1 content of the food consumed and 
the food consumption (dry weight) was 0.075%. The correlation between FB1 intake 
and the urinary biomarker is influenced by the low proportion of FB1 excreted in urine 
and the inter-individual variation of absorption and excretion of FB1 (19, 28, 29). This 
variation was observed in vervet monkeys where toxicokinetic studies revealed 
individual variations in urinary excretion with values of 0.25, 0.66, 1.0 and 1.5% (28, 
29). Experimental studies in rodents and swine reported urinary excretion of 0.4-2% 
(27, 30). A more recent study in swine reported a 0.9% urinary excretion with peak 
urinary excretion between 8 and 24 h following administration of a single oral dose of 
5 mg FB1/kg (31). In a preliminary human study in US participants consumed maize-
based food that approximated maize consumption in urban Guatemala (32). The 
food was prepared from commercial masa and maize flour, containing 0.8 to 2.5 mg 
FB1/kg. The urinary excretion of < 1% FB1 measured in the US study was ten-fold 
higher than the < 0.075% measured in this current study. It remains possible that 
there are ethnic differences or food matrix effects which influence urinary FB1 
excretion in human populations. Future studies to measure FB1 PDI in population 
would certainly be useful to improve our understanding on individual and ethnic 
variation in FB1 excretion through urine. 
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Due to the rapid urinary excretion rate of FB1, first void urine was collected 12 h 
following the last porridge meal consumed by the participants on two consecutive 
days at both baseline and intervention phases of the study. In a rat study following a 
single FB1 gavage dose (25 mg/kg body weight) UFB1 levels peaked at 12 h, 
whereafter levels declined rapidly, but FB1 was still detectable 10 days later (30). 
This study also suggested that UFB1 may reflect long-term exposure with chronic 
FB1 exposure at low levels in rats (1.0 mg/kg body weight/day). Therefore, residual 
FB1 from the previous days’ maize consumption in the current study could have 
contributed to the measured UFB1. Sources of FB1 other than maize could also have 
contributed to the individual exposure. However, as this subsistence community is 
reliant on maize almost to the exclusion of all other food commodities, the 
contribution of other sources is expected to be insignificant. This was verified by 
utilising a validated questionnaire specifically designed for the local customary diet 
practices to obtain individual maize-based food consumption (33). The 52% 
reduction (p<0.05) observed in UFB1 (41% in UFB1C) levels following intervention 
were comparable to the 62% reduction in FB1 exposure as previously assessed by 
food analysis and food intake data (21). Indeed one of the advantages of assessing 
the intervention using a biomarker is that it provides a measure of the effect of the 
intervention on FB1 exposure from all dietary sources whereas, by definition, the 
maize and food analysis indicates only the effect on the target commodity itself.  
 
Conclusion 
The FB1 urinary biomarker is quantitatively correlated with FB1 exposure at the 
individual level. The biomarker permitted confirmation of the reduction in fumonisin 
exposure achieved with the culturally acceptable intervention method of hand sorting 
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and washing maize. Utilisation of this biomarker will improve assessment of 
fumonisin exposure and thus contribute to the assessment of the possible health 
impacts of fumonisin exposure as well as permitting evaluation of intervention 
strategies to reduce fumonisin exposure. Future intervention studies could be 
expanded to include larger numbers of both male and female participants including 
children. Significant advances in food safety and health in subsistence maize farming 
communities exposed to high levels of fumonisin could be possible by further 
development of these approaches.  
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Conclusion 
 

The fumonisin levels in maize intended for human consumption from the State of 
Santa Catarina, Brazil, were similar to the high levels determined in other high 
oesophageal cancer incidence regions of the world where contaminated maize is 
consumed. The mean FB1 level in maize samples from Santa Catarina intended for 
human consumption was 1.89 mg/kg, which is similar to levels reported in South 
Africa (2.10 mg/kg), Iran (2.27 mg/kg) and China (1.32 mg/kg) (Marasas 2001; 
Shephard et al. 2000; Yoshizawa et al., 1994). This is a further indicator for an 
association between the consumption of maize contaminated with fumonisins and 
oesophageal cancer. 
 
The investigation into the disruption of sphingolipid biosynthesis in rats showed that 
FB1-induced hepatocyte nodules were not resistant to the disruption of sphingolipid 
biosynthesis and is therefore not a major growth stimulus in their outgrowth. 
However, normal proliferating hepatocytes are more sensitive to the disruption of 
sphingolipid biosynthesis by FB1 than quiescent hepatocytes. Although the inhibitory 
effect of FB1 on ceramide synthase was reversible in hepatocyte nodules, 
sphingosine was apparently delayed in returning to initial levels. However, the 
delayed recovery effect of the sphingosine levels in the FB1 -induced nodules 
compared to the surrounding tissue, and the sensitization of sphingosine 
accumulation in the nodules upon subsequent FB1 exposure, could provide a 
selective growth stimulus possibly induced by bio-active sphingoid intermediates 
such as sphingosine 1-phosphate. 
 
Previous studies conducted in the former Transkei region of the Eastern Cape 
Province of South Africa have shown that the oesophageal cancer incidence rate in 

Centane is higher than in Bizana and that the home-grown maize consumed as the 
staple diet in Centane was contaminated with higher levels of fumonisins than in 
Bizana (Marasas, 2001; Rheeder et al., 1992; Shephard et al., 2007; Somdyala et 
al., 2003). Based on the mean total fumonisin levels in good home-grown maize, the 
fumonisin exposure in both Centane (2000) and Bizana (2000) exceeded the 
maximum tolerable daily intake for total fumonisins approximately three-fold as 
determined by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) 
(Bolger et al., 2001). Since consumption of higher levels of fumonisin causes an 
increase in sphinganine and the sphinganine/sphingosine ratio in animal studies, it 
was hypothesised that the higher fumonisin exposure would result in higher 
sphinganine levels and sphinganine/sphingosine ratios in plasma and urine of 
participants in Centane than in Bizana. As postulated, the plasma sphinganine and 
sphingosine levels, as well as the sphinganine/sphingosine ratios of both the male 
and female participants, were higher in Centane than in Bizana. However, in contrast 
to previous studies conducted in these areas, the mean total fumonisin level in the 
maize collected contemporaneously with the blood and urine from these regions was 
lower (p>0.05) in Centane than in Bizana. The mean total fumonisin levels for 
Centane were similar to the lower levels reported for previous seasons in Centane, 
whereas the level for Bizana was higher than previously reported for Bizana. Further 
complicating the investigation into the long term effect of fumonisin exposure and the 
consequence on the sphingoid bases and their role as a biomarker in humans is the 
seasonal variation in fumonisin levels. Therefore subsequent studies were aimed at 
a comparison of sphingolipid biomarkers and fumonisin exposure on an individual 
basis. 
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
The follow-up study was the first in Southern Africa assessing individual fumonisin 
exposure and concurrently evaluated sphinganine, sphingosine and sphinganine/ 
sphingosine ratios in plasma and urine of each participant as possible biomarkers of 
fumonisin exposure. Individual fumonisin exposure was assessed by quantifying 
individual maize consumption with weighed food records and fumonisin levels from 
maize in each participant’s household. The mean fumonisin levels of the first two 
seasons of the study were similar between the areas and only in the third season a 
five-fold higher mean fumonisin level was observed in Centane. The high 
consumption of 400 g maize/day (dry weight) in both areas confirms the reliance on 
maize as the dietary staple. The mean probable daily intake PDI in each area was 
approximately double the JECFA provisional maximum tolerable daily intake 
(PMTDI); with 20/59 participants exposed to levels exceeding the PMTDI, showing 
that certain individual participants were exposed to extremely high levels of 
fumonisin. Despite a very wide range of fumonisin exposure and direct comparison 
on an individual basis, sphinganine, sphingosine and sphinganine/sphingosine ratios 
failed to show a relationship with fumonisin exposure. Even comparison of the PDI of 
the participants exposed above and below the PMTDI did not show any difference in 
plasma or urinary sphingoid base profiles. Therefore, the sphingoid bases and ratios 
could not be associated with fumonisin exposure in this study and were negated as 
potential biomarkers of fumonisin exposure in humans.  
 
The reduction of fumonisins in home-grown maize, based on customary methods of 
a subsistence farming community, was optimised under laboratory-controlled 
conditions. Hand-sorting by removal of only the most visibly infected or damaged 
kernels to reduce fumonisin contamination was possible due to the non-
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
homogeneous distribution of fumonisins among the kernels. A mean fumonisin 
reduction of 71% was achieved by selectively discarding only 2.5% of the 
infected/damaged kernels by weight of the original unsorted batch, which had a 
mean total fumonisin level of 2.32 mg/kg. Hence a small sacrifice in food quantity 
substantially improved the quality of the maize kernels for food preparation. The 
additional 13% reduction achieved with a 10 minute ambient water wash was 
deemed optimal, bearing in mind practicality and acceptability in the rural setting. 
Therefore, the optimised protocol consists of the removal of the infected/damaged 
kernels from the maize followed by a 10 minute ambient temperature wash with 
sufficient water to cover the maize. This recommendation was tested in an 
intervention study conducted in a subsistence farming community. 
 
This intervention study was the first to report reduction in fumonisin exposure based 
on the customary maize-based food preparation practices in a subsistence farming 
community. The simple and culturally acceptable intervention method of sorting and 
washing as performed by the participants reduced fumonisin contamination in home-
grown maize by 84%. The mean fumonisin level in the porridge prepared from the 
sorted and washed maize during intervention was reduced by 65% compared to the 
porridge prepared by the participants at baseline. Customised hand-sorting and 
washing of fumonisin contaminated-maize by the subsistence farmers to reduce 
fumonisin exposure was implemented effectively as fumonisin exposure, based on 
fumonisin levels and porridge consumption, was reduced by 62%. The simple two-
step intervention method prior to the actual cooking of the maize did not prolong the 
food preparation time unduly and would thus be culturally sustainable. The 
intervention was implemented successfully, since fumonisin exposure was reduced 

as assessed by food intake profiles and fumonisin food analysis in this subsistence 
farming community. 
 
The urinary FB1 biomarker study was the first to report a quantitative correlation 
between a fumonisin biomarker and individual exposure, thus validating the urinary 
FB1 biomarker and confirming the reduction in fumonisin exposure at an individual 
level. The reduction achieved with the urinary FB1 biomarker was 52% and when 
normalized with creatinine the urinary FB1 it was 41%. Although the mean urinary 
FB1 excretion was 0.08%, the reduced FB1 exposures was significantly correlated 
with both the mean levels of both urinary FB1 and the creatinine normalized urinary 
FB1. 
 
The biomarker was thus well correlated with fumonisin exposure and therefore 
confirmed the efficacy of the simple and culturally acceptable intervention method. 
Utilisation of the urinary FB1 biomarker will improve assessment of fumonisin 
exposure and thus contribute to the assessment of the possible health impacts of 
fumonisin exposure as well as permitting evaluation of intervention strategies to 
reduce fumonisin exposure. Future intervention studies could be expanded to 
include larger numbers of both male and female participants including children. 
Significant advances in food safety and health in subsistence maize farming 
communities exposed to high levels of fumonisin could be possible by further 
development of these approaches. 
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Addendum A 
 
Total fumonisin levels in maize collected from the Centane and Bizana magisterial 
districts, Eastern Cape Province, South Africa can now be updated [Table 2 (p. 28) 
in the Literature Overview (Chapter 2)] following the publication of Van der 
Westhuizen 2008; 2010a; 2010b and 2010c (Tabel 1). 
 
Addendum A - Table 1 Mean total fumonisin (FB1 + FB2 + FB3) levels in maize 
intended for human consumption from Centane and Bizana 
collected over several harvest seasons. 
 
Centane Bizana 
Harvest 
Season n 
Fumonisins 
(mg/kg) n 
Fumonisins 
(mg/kg) 
1985 a 12 2.1 (nd–7.90) 12 0.083 (nd–0.55) 
1989 a 6 1.63 (nd–6.70) 8 0.47 (nd–4.28) 
1997 b 40 0.578 ± 1.28   
2000 b 41 0.882 ± 1.78 41 0.927 ± 1.71 
2001 c 3 1.14 ± 0.575 7 1.02 ± 1.36 
2002 c 9 0.404 ± 0.428 8 0.443 ± 0.61 
2003 d 21 2.18 ± 2.27 36 0.356 ± 1.15 
2007 e 6 2.32 ± 1.16   
2008 f 22 2.12 ± 1.37   
Values are means (range) or means ± standard deviation 
nd = not detected, < 0.05 mg/kg 
a Rheeder et al., 1992 FB1 + FB2 only as the FB3 standards was not available 
b Van der Westhuizen et al., 2008 
c Van der Westhuizen et al., 2010a 
d Rheeder unpublished data 
e Van der Westhuizen et al., 2010b 
f Van der Westhuizen et al., 2010c 
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Addendum A - Figure 1 Mean total fumonisin levels in maize intended for human 
consumption from Centane and Bizana collected over 
several harvest seasons. 
 
References 
Rheeder JP, Marasas WFO, Thiel PG, Sydenham EW, Shephard GS, Van 
Schalkwyk DJ. Fusarium moniliforme and fumonisins in corn in relation to human 
esophageal cancer in Transkei. Phytopathology 1992; 82: 353–357. 
Van der Westhuizen L, Shephard GS, Rheeder JP, Somdyala NIM, Marasas WFO. 
Sphingoid base levels in humans consuming fumonisin contaminated maize from 
rural areas in the former Transkei, South Africa: A cross sectional study. Food Addit. 
Contam. Part A 2008; 25: 1385–1391. 
Van der Westhuizen L, Shephard GS, Rheeder JP, Burger HM. Individual fumonisin 
exposure and sphingoid base levels in rural populations consuming maize in South 
Africa. Food Chem Toxicol 2010a; 4 8: 1698–1703. 


Van der Westhuizen L, Shephard GS, Burger HM et al. Optimising sorting and 
washing of home-grown maize to reduce fumonisin contamination under laboratory-
controlled conditions. Food Control 2010b; In press 10.1016/j.foodcont.2010.09.009. 
Van der Westhuizen L, Shephard GS, Burger HM et al. Implementation of a simple 
intervention method to reduce fumonisin exposure in a subsistence maize farming 
community of South Africa. Food Addit Contam 2010c; 27: 1582–1588. 



Addendum B 
 
Candidate’s Contributions 
 
Chapter 3.1 Fumonisin contamination and Fusarium incidence in corn from Santa 
Catarina, Brazil 
• Primary author 
• Generation of fumonisin data 
• Analysis and interpretation of data 
 
Chapter 4.1 Disruption of sphingolipid biosynthesis in hepatocyte nodules: selective 
proliferative stimulus induced by fumonisin B1 
• Primary author 
• Conceptualisation and planning of study 
• Wrote protocol for ethical approval 
• Managed animal study and collected data 
• Generation of sphingoid base data 
• Analysis and interpretation of data 
 
Chapter 5.1 Sphingoid base levels in humans consuming fumonisin contaminated 
maize from low and high oesophageal cancer incidence areas: a cross 
sectional study 
• Primary author 
• Planning of study 
• Generation of fumonisin and sphingoid base data 
• Analysis and interpretation of data 
 
Chapter 5.2 Individual fumonisin exposure and sphingoid base levels in rural 
populations consuming maize in South Africa 
• Primary author  
• Planning of study 
• Generation of fumonisin and sphingoid base data 


• Analysis and interpretation of data 
 
Chapter 6.1 Optimising sorting and washing of home-grown maize to reduce 
fumonisin contamination under laboratory-controlled conditions 
• Primary author  
• Conceptualisation and planning of study 
• Wrote protocol for ethical approval 
• Fieldwork: collection of data 
• Generation of fumonisin data 
• Analysis and interpretation of data 
 
Chapter 6.2 Implementation of simple intervention methods to reduce fumonisin 
exposure in a subsistence maize farming community of South Africa 
• Primary author  
• Conceptualisation and planning of study  
• Wrote protocol for ethical approval  
• Fieldwork: collection of data 
• Generation of fumonisin data 
• Analysis and interpretation of data 
 
Chapter 6.3 Fumonisin B1 as a urinary biomarker of exposure in a maize 
intervention study among South African subsistence farmers 
• Primary author  
• Conceptualisation and planning of study  
• Wrote protocol for ethical approval  
• Fieldwork: collection of data 
• Generation of fumonisin data 
• Analysis and interpretation of data 


The following lists are additional contributions the candidate has made with regards 
to material covered in this manuscript. 
 
Publication List 
 
1. Burger HM, Lombard MJ, Shephard GS, Rheeder JP, Van der Westhuizen L 
and Gelderblom WCA. (2010) Dietary fumonisin exposure in a rural population 
of South Africa. Food Chem Toxicol 48: 2103–2108. (Impact factor 2.321) 
2. Ghiasian SA, Aghamirian MR, Adibpour M, Shephard GS and Van der 
Westhuizen L. (2009) Occurrence of fumonisins in maize imported into Iran 
during 2001-2002. Mycotoxin Research 25: 25–28. (Not indexed). 
3. Shephard GS, Marasas WFO, Burger HM, Somdyala NIM, Rheeder JP, Van 
der Westhuizen L, Gatyeni PM and Van Schalkwyk DJ. (2007) Exposure 
assessment for fumonisins in the former Transkei region of South Africa. Food 
Addit. Contam. 24: 621–629. 
4. Shephard GS, Van der Westhuizen L and Sewram V. (2007) Biomarkers of 
exposure to fumonisin mycotoxins: A review. Food Addit. Contam. 24: 1196–
1201. 
5. Ghiasian SA, Maghsood AH, Yazdanpanah H, Shephard GS, Van der 
Westhuizen L, Vismer HF, Rheeder JP and Marasas WFO. (2006) Incidence of 
Fusarium verticillioides and levels of fumonisins in corn from main production 
areas in Iran. J. Agric. Food Chem: 54: 6118–6122. 
6. Yazdanpanah H, Shephard GS, Marasas WFO, Van der Westhuizen L, 
Rahimian H, Safari SN, Eskandari P and Ghiasian SA. (2006) Human dietary 
exposure to fumonisin B1 from Iranian maize harvested during 1998–2000. 
Mycopathologia 161: 395–401. 


7. Shephard GS, Van der Westhuizen L, Gatyeni PM, Somdyala NIM, Burger HM 
and Marasas WFO. (2005) Fumonisin mycotoxins in traditional Xhosa beer in 
South Africa. J. Agric. Food Chem. 53: 9634–9637. 
8. Ghiasian SA, Rezayat SM, Kord-Bacheh P, Maghsood H, Yazdanpanah H, 
Shephard GS, Van der Westhuizen L, Vismer HF and Marasas WFO (2005) 
Fumonisin production by Fusarium species isolated from freshly harvested corn 
in Iran. Mycopathologia 159: 31–40. 
 
Presentations at Conferences 
 
International 
 
1. Van der Westhuizen L, Shephard GS, Burger HM, Rheeder JP, Gelderblom 
WCA, Wild CP and Gong YY. Reduction in Fumonisin Exposure by Practical 
Intervention Methods in a Rural Area of South Africa, 15th World Congress of 
Food Science & Technology, Cape Town International Convention Centre, 
Cape Town, South Africa, 22-26 August 2010, Oral 
2. Van der Westhuizen L, Gong YY, Shephard GS, Burger HM, Rheeder JP, 
Gelderblom WCA and Wild CP. Reducing Fumonisin Exposure by Simple 
Intervention Methods in a Rural Area of South Africa. 2010 VI Latinamerican 
Congress of Mycotoxins, Merida, Yucatan, Mexico, 27 June - 01 July 2010, 
Poster 
3. Gong YY, Van der Westhuizen L, Wild CP, Burger HM, Rheeder JP, 
Gelderblom WCA and Shephard GS. Urinary Biomarker for Fumonisin 
Exposure in a South African Rural Intervention Study 2010 VI Latinamerican 
Congress of Mycotoxins, Merida, Yucatan, Mexico, 27 June - 01 July 2010, 
Oral 


4. Burger HM, Lombard T, Shephard GS, van der Westhuizen L, Gelderblom 
WCA. Measuring fumonisin exposure among rural South African population 
using a validated dietary assessment tool. 19th International Congress of 
Nutrition, BITEC, Bangkok, Thailand, 4-9 October 2009. (Poster) 
5. Gong YY, Van der Westhuizen L, Wild CP, Rheeder JP, Burger HM 
Gelderblom WCA and Shephard GS. Urinary fumonisin B1 as an exposure 
biomarker in a rural South African community intervention study. ISM 
Conference 2009, Tulln, Austria, 9-11 September 2009. (Poster) 
6. Van der Westhuizen L, Gong YY, Shephard GS, Burger HM Rheeder JP, 
Gelderblom WCA and Wild CP. Practical Intervention Methods to Reduce 
Fumonisin Exposure Implemented in a Rural Community of South Africa. ISM 
Conference 2009, Tulln, Austria, 9-11 September 2009. (Oral) 
7. Gong YY, Van der Westhuizen L, Shephard GS, Burger HM Rheeder JP, 
Gelderblom WCA and Wild CP. Urinary fumonisin B1 as a biomarker of 
fumonisin exposure and its application in intervention studies. 10th International 
Conference on Environmental Mutagens (ICEM), Firenze, Italy, August 20-25, 
2009. (Poster) 
8. Gong YY, Van der Westhuizen L, Shephard GS, Burger HM Rheeder JP, 
Gelderblom WCA and Wild CP. Urinary fumonisin B1 as a biomarker of 
fumonisin exposure and its application in intervention studies. 32nd Annual 
Meeting of the United Kingdom Environmental Mutagen Society (UKEMS), 
Leeds, UK, 12-15 July 2009. (Oral) 
9. Burger HM, Lombard MJ, Shephard GS, van der Westhuizen L and Gelderblom 
WCA. Measuring fumonisin exposure among a rural South African population 
using a validated dietary assessment tool. Gordon Research Conference: 
Mycotoxins and Phycotoxins, New London, NH, USA, 21-26 June 2009. 
(Poster) 


10. Rheeder JP, Van der Westhuizen L, Shephard GS, Volkwyn YE, Gouse M and 
Pray CE. Reduction of fumonisin levels in maize in rural KwaZulu-Natal, South 
Africa: transgenic versus conventional maize hybrids. 3rd Pan African Medical 
Mycology Society (PAMMS) Conference, Abuja, Nigeria, 25-27 February 2009. 
11. Van der Westhuizen L, Gong YY, Shephard GS, Rheeder JP, Burger HM 
Gelderblom WCA and Wild CP. Reducing Fumonisin Contamination of Maize 
Staple Foods by Simple Intervention Procedures in a Rural Area of South 
Africa. World Mycotoxin Forum –The fifth Conference, Noordwijk, the 
Netherlands, 17-18 November 2008. (Poster) 
12. Volkwyn Y, Van der Westhuizen L, Shephard GS, Rheeder JP, Gouse M and 
Pray CE. Fumonisin levels in transgenic and conventional maize from rural 
areas in Kwazulu-Natal, South Africa. World Mycotoxin Forum –The fifth 
Conference, Noordwijk, the Netherlands, 17-18 November 2008. (Poster) 
13. Burger HM, Lombard MJ, Shephard GS, Van der Westhuizen L and 
Gelderblom WCA. The use of a validated dietary assessment tool in a human 
mycotoxin exposure study: a case for mycotoxin exposure in the former 
Transkei region, South Africa. PAEMS 2008, Cape Town International 
Convention Centre, 3-5 November (Poster). 
14. Van der Westhuizen L, Gong YY, Shephard GS, Rheeder JP, Burger HM 
Gelderblom WCA and Wild CP. Reducing Fumonisin Contamination of Maize 
Staple Foods by Simple Intervention Procedures in a Rural Area of South 
Africa. PAEMS 2008, Cape Town International Convention Centre, 3-5 
November 2008 (Poster).  
15. Volkwyn Y, Van der Westhuizen L, Shephard GS, Rheeder JP, Gouse M and 
Pray CE. Fumonisin levels in transgenic and conventional maize from rural 
areas in Kwazulu-Natal, South Africa. PAEMS 2008, Cape Town International 
Convention Centre, 3-5 November 2008 (Poster). 


16. Van der Westhuizen L, Gong YY, Shephard GS, Rheeder JP, Burger HM 
Gelderblom WCA and Wild CP. Reducing Toxic Contamination of Staple Foods 
in Developing Countries by Simple Intervention Programmes. Presentation at 
the Molecular Epidemiology Unit, Leeds Institute of Genetics, Health and 
Therapeutics, Faculty of Medicine and Health, University of Leeds, UK, 13 
October 2008 
17. Van der Westhuizen L, Shephard GS, Rheeder JP and Marasas WFO. 
Sphingoid base levels in humans consuming fumonisin contaminated maize 
from high and low oesophageal cancer incidence areas. XII International 
IUPAC Symposium on Mycotoxins and Phycotoxins, Istanbul, Turkey, 21-25 
May 2007. (Poster) 
18. Shephard GS, Gatyeni PM, Van der Westhuizen L, Somdyala NIM, Burger HM 
and Marasas WFO. Fumonisins in traditional Xhosa maize beer in South Africa. 
XII International IUPAC Symposium on Mycotoxins and Phycotoxins, Istanbul, 
Turkey, 21-25 May 2007. (Poster) 
19. Ghiasian SA, Maghsood AH, Yazdanpanah H, Shephard GS, Van der 
Westhuizen L and Marasas WFO. Occurrence of fumonisins in maize imported 
into Iran during 2001-2002. XII International IUPAC Symposium on Mycotoxins 
and Phycotoxins, Istanbul, Turkey, 21-25 May 2007. (Poster) 
20. Shephard GS, Van der Westhuizen L and Sewram V. Biomarkers of exposure 
to fumonisin mycotoxins. 10th UJNR International Symposium on Toxic 
Microorganisms (United States-Japan Cooperative Program on Development & 
Utilization of Natural Resources Joint Panel on Toxic Microorganisms), College 
Park, Maryland, USA, 7-9 November 2006 (Oral). 
21. Van der Westhuizen L, Shephard GS, Rheeder JP and Marasas WFO. 
Sphingoid base levels in humans consuming contaminated maize from high 
oesophageal cancer incidence areas. The 4th World Mycotoxin Forum, 
Cincinnati, Ohio, USA, 6-8 November 2006. (Poster) 


22. Gatyeni PM, Shephard GS, Van der Westhuizen L, Somdyala NIM, Burger HM 
and Marasas WFO. Fumonisins in traditional maize beer in South Africa. The 
4th World Mycotoxin Forum, Cincinnati, Ohio, USA, 6-8 November 2006. 
(Poster) 
23. Shephard GS, Van der Westhuizen L and Sewram V. Biomarkers of exposure 
to fumonisin mycotoxins. Myco-Globe International Conference: Advances in 
Genomics, Biodiversity and Rapid Systems for Detection of Toxigenic Fungi 
and Mycotoxins, Bari, Italy, 26-29 September 2006. (Keynote Lecture) 
24. Gelderblom WCA, Riedel S, Burger HM, Abel S, van der Westhuizen L, 
Marnewick JL and Marasas WFO Carcinogenesis by the fumonisins: 
mechanisms, risk analyses and implications. 232nd American Chemical Society 
Meeting, San Francisco, 11 - 14 September 2006. (Invited Oral Presentation) 
25. Ghiasian SA, Maghsood AH, Yazdanpanah H, Shephard GS, Van der 
Westhuizen L, Vismer HF, Rheeder JP and Marasas WFO. Incidence of 
Fusarium verticillioides and levels of mycotoxin fumonisins in corn from high- 
and low-risk areas for human oesophageal cancer in Iran. 16th Congress of the 
International Society for Human and Animal Mycology, Paris, France, 25 - 29 
June 2006. (Poster) 
26. Vismer H, Rheeder JP, Van der Westhuizen L, Imrie G, Gatyeni PM, Thomas 
D, Shephard GS, Marasas WFO and Flett B. Effect of Bt corn hybrids on insect 
damage, incidence of fumonisin-producing Fusarium species and fumonisin 
levels in South Africa. 2005 Annual Meeting of the American Phytopathological 
Society, Austin, Texas, USA, 30 July - 3 August 2005 (Oral Presentation).  
27. Van der Westhuizen L, Shephard GS, Scussel VM, Costa LLF, Rheeder JP, 
Vismer HF and Marasas WFO. Fumonisin contamination and Fusarium 
incidence in corn from Santa Catarina, Brazil. XI International IUPAC 
Symposium on Mycotoxins and Phycotoxins, Natcher Conference Center, NIH, 
Bethesda, Maryland, USA, 17-21 May 2004 (Poster). 

	
28. Van der Westhuizen L, Shephard GS, Somdyala NIM, Burger HM and Marasas 
WFO. Sphingoid Base Levels in Blood of Humans Consuming Fumonisin 
Contaminated Corn in Transkei, South Africa. 2003 Gordon Research 
Conference on Mycotoxins and Phycotoxins, Waterville, Maine, USA, 15-20 
June 2003 (Poster). 
29. Van der Westhuizen L, Shephard GS, Scussel VM, Costa LLF and Marasas 
WFO. Fumonisin occurrence in maize from Santa Catarina, Brazil. Analitika 
2002, International Symposium on Analytical Science, University of 
Stellenbosch, Stellenbosch, 4-10 December 2002 (Poster). 
30. Van der Westhuizen L, Shephard GS, Rheeder JP and Marasas WFO. 
Fumonisin levels in maize and sphinganine/sphingosine ratio in plasma in 
humans in the Transkei region of South Africa. International Union of 
Biochemistry and Molecular Biology & South African Society of Biochemistry 
and Molecular Biology (IUBMB/SASBMB) Special Meeting on the Biochemical 
and Molecular Basis of Disease, Rondebosch, Cape Town, 19-23 November 
2001 (Poster). 
31. Van der Westhuizen L, Shephard GS, Abel S and Gelderblom WCA. The role 
of sphingolipid bases in the induction of hepatocyte nodules by fumonisin B1. 
International Union of Biochemistry and Molecular Biology & South African 
Society of Biochemistry and Molecular Biology (IUBMB/SASBMB) Special 
Meeting on the Biochemical and Molecular Basis of Disease, Rondebosch, 
Cape Town, 19-23 November 2001 (Poster). 
32. Van der Westhuizen L, Leggott NL, Marasas WFO, Swanevelder S and 
Shephard GS. Sphinganine/sphingosine ratio in plasma and urine as a possible 
biomarker for fumonisin exposure in humans in rural areas of Africa. 10th 
International IUPAC Symposium on Mycotoxins and Phycotoxins, Guaruja, 
Brazil, May 2000 (Poster). 
 

National 
 
1. Van der Westhuizen L, Shephard GS, Burger HM, Rheeder JP, Gelderblom 
WCA, Wild CP and Gong YY. Urinary fumonisin B1 as a biomarker in a rural 
intervention study. 192nd Biology Group (EBG) Forum, University of 
Stellenbosch, 10 June 2010, Oral 
2. Van der Westhuizen L, Shephard GS, Burger HM, Rheeder JP, Gelderblom 
WCA, Wild CP and Gong YY. Fumonisin B1 as a biomarker of exposure in a 
rural intervention study. Analitika 2010, Stellenbosch University, Stellenbosch, 
South Africa, 5-9 Desember 2010, Poster 
3. Burger HM, Lombard MJ, Shephard GS, Van der Westhuizen L and 
Gelderblom WCA. The importance of using validated dietary assessment tools 
in human exposure studies: a case for mycotoxin exposure in the former 
Transkei region, South Africa. MRC Research Day, MRC Conference Centre, 
Cape Town, 16-17 October 2008.  
4. Gelderblom WCA, Riedel S, HM Burger, HM Abel, S Van der Westhuizen L, 
Marnewick JL and Marasas WFO. Implications, mechanisms and risk analyses 
of the fumonisins: a natural fungal contaminant in maize. 19th SAAFOST 
Biennial Congress and Exhibition, Durban, 2 -5 September 2007. (Invited 
speaker) 
5. Van der Westhuizen L, Shephard GS, Rheeder JP and Marasas WFO. 
Sphingoid base levels in humans consuming contaminated maize from high 
oesophageal cancer incidence areas. Analitika 2006, Pilansberg, South Africa, 
10-13 September 2006. (Poster) 
6. Gatyeni PM, Shephard GS, Van der Westhuizen L, Somdyala NIM, Burger HM 
and Marasas WFO. Fumonisins in traditional maize beer in South Africa 
Analitika 2006, Pilansberg, South Africa, 10-13 September 2006. (Poster) 


7. Shephard GS, Van der Westhuizen L and Sewram V Biomarkers of exposure to 
fumonisin mycotoxins. Joint UWC, UCT, US and MRC 8th Annual Medical 
Research Day (AstraZeneca), 20 October 2006, MRC Conference centre, 
Tygerberg. (Keynote Lecture). 
8. Vismer HF, Van der Westhuizen L, Rheeder JP, Imrie G, Gatyeni PM, Thomas 
D, Shephard GS, Marasas WFO and Flett BC. Potential reduction of fumonisins 
in Bt versus non-Bt maize hybrids in naturally high Fusarium incidence areas in 
South Africa. Joint UWC, UCT, US and MRC 7th Annual Medical Research Day 
(AstraZeneca), 25 October 2005, University of the Western Cape, Bellville. 
(Keynote Lecture). 
9. Vismer HF, Van der Westhuizen L, Rheeder JP, Imrie G, Gatyeni P, Thomas D, 
Shephard GS, Marasas WFO and Flett BC Effect of Bt maize hybrids on the 
incidence of fumonisin-producing Fusarium species, insect damage and the 
levels of mycotoxins in naturally high Fusarium incidence areas in SA. 43rd 
Congress of the Southern African Society for Plant Pathology (SASPP), 
Hartenbos, 23-26 January 2005 (Oral Presentation). 
10. Van der Westhuizen L, Shephard GS, Gelderblom WCA and Swanevelder S. 
Disruption of Sphingolipid Biosynthesis in Hepatocyte Nodules: Selective 
Proliferative Stimulus Induced by Fumonisin B1. XIXth SASBMB Conference, 
University of Stellenbosch, Stellenbosch, South Africa, 16 - 20 January 2005 
(Poster). 
11. Van der Westhuizen L, Shephard GS, Somdyala NIM, Gatyeni PM, Burger HM 
and Marasas WFO. Sphingoid base levels in blood and urine of humans 
consuming fumonisin contaminated maize in the former Transkei, South Africa. 
Chromatography Mass Spectrometry 2004, Buffelspoort, North West Province, 
South Africa, 17-20 October 2004 (Oral Presentation). 
12. Gatyeni PM, Van der Westhuizen L, Shephard GS, Rheeder JP and Marasas 
WFO. Fumonisin contamination of home-grown maize in two magisterial areas 
of the former Transkei, South Africa. Chromatography Mass Spectrometry 

2004, Buffelspoort, North West Province, South Africa, 17-20 October 2004 
(Poster). 
13. Burger HM, Lombard MJ, Van der Westhuizen L, Shephard GS, Gelderblom 
WCA and Marasas WFO. Eating habits and other risk factors associated with 
the development of oesophageal cancer. Nutrition Congress 2004, Worcester, 
Western Cape Province, 23 - 27 August 2004 (Oral Presentation). 
14. Shephard GS, Marasas WFO, Somdyala NIM, Van der Westhuizen L and 
Burger HM. Assessment of fumonisin exposure in populations at risk for 
oesophageal cancer on a maize staple diet in the Transkei region of the 
Eastern Cape Province, CANSA, Mykonos 4, Langebaan, 6-9 April 2003 (Oral 
Presentation by Van der Westhuizen, L.). 
15. Webber AL, Vismer HF, Van der Westhuizen L, Rheeder JP and Marasas 
WFO. Screening Fusarium verticillioides strains from the Transkei region in 
South Africa for high producers of fumonisins. 40th Congress of the Southern 
African Society for Plant Pathology, Dikhololo, 20 - 23 January 2002. (Poster). 
